<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - Advance Access</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of articles</description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep060v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep059v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep061v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep055v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep039v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep056v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep057v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep050v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep053v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep049v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep052v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep048v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep047v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep042v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep045v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep043v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep036v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep038v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep016v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep044v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep040v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep041v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep035v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep037v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep028v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep033v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep030v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep034v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep032v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep031v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep029v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep024v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep022v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep027v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep025v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep023v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep018v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep026v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep021v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep020v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep019v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep014v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep015v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep010v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen090v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep006v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep011v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep005v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep004v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep007v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep009v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep012v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep013v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen089v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep003v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep002v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nep001v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen091v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen074v3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen088v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen086v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen087v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen085v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen084v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen081v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen083v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen082v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen080v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen079v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen066v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen078v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen077v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen075v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen070v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen068v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen072v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen069v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen034v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen071v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen067v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen062v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen063v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen065v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen064v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen061v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen060v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen058v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen056v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen059v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen057v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen052v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen055v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen051v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen053v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen050v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen047v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen037v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem182v3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen045v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen049v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen044v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem179v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen048v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen040v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen036v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen042v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen043v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen041v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen039v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen038v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen032v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen033v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen031v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen029v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen027v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen026v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen030v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen028v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen025v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen024v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen021v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen020v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen019v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen023v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen022v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen011v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen018v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen017v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen007v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen010v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen009v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen001v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem155v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen006v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen003v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem177v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen004v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem188v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem187v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem186v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem185v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem183v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem184v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem181v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem180v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem176v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem178v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem140v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem172v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem170v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem159v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem171v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem167v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem162v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem150v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem129v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem124v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem168v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem165v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem153v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem169v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem118v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem120v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem166v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem161v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem146v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem143v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem136v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem163v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem160v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem151v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem126v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem156v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem144v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem142v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem141v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem127v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem125v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem102v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem158v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem152v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem148v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem147v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem137v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem138v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem103v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem128v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem119v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem101v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem076v1?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep060v1?rss=1">
<title><![CDATA[Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H+, K+-ATPase/H. pylori Inhibition and Anti-oxidative Mechanism]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep060v1?rss=1</link>
<description><![CDATA[
<p><I>Zinger officinale</I> has been used as a traditional source against gastric disturbances from time immemorial. The ulcer-preventive properties of aqueous extract of ginger rhizome (GRAE) belonging to the family Zingiberceae is reported in the present study. GRAE at 200 mg kg<sup>&ndash;1</sup> b.w. protected up to 86% and 77% for the swim stress-/ethanol stress-induced ulcers with an ulcer index (UI) of 50 &plusmn; 4.0/46 &plusmn; 4.0 respectively, similar to that of lansoprazole (80%) at 30 mg kg<sup>&ndash;1</sup> b.w. Increased H<sup>+</sup>, K<sup>+</sup>-ATPase activity and thiobarbituric acid reactive substances (TBARS) were observed in ulcer-induced rats, while GRAE fed rats showed normalized levels and GRAE also normalized depleted/amplified anti-oxidant enzymes in swim stress and ethanol stress-induced animals. Gastric mucin damage was recovered up to 77% and 74% in swim stress and ethanol stress, respectively after GRAE treatment. GRAE also inhibited the growth of <I>H. pylori</I> with MIC of 300 &plusmn; 38 &micro;g and also possessed reducing power, free radical scavenging ability with an IC<SUB>50</SUB> of 6.8 &plusmn; 0.4 &micro;g ml<sup>&ndash;1</sup> gallic acid equivalent (GAE). DNA protection up to 90% at 0.4 &micro;g was also observed. Toxicity studies indicated no lethal effects in rats fed up to 5 g kg<sup>&ndash;1</sup> b.w. Compositional analysis favored by determination of the efficacy of individual phenolic acids towards their potential ulcer-preventive ability revealed that between cinnamic (50%) and gallic (46%) phenolic acids, cinnamic acid appear to contribute to better H<sup>+</sup>, K<sup>+</sup>-ATPase and <I>Helicobacter pylori</I> inhibitory activity, while gallic acid contributes significantly to anti-oxidant activity.</p>
]]></description>
<dc:creator><![CDATA[Nanjundaiah, S. M., Annaiah, H. N. M., M.Dharmesh, S.]]></dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep060</dc:identifier>
<dc:title><![CDATA[Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H+, K+-ATPase/H. pylori Inhibition and Anti-oxidative Mechanism]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep059v1?rss=1">
<title><![CDATA[Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, may Prevent 1,2-dimethylhydrazine-induced Rat Colon Carcinogenesis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep059v1?rss=1</link>
<description><![CDATA[
<p>The study tried to assess the chemoprotective effect of abnormal Savda Munziq (ASMq) on 1,2-dimethylhydrazine (DMH)-induced rat colon carcinogenesis. Male F344 rats were randomized into eight groups: Group 1 was served as control, no DMH injection was given and treated daily with normal saline. Rats in Groups 2&ndash;8 were given a single intraperitoneal injection of DMH (20 mg/kg body weight) at the beginning of the study. Group 2 was served as negative control, administered with normal saline until the end of the experiment after the single DMH injection. Groups 3&ndash;5 were served as pretreatment group, administered with ASMq ethanol extract at 400, 800 and 1600 mg/kg body weight, respectively, until the 45th day, continued by normal saline administration for another 45 days. Groups 6&ndash;8 were served as the treatment group, administered with normal saline for the first 45 days from the day of DMH injection, ASMq ethanol extract at three different doses to be administered until the end of the second 45th day. All rats were sacrificed at 91st day and the colons were analyzed for aberrant crypt foci (ACF) formation and crypt multiplicity. Results showed that ASMq ethanol extract reduced the number of ACF, AC and crypt multiplicity significantly (<I>P</I> &lt; 0.05). It suggested that ASMq ethanol extract had chemoprotective effects on DMH-induced colon carcinogenesis, by suppressing the development of preneoplastic lesions, and probably exerted protection against the initiation and promotion steps of colon carcinogenesis.</p>
]]></description>
<dc:creator><![CDATA[Yusup, A., Upur, H., Umar, A., Berke, B., Yimit, D., Lapham, J. C., Moore, N., Cassand, P.]]></dc:creator>
<dc:date>2009-06-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep059</dc:identifier>
<dc:title><![CDATA[Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, may Prevent 1,2-dimethylhydrazine-induced Rat Colon Carcinogenesis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-26</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep061v1?rss=1">
<title><![CDATA[Podophyllum hexandrum-Mediated Survival Protection and Restoration of Other Cellular Injuries in Lethally Irradiated Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep061v1?rss=1</link>
<description><![CDATA[
<p>This study aims at the development of a safe and effective formulation to counter the effects of lethal irradiation. The sub-fraction (G-001M), prepared from <I>Podophyllum hexandrum</I> has rendered high degree of survival (&gt;90%) at a dose of 6 mg kg<sup>&ndash;1</sup> body weight (intramuscular) in lethally irradiated mice. Therapeutic dose of G-001M, at about 20 times lower concentration than its LD<SUB>100</SUB>, has revealed a DRF of 1.62. Comet assay studies in peripheral blood leukocytes have reflected that, treatment of G-001M before irradiation has significantly reduced DNA tail length (<I>P</I> &lt; 0.001) and DNA damage score (<I>P</I> &lt; 0.001), as compared to radiation-only group. Spleen cell counts in irradiated animals had declined drastically at the very first day of exposure, and the fall continued till the 5th day (<I>P</I> &lt; 0.001). In the treated irradiated groups, there was a steep reduction in the counts initially, but this phase did not prolong. More than 60% decline in thymocytes of irradiated group animals was registered at 5 h of irradiation when compared with controls, and the fall progressed further downwards with the similar pace till 5th day of exposure (<I>P</I> &lt; 0.001). At later intervals, thymus was found fully regressed. In G-001M pre-treated irradiated groups also, thymocytes decreased till the 5th day but thereafter rejuvenated and within 30 days of treatment the values were close to normal. Current studies have explicitly indicated that, G-001M in very small doses has not only rendered high survivability in lethally irradiated mice, but also protected their cellular DNA, besides supporting fast replenishment of the immune system.</p>
]]></description>
<dc:creator><![CDATA[Sankhwar, S., Gupta, M. L., Gupta, V., Verma, S., Suri, K. A., Devi, M., Sharma, P., Khan, E. A., Alam, M. S.]]></dc:creator>
<dc:date>2009-06-24</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep061</dc:identifier>
<dc:title><![CDATA[Podophyllum hexandrum-Mediated Survival Protection and Restoration of Other Cellular Injuries in Lethally Irradiated Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep055v1?rss=1">
<title><![CDATA[Feldenkrais Method Balance Classes Improve Balance in Older Adults: A Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep055v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to investigate the effects of Feldenkrais Method balance classes on balance and mobility in older adults. This was a prospective non-randomized controlled study with pre/post measures. The setting for this study was the general community. A convenience sample of 26 community-dwelling older adults (median age 75 years) attending Feldenkrais Method balance classes formed the Intervention group. Thirty-seven volunteers were recruited for the Control group (median age 76.5 years). A series of Feldenkrais Method balance classes (the &lsquo;Getting Grounded Gracefully&rsquo; series), two classes per week for 10 weeks, were conducted. Main outcome measures were Activities-Specific Balance Confidence (ABC) questionnaire, Four Square Step Test (FSST), self- selected gait speed (using GAITRite<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> instrumented gait mat). At re-testing, the Intervention group showed significant improvement on all of the measures (ABC, <I>P</I> = 0.016, FSST, <I>P</I> = 0.001, gait speed, <I>P</I> &lt; 0.001). The Control group improved significantly on one measure (FSST, <I>P</I> &lt; 0.001). Compared to the Control group, the Intervention group made a significant improvement in their ABC score (<I>P</I> = 0.005), gait speed (<I>P</I> = 0.017) and FSST time (<I>P</I> = 0.022). These findings suggest that Feldenkrais Method balance classes may improve mobility and balance in older adults.</p>
]]></description>
<dc:creator><![CDATA[Connors, K. A., Galea, M. P., Said, C. M.]]></dc:creator>
<dc:date>2009-06-24</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep055</dc:identifier>
<dc:title><![CDATA[Feldenkrais Method Balance Classes Improve Balance in Older Adults: A Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep039v1?rss=1">
<title><![CDATA[Evaluation of the Wound Healing Potential of Achillea biebersteinii Afan. (Asteraceae) by in vivo Excision and Incision Models]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep039v1?rss=1</link>
<description><![CDATA[
<p><I>Achillea</I> species are widely used for diarrhea, abdominal pain, stomachache and healing of wounds in folk medicine. To evaluate the wound healing activity of the plant, extracts were prepared with different solvents; hexane, chloroform, ethyl acetate and methanol, respectively from the roots of <I>Achillea biebersteinii</I>. Linear incision by using tensiometer and circular excision wound models were employed on mice and rats. The wound healing effect was comparatively evaluated with the standard skin ointment Madecassol&reg;. The n-hexane extract treated groups of animals showed 84.2% contraction, which was close to contraction value of the reference drug Madecassol&reg; (100%). On the other hand the same extract on incision wound model demonstrated a significant increase (40.1%) in wound tensile strength as compared to other groups. The results of histoptological examination supported the outcome of linear incision and circular excision wound models as well. The experimental data demonstrated that <I>A. biebersteinii</I> displayed remarkable wound healing activity.</p>
]]></description>
<dc:creator><![CDATA[Akkol, E. K., Koca, U., Pesin, I., Yilmazer, D.]]></dc:creator>
<dc:date>2009-06-22</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep039</dc:identifier>
<dc:title><![CDATA[Evaluation of the Wound Healing Potential of Achillea biebersteinii Afan. (Asteraceae) by in vivo Excision and Incision Models]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep056v1?rss=1">
<title><![CDATA[Antihypertension Induced by Tanshinone IIA Isolated from the Roots of Salvia Miltiorrhiza]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep056v1?rss=1</link>
<description><![CDATA[
<p>Tanshinone IIA is one of the active principles in danshen (<I>Salvia miltiorrhiza</I> Bge) widely used in treatment of cardiovascular disorders. We investigated the effect of danshen or tanshinone IIA on blood pressure and its possible mechanisms. An i.p. injection of danshen at 10 mg kg<sup>&ndash;1</sup> significantly lowered systolic blood pressure (SBP) of spontaneously hypertensive rats (SHRs) but failed to modify the SBP in normotensive Wistar&ndash;Kyoto rats (WKY). Oral administration of tanshinone IIA also decreased SBP in SHR but not in WKY. Tanshinone IIA produced a concentration-dependent relaxation in isolated SHR aortic rings precontracted with phenylephrine (10 nmol l<sup>&ndash;1</sup>) or potassium chloride (KCl) (40 mmol l<sup>&ndash;1</sup>). The relaxing effect of tanshinone IIA on tonic contraction of phenylephrine in isolated aortic rings without endothelium remained produced. Glibenclamide at concentration sufficient to block adenosine triphosphatase (ATP)-sensitive potassium (K<sup>+</sup>) channel attenuated this tanshinone IIA-induced relaxation that was not influenced by other inhibitors. We further investigated the effect of tanshinone IIA on the changes of intracellular calcium concentration ([Ca<sup>2+</sup>]i) in cultured aortic smooth muscle (A7r5) cells using fura-2 as indicator. Tanshinone IIA decreased [Ca<sup>2+</sup>]i elicited by phenylephrine (10 nmol l<sup>&ndash;1</sup>) or KCl (40 mmol l<sup>&ndash;1</sup>) in a concentration-dependent manner; glibenclamide, but not other inhibitors for K<sup>+</sup> channel, abated this effect. Our results suggest that tanshinone IIA acts as an active principle of danshen showing vasodilation through ATP-sensitive K<sup>+</sup> channel to lower [Ca<sup>2+</sup>]i.</p>
]]></description>
<dc:creator><![CDATA[Chan, P., Liu, I-M., Li, Y.-X., Yu, W.-J., Cheng, J.-T.]]></dc:creator>
<dc:date>2009-06-19</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep056</dc:identifier>
<dc:title><![CDATA[Antihypertension Induced by Tanshinone IIA Isolated from the Roots of Salvia Miltiorrhiza]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep057v1?rss=1">
<title><![CDATA[Cytotoxic Activities of Physalis minima L. Chloroform Extract on Human Lung Adenocarcinoma NCI-H23 Cell Lines by Induction of Apoptosis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep057v1?rss=1</link>
<description><![CDATA[
<p><I>Physalis minima</I> L. is reputed for having anticancer property. In this study, the chloroform extract of this plant exhibited remarkable cytotoxic activities on NCI-H23 (human lung adenocarcinoma) cell line at dose- and time-dependent manners (after 24, 48 and 72 h of incubation). Analysis of cell-death mechanism demonstrated that the extract exerted apoptotic programed cell death in NCI-H23 cells with typical DNA fragmentation, which is a biochemical hallmark of apoptosis. Morphological observation using transmission electron microscope (TEM) also displayed apoptotic characteristics in the treated cells, including clumping and margination of chromatins, followed by convolution of the nuclear and budding of the cells to produce membrane-bound apoptotic bodies. Different stages of apoptotic programed cell death as well as phosphatidylserine externalization were confirmed using annexin V and propidium iodide staining. Furthermore, acute exposure to the extract produced a significant regulation of c-myc, caspase-3 and p53 mRNA expression in this cell line. Due to its apoptotic effect on NCI-H23 cells, it is strongly suggested that the extract could be further developed as an anticancer drug.</p>
]]></description>
<dc:creator><![CDATA[Leong, O. K., Muhammad, T. S. T., Sulaiman, S. F.]]></dc:creator>
<dc:date>2009-06-18</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep057</dc:identifier>
<dc:title><![CDATA[Cytotoxic Activities of Physalis minima L. Chloroform Extract on Human Lung Adenocarcinoma NCI-H23 Cell Lines by Induction of Apoptosis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-18</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep050v1?rss=1">
<title><![CDATA[Evaluation of influence of Acupuncture and Electro-acupuncture for Blood Perfusion of Stomach by Laser Doppler Blood Perfusion Imaging]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep050v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study is to observe effects of acupuncture and electro-acupuncture (EA) on blood perfusion in the stomach, and probe into the application of laser Doppler blood perfusion imaging technique in the study of the effect of acupuncture and moxibustion on the entrails. In the acupuncture group of 20 rats, acupuncture was given at &lsquo;Zusanli&rsquo; (ST 36) and in EA group of 18 rats, EA was applied at &lsquo;Zusanli&rsquo; (ST 36), with 18 rats without acupuncture used as control group. Changes of blood perfusion and microcirculation distribution in the stomach were investigated with laser Doppler blood perfusion imager (LDPI). The laser Doppler blood perfusion image could clearly display changes of blood flow distribution in the stomach before and after acupuncture. After acupuncture or EA was given at &lsquo;Zusanli&rsquo; (ST 36), the blood perfusion in the stomach increased significantly, the blood perfusion in the blood vessels and microcirculation of other parts significantly increased, and the maximum increase of the blood perfusion was found at 10 min after acupuncture or EA, with increases of 0.50 &plusmn; 0.11 (PU) and 0.66 &plusmn; 0.16 (PU), respectively, and the blood perfusion still kept at a higher degree within 10 min after ceasing of the acupuncture or EA. While the blood perfusion in the stomach in the rat of the control group tended to gradual decrease. It has been concluded that both acupuncture and EA can increase blood perfusion in the stomach, the EA having stronger action, and LDPI can display the regulative action of acupuncture on the blood vessel of the stomach by using an image.</p>
]]></description>
<dc:creator><![CDATA[Dong, Z., Shun-Yue, L., Shu-You, W., Hui-Min, M.]]></dc:creator>
<dc:date>2009-06-16</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep050</dc:identifier>
<dc:title><![CDATA[Evaluation of influence of Acupuncture and Electro-acupuncture for Blood Perfusion of Stomach by Laser Doppler Blood Perfusion Imaging]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep053v1?rss=1">
<title><![CDATA[An Angiotensin I Converting Enzyme Polymorphism is Associated With Clinical Phenotype When Using Differentiation-Syndrome to Categorize Korean Bronchial Asthma Patients]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep053v1?rss=1</link>
<description><![CDATA[
<p>In this study, genetic analysis was conducted to investigate the association of angiotensin I converting enzyme (ACE) gene polymorphism with clinical phenotype based on differentiation-syndrome of bronchial asthma patients. Differentiation-syndrome is a traditional Korean medicine (TKM) theory in which patients are classified into a Deficiency Syndrome Group (DSG) and an Excess Syndrome Group (ESG) according to their symptomatic classification. For this study, 110 participants were evaluated by pulmonary function test. Among them, 39 patients were excluded because they refused genotyping. Of the remaining patients, 52 with DSG of asthma (DSGA) and 29 with ESG of asthma (ESGA), as determined by the differentiation-syndrome techniques were assessed by genetic analysis. ACE insertion/deletion (I/D) polymorphism analysis was conducted using polymerase chain reaction (PCR). Student's <I>t</I>, chi-square, Fisher and Hardy&ndash;Weinberg equilibrium tests were used to compare groups. No significant differences in pulmonary function were observed between DSGA and ESGA. The genotypic frequency of ACE I/D polymorphism was found to differ slightly between DSGA and ESGA (<I>P</I> = 0.0495). However, there were no significant differences in allelic frequency observed between DSGA and ESGA (<I>P</I> = 0.7006, <I>OR</I> = 1.1223). Interestingly, the allelic (<I>P</I> = 0.0043, <I>OR</I> = 3.4545) and genotypic (<I>P</I> = 0.0126) frequencies of the ACE I/D polymorphism in female patients differed significantly between DSGA and ESGA. Taken together, the results presented here indicate that the symptomatic classification of DSGA and ESGA by differentiation-syndrome in Korean asthma patients could be useful in evaluation of the pathogenesis of bronchial asthma.</p>
]]></description>
<dc:creator><![CDATA[Jung, S.-k., Ra, J., Seo, J., Jung, H.-J., Choi, J.-Y., Cho, Y.-J., Hong, M.-S., Chung, J.-H., Kim, J.]]></dc:creator>
<dc:date>2009-06-12</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep053</dc:identifier>
<dc:title><![CDATA[An Angiotensin I Converting Enzyme Polymorphism is Associated With Clinical Phenotype When Using Differentiation-Syndrome to Categorize Korean Bronchial Asthma Patients]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep049v1?rss=1">
<title><![CDATA[Is Placebo Acupuncture What It is Intended to Be?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep049v1?rss=1</link>
<description><![CDATA[
<p>Randomized, placebo-controlled clinical trials are recommended for evaluation of a treatment's efficacy with the goal of separating the specific effects (verum) from the non-specific ones (placebo). In order to be able to carry out placebo-controlled acupuncture trials, minimal/sham acupuncture procedures and a sham acupuncture needle has been used with the intention of being inert. However, clinical and experimental results suggest that sham/minimal acupuncture is not inert since it is reported that both verum acupuncture and sham/minimal acupuncture induce a significant alleviation of pain. This alleviation is as pronounced as the alleviation obtained with standard treatment and more obvious than the one obtained with placebo medication or by the use of waiting list controls. These results also suggest that sham acupuncture needles evoke a physiological response. In healthy individuals sham acupuncture results in activation of limbic structures, whereas a deactivation is seen in patients with pain, i.e. results from healthy individuals do not reflect what is seen in clinical conditions. Also, depending on the etiology of pain (or any under clinical condition under investigation), the response to sham acupuncture is varying. The acupuncture ritual may also be seen as an emotional focused therapy allowing for psychological re-orientation. Sham needling in such context may be as powerful as verum acupuncture. We recommend that the evaluated effects of acupuncture could be compared with those of standard treatment, also taking the individual response into consideration, before its use or non-use is established.</p>
]]></description>
<dc:creator><![CDATA[Lundeberg, T., Lund, I., Sing, A., Naslund, J.]]></dc:creator>
<dc:date>2009-06-12</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep049</dc:identifier>
<dc:title><![CDATA[Is Placebo Acupuncture What It is Intended to Be?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-12</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep052v1?rss=1">
<title><![CDATA[Preventive Effects of Salacia reticulata on Obesity and Metabolic Disorders in TSOD Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep052v1?rss=1</link>
<description><![CDATA[
<p>The extracts of <I>Salacia reticulata</I> (<I>Salacia</I> extract), a plant that has been used for the treatment of early diabetes, rheumatism and gonorrhea in Ayurveda, have been shown to have an anti-obesity effect and suppress hyperglycemia. In this study, the effects of <I>Salacia</I> extract on various symptoms of metabolic disorder were investigated and compared using these TSOD mice and non-obese TSNO mice. Body weight, food intake, plasma biochemistry, visceral and subcutaneous fat (X-ray and CT), glucose tolerance, blood pressure and pain tolerance were measured, and histopathological examination of the liver was carried out. A significant dose-dependent decline in the gain in body weight, accumulation of visceral and subcutaneous fat and an improvement of abnormal glucose tolerance, hypertension and peripheral neuropathy were noticed in TSOD mice. In addition, hepatocellular swelling, fatty degeneration of hepatocytes, inflammatory cell infiltration and single-cell necrosis were observed on histopathological examination of the liver in TSOD mice. <I>Salacia</I> extract markedly improved these symptoms upon treatment. Based on the above results, it is concluded that <I>Salacia</I> extract has remarkable potential to prevent obesity and associated metabolic disorders including the development of metabolic syndrome.</p>
]]></description>
<dc:creator><![CDATA[Akase, T., Shimada, T., Harasawa, Y., Akase, T., Ikeya, Y., Nagai, E., Iizuka, S., Nakagami, G., Iizaka, S., Sanada, H., Aburada, M.]]></dc:creator>
<dc:date>2009-06-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep052</dc:identifier>
<dc:title><![CDATA[Preventive Effects of Salacia reticulata on Obesity and Metabolic Disorders in TSOD Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep048v1?rss=1">
<title><![CDATA[Looking for a Person-centered Medicine: Non Conventional Medicine in the Conventional European and Italian Setting]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep048v1?rss=1</link>
<description><![CDATA[
<p>In Italy, the use of non conventional medicines (NCMs) is spreading among people as in the rest of Europe. Sales of alternative remedies are growing, and likewise the number of medical doctors (MDs) who practise NCM/complementary and alternative medicine (CAM). However, in Italy as in other countries of the European Union, at the present time the juridical/legal status of NCM/CAM is not well established, mainly due to the lack of any national law regulating NCM/CAM professional training, practice and public supply and the absence of government-promoted scientific research in this field. This is an obstacle to safeguarding the patient's interests and freedom of choice, especially now that dissatisfaction with biomedicine is inclining more and more people to look for a holistic and patient-centered form of medicine.</p>
]]></description>
<dc:creator><![CDATA[Sarsina, P. R. d., Iseppato, I.]]></dc:creator>
<dc:date>2009-06-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep048</dc:identifier>
<dc:title><![CDATA[Looking for a Person-centered Medicine: Non Conventional Medicine in the Conventional European and Italian Setting]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep047v1?rss=1">
<title><![CDATA[Exploring the Evidence Base for Acupuncture in the Treatment of Meniere's Syndrome--A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep047v1?rss=1</link>
<description><![CDATA[
<p>M&eacute;ni&egrave;re's syndrome is a long-term, progressive disease that damages the balance and hearing parts of the inner ear. To address the paucity of information on which evidence-based treatment decisions should be made, a systematic review of acupuncture for M&eacute;ni&egrave;re's syndrome was undertaken. The method used was a systematic review of English and Chinese literature, from six databases for randomized, non-randomized and observational studies. All studies were critically appraised and a narrative approach to data synthesis was adopted. Twenty-seven studies were included in this review (9 in English and 18 in Chinese languages): three randomized controlled trials, three non-randomized controlled studies and four pre-test, post-test designs. All but one of the studies was conducted in China. The studies covered body acupuncture, ear acupuncture, scalp acupuncture, fluid acupuncture point injection and moxibustion. The studies were of varying quality. The weight of evidence, across all study types, is of beneficial effect from acupuncture, for those in an acute phase or those who have had M&eacute;ni&egrave;re's syndrome for a number of years. The review reinforces the importance of searching for studies from English and Chinese literature. The transferability of the findings from China to a Western context needs confirmation. Further research is also needed to clarify questions around the appropriate frequency and number of treatment/courses of acupuncture. The weight of evidence suggests a potential benefit of acupuncture for persons with M&eacute;ni&egrave;re's disease, including those in an acute phase and reinforces the importance of searching for published studies in the Chinese language.</p>
]]></description>
<dc:creator><![CDATA[Long, A. F., Xing, M., Morgan, K., Brettle, A.]]></dc:creator>
<dc:date>2009-06-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep047</dc:identifier>
<dc:title><![CDATA[Exploring the Evidence Base for Acupuncture in the Treatment of Meniere's Syndrome--A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep042v1?rss=1">
<title><![CDATA[Bioactivity of the Murex Homeopathic Remedy and of Extracts from an Australian Muricid Mollusc Against Human Cancer Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep042v1?rss=1</link>
<description><![CDATA[
<p>Marine molluscs from the family Muricidae are the source of a homeopathic remedy <I>Murex</I>, which is used to treat a range of conditions, including cancer. The aim of this study was to evaluate the <I>in vitro</I> bioactivity of egg mass extracts of the Australian muricid <I>Dicathais orbita</I>, in comparison to the <I>Murex</I> remedy, against human carcinoma and lymphoma cells. Liquid chromatography coupled with mass spectrometry (LC-MS) was used to characterize the chemical composition of the extracts and homeopathic remedy, focusing on biologically active brominated indoles. The MTS (tetrazolium salt) colorimetric assay was used to determine effects on cell viability, while necrosis and apoptosis induction were investigated using flow cytometry (propidium iodide and Annexin-V staining respectively). Cells were treated with varying concentrations (1&ndash;0.01 mg/ml) of crude and semi-purified extracts or preparations (dilute 1 M and concentrated 4 mg/ml) from the <I>Murex</I> remedy (4 h). The <I>Murex</I> remedy showed little biological activity against the majority of cell lines tested. In contrast, the <I>D. orbita</I> egg extracts significantly decreased cell viability in the majority of carcinoma cell lines. Flow cytometry revealed these extracts induce necrosis in HT29 colorectal cancer cells, whereas apoptosis was induced in Jurkat cells. These findings highlight the biomedical potential of Muricidae extracts in the development of a natural therapy for the treatment of neoplastic tumors and lymphomas.</p>
]]></description>
<dc:creator><![CDATA[Benkendorff, K., McIver, C. M., Abbott, C. A.]]></dc:creator>
<dc:date>2009-06-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep042</dc:identifier>
<dc:title><![CDATA[Bioactivity of the Murex Homeopathic Remedy and of Extracts from an Australian Muricid Mollusc Against Human Cancer Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep045v1?rss=1">
<title><![CDATA[Meta-analysis of the Related Nutritional Supplements Dimethyl Sulfoxide and Methylsulfonylmethane in the Treatment of Osteoarthritis of the Knee]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep045v1?rss=1</link>
<description><![CDATA[
<p>Dimethyl sulphoxide and methylsulfonylmethane are two related nutritional supplements used for symptomatic relief of osteoarthritis (OA). We conducted a meta-analysis to evaluate their efficacy in reducing pain associated with OA. Randomized or quasi-randomized controlled trials (RCTs), identified by systematic electronic searches, citation tracking and searches of clinical trial registries, assessing these supplements in osteoarthritis of any joint were considered for inclusion. Meta-analysis, based on difference in mean pain related outcomes between treatment and comparator groups, was carried out based on a random effect model. Seven potential trials were identified of which three RCTs, two DMSO and one MSM (total <I>N</I> = 326 patients) were eligible for inclusion. All three trials were considered high methodological quality. A significant degree of heterogeneity (<sup>2</sup> = 6.28, <I>P</I> = 0.043) was revealed. Two studies demonstrated statistically significant (but not clinically relevant) reduction in pain compared with controls; with one showing no group difference. The meta-analysis confirmed a non significant reduction of pain on visual analogue scale of 6.34 mm (SE = 3.49, 95% CI, &ndash;0.49, 13.17). The overall effect size of 1.82 was neither statistically nor clinically significant. Current evidence suggests DMSO and MSM are not clinically effective in the reduction of pain in the treatment of OA. No definitive conclusions can currently be drawn from the data due to the mixed findings and the use of inadequate dosing periods.</p>
]]></description>
<dc:creator><![CDATA[Brien, S., Prescott, P., Lewith, G.]]></dc:creator>
<dc:date>2009-05-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep045</dc:identifier>
<dc:title><![CDATA[Meta-analysis of the Related Nutritional Supplements Dimethyl Sulfoxide and Methylsulfonylmethane in the Treatment of Osteoarthritis of the Knee]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep043v1?rss=1">
<title><![CDATA[Dejian Mind-Body Intervention on Depressive Mood of Community-Dwelling Adults: A Randomized Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep043v1?rss=1</link>
<description><![CDATA[
<p>The present study evaluated the effectiveness of a short-term mind-body intervention program on improving the depressive mood of an adult community sample. Forty adult volunteers with various degrees of depressive mood were randomly assigned to the experimental group (<I>Dejian</I> Mind-Body Intervention, DMBI) and control group (Cognitive-Behavioral Therapy, CBT). For each group, a total of four 90-min weekly sessions were conducted. Treatment-related changes were measured using the Beck Depression Inventory (BDI-II), an electroencephalographic indicator of positive affect (i.e. prefrontal activation asymmetry), and self-report ratings on physical health. Results indicated that both the DMBI and the CBT group demonstrated significant reduction in depressive mood. However, among individuals with moderate to severe depressive mood at baseline, only those in the DMBI but not the CBT group showed significant reduction in depressive mood. Besides, only the DMBI group demonstrated a significant increase in prefrontal activation asymmetry, suggesting increase in positive affect. While most psychological therapies for depressive mood normally take several months to show treatment effect, the present findings provided initial data suggesting that the DMBI was effective in improving depressive mood of community adults after 1 month of training.</p>
]]></description>
<dc:creator><![CDATA[Chan, A. S., Cheung, M.-c., Tsui, W. J., Sze, S. L., Shi, D.]]></dc:creator>
<dc:date>2009-05-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep043</dc:identifier>
<dc:title><![CDATA[Dejian Mind-Body Intervention on Depressive Mood of Community-Dwelling Adults: A Randomized Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep036v1?rss=1">
<title><![CDATA[Homeopathic Preparations of Quartz, Sulfur and Copper Sulfate Assessed by UV-Spectroscopy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep036v1?rss=1</link>
<description><![CDATA[
<p>Homeopathic preparations are used in homeopathy and anthroposophic medicine. Although there is evidence of effectiveness in several clinical studies, including double-blinded randomized controlled trials, their nature and mode of action could not be explained with current scientific approaches yet. Several physical methods have already been applied to investigate homeopathic preparations but it is yet unclear which methods are best suited to identify characteristic physicochemical properties of homeopathic preparations. The aim of this study was to investigate homeopathic preparations with UV-spectroscopy. In a blinded, randomized, controlled experiment homeopathic preparations of copper sulfate (CuSO<SUB>4</SUB>; 11c&ndash;30c), quartz (SiO<SUB>2</SUB>; 10c&ndash;30c, i.e. centesimal dilution steps) and sulfur (S; 11<FONT FACE="arial,helvetica">x</FONT>&ndash;30<FONT FACE="arial,helvetica">x</FONT>, i.e. decimal dilution steps) and controls (one-time succussed diluent) were investigated using UV-spectroscopy and tested for contamination by inductively coupled plasma mass spectrometry (ICP-MS). The UV transmission for homeopathic preparations of CuSO<SUB>4</SUB> preparations was significantly lower than in controls. The transmission seemed to be also lower for both SiO<SUB>2</SUB> and S, but not significant. The mean effect size (95% confidence interval) was similar for the homeopathic preparations: CuSO<SUB>4</SUB> (pooled data) 0.0544% (0.0260&ndash;0.0827%), SiO<SUB>2</SUB> 0.0323% (&ndash;0.0064% to 0.0710%) and S 0.0281% (&ndash;0.0520% to 0.1082%). UV transmission values of homeopathic preparations had a significantly higher variability compared to controls. In none of the samples the concentration of any element analyzed by ICP-MS exceeded 100 ppb. Lower transmission of UV light may indicate that homeopathic preparations are less structured or more dynamic than their succussed pure solvent.</p>
]]></description>
<dc:creator><![CDATA[Wolf, U., Wolf, M., Heusser, P., Thurneysen, A., Baumgartner, S.]]></dc:creator>
<dc:date>2009-05-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep036</dc:identifier>
<dc:title><![CDATA[Homeopathic Preparations of Quartz, Sulfur and Copper Sulfate Assessed by UV-Spectroscopy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep038v1?rss=1">
<title><![CDATA[Searching for Controlled Trials of Complementary and Alternative Medicine: a Comparison of 15 Databases]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep038v1?rss=1</link>
<description><![CDATA[
<p>This project aims to assess the utility of bibliographic databases beyond the three major ones (MEDLINE, EMBASE and Cochrane CENTRAL) for finding controlled trials of complementary and alternative medicine (CAM). Fifteen databases were searched to identify controlled clinical trials (CCTs) of CAM not also indexed in MEDLINE. Searches were conducted in May 2006 using the revised Cochrane highly sensitive search strategy (HSSS) and the PubMed CAM Subset. Yield of CAM trials per 100 records was determined, and databases were compared over a standardized period (2005). The Acudoc2 RCT, Acubriefs, Index to Chiropractic Literature (ICL) and Hom-Inform databases had the highest concentrations of non-MEDLINE records, with more than 100 non-MEDLINE records per 500. Other productive databases had ratios between 500 and 1500 records to 100 non-MEDLINE records&mdash;these were AMED, MANTIS, PsycINFO, CINAHL, Global Health and Alt HealthWatch. Five databases were found to be unproductive: AGRICOLA, CAIRSS, Datadiwan, Herb Research Foundation and IBIDS. Acudoc2 RCT yielded 100 CAM trials in the most recent 100 records screened. Acubriefs, AMED, Hom-Inform, MANTIS, PsycINFO and CINAHL had more than 25 CAM trials per 100 records screened. Global Health, ICL and Alt HealthWatch were below 25 in yield. There were 255 non-MEDLINE trials from eight databases in 2005, with only 10% indexed in more than one database. Yield varied greatly between databases; the most productive databases from both sampling methods were Acubriefs, Acudoc2 RCT, AMED and CINAHL. Low overlap between databases indicates comprehensive CAM literature searches will require multiple databases.</p>
]]></description>
<dc:creator><![CDATA[Cogo, E., Sampson, M., Ajiferuke, I., Manheimer, E., Campbell, K., Daniel, R., Moher, D.]]></dc:creator>
<dc:date>2009-05-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep038</dc:identifier>
<dc:title><![CDATA[Searching for Controlled Trials of Complementary and Alternative Medicine: a Comparison of 15 Databases]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep016v2?rss=1">
<title><![CDATA[Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep016v2?rss=1</link>
<description><![CDATA[
<p>Shi-Liu-Wei-Liu-Qi-Yin (SLWLQY) was traditionally used to treat cancers. However, scientific evidence of the anticancer effects still remains undefined. In this study, we aimed to clarify the possible mechanisms of SLWLQY in treating cancer. We evaluated the effects of SLWLQY on apoptosis-related experiments inducing in TSGH-8301 cells by (i) 3-(4,5-dimethylthiazol-zyl)-2,5-diphenylterazolium bromide (MTT) for cytotoxicity; (ii) cell-cycle analysis and (iii) western blot analysis of the G2/M-phase and apoptosis regulatory proteins. Human bladder carcinoma TSGH-8301 cells were transplanted into BALB/c nude mice as a tumor model for evaluating the antitumor effect of SLWLQY. Treatment of SLWLQY resulted in the G2/M phase arrest and apoptotic death in a dose-dependent manner, accompanied by a decrease in cyclin-dependent kinases (cdc2) and cyclins (cyclin B1). SLWLQY stimulated increases in the protein expression of Fas and FasL, and induced the cleavage of caspase-3, caspase-9 and caspase-8. The ratio of Bax/Bcl<SUB>2</SUB> was increased by SLWLQY treatment. SLWLQY markedly reduced tumor size in TSGH-8301 cells-xenografted tumor tissues. In the tissue specimen, SLWLQY up-regulated the expression of Fas, FasL and Bax proteins, and down-regulated Bcl<SUB>2</SUB> as well as in <I>in vitro</I> assay. Our results showed that SLWLQY reduced tumor growth, caused cell-cycle arrest and apoptosis in TSGH-8301 cells via the Fas and mitochondrial pathway.</p>
]]></description>
<dc:creator><![CDATA[Ou, T.-T., Wang, C.-J., Hung, G.-U., Wu, C.-H., Lee, H.-J.]]></dc:creator>
<dc:date>2009-05-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep016</dc:identifier>
<dc:title><![CDATA[Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep044v1?rss=1">
<title><![CDATA[How Much of CAM is Based on Research Evidence?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep044v1?rss=1</link>
<description><![CDATA[
<p>The aim of this article is to provide a preliminary estimate of how much CAM is evidence-based. For this purpose, I calculated the percentage of 685 treatment/condition pairings evaluated in the &lsquo;Desktop Guide to Complementary and Alternative Medicine&rsquo; which ere supported by sound data. The resulting figure was 7.4%. For a range of reasons, it might be a gross over-estimate. Further investigations into this subject are required to arrive at more representative figures.</p>
]]></description>
<dc:creator><![CDATA[Ernst, E.]]></dc:creator>
<dc:date>2009-05-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep044</dc:identifier>
<dc:title><![CDATA[How Much of CAM is Based on Research Evidence?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-21</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep040v1?rss=1">
<title><![CDATA[Changes in Attitudes of Japanese Doctors toward Complementary and Alternative Medicine--Comparison of Surveys in 1999 and 2005 in Kyoto]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep040v1?rss=1</link>
<description><![CDATA[
<p>We surveyed the attitudes of Japanese medical doctors toward complementary and alternative medicine (CAM) in 1999. It is supposed that the situation concerning CAM has been changing recently. The aim of the present study is to survey the attitude of doctors toward CAM again, and to examine changes in attitude over the last 6 years. The attitudes of medical doctors belonging to the Kyoto Medical Association toward CAM were surveyed by a structured, self-administered questionnaire in 1999 and 2005. The results showed that the doctors familiar with the term &lsquo;CAM&rsquo;, practicing CAM therapies, and attending meetings or training courses related with CAM, increased significantly from 1999 to 2005. The doctors who possessed knowledge of CAM also increased significantly from 1999 to 2005. Almost all doctors believed in the effectiveness of Kampo (Japanese traditional herbal medicine) and acupuncture. The number of doctors who believed in the effectiveness of aromatherapy and ayurveda increased significantly in 2005, compared with 1999. In the near future, 58% of doctors desired to practice CAM therapies. In conclusion, the numbers of doctors who practice CAM therapies, possess CAM knowledge and desire to practice such therapies have increased over the last 6 years in Japan.</p>
]]></description>
<dc:creator><![CDATA[Fujiwara, K., Imanishi, J., Watanabe, S., Ozasa, K., Sakurada, K.]]></dc:creator>
<dc:date>2009-05-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep040</dc:identifier>
<dc:title><![CDATA[Changes in Attitudes of Japanese Doctors toward Complementary and Alternative Medicine--Comparison of Surveys in 1999 and 2005 in Kyoto]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-21</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep041v1?rss=1">
<title><![CDATA[Health-Beneficial Phenolic Aldehyde in Antigonon leptopus Tea]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep041v1?rss=1</link>
<description><![CDATA[
<p>Tea prepared from the aerial parts of <I>Antigonon leptopus</I> is used as a remedy for cold and pain relief in many countries. In this study, <I>A. leptopus</I> tea, prepared from the dried aerial parts, was evaluated for lipid peroxidation (LPO) and cyclooxygenase (COX-1 and COX-2) enzyme inhibitory activities. The tea as a dried extract inhibited LPO, COX-1 and COX-2 enzymes by 78%, 38% and 89%, respectively, at 100 &micro;g/ml. Bioassay-guided fractionation of the extract yielded a selective COX-2 enzyme inhibitory phenolic aldehyde, 2,3,4-trihydroxy benzaldehyde. Also, it showed LPO inhibitory activity by 68.3% at 6.25 &micro;g/ml. Therefore, we have studied other hydroxy benzaldehydes and their methoxy analogs for LPO, COX-1 and COX-2 enzymes inhibitory activities and found that compound <b>1</b> gave the highest COX-2 enzyme inhibitory activity as indicated by a 50% inhibitory concentration (IC<SUB>50</SUB>) at 9.7 &micro;g/ml. The analogs showed only marginal LPO activity at 6.25 &micro;g/ml. The hydroxy analogs <b>6</b>, <b>7</b> and <b>9</b> showed 55%, 61% and 43% of COX-2 inhibition at 100 &micro;g/ml. However, hydroxy benzaldehydes <b>3</b> and <b>12</b> showed selective COX-1 inhibition while compounds <b>4</b> and <b>10</b> gave little or no COX-2 enzyme inhibition at 100 &micro;g/ml. At the same concentration, compounds <b>14</b>, <b>21</b> and <b>22</b> inhibited COX-1 by 83, 85 and 70%, respectively. Similarly, compounds <b>18</b>, <b>19</b> and <b>23</b> inhibited COX-2 by 68%, 72% and 70%, at 100 &micro;g/ml. This is the first report on the isolation of compound <b>1</b> from <I>A. leptopus</I> tea with selective COX-2 enzyme and LPO inhibitory activities.</p>
]]></description>
<dc:creator><![CDATA[Mulabagal, V., Alexander-Lindo, R. L., DeWitt, D. L., Nair, M. G.]]></dc:creator>
<dc:date>2009-05-19</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep041</dc:identifier>
<dc:title><![CDATA[Health-Beneficial Phenolic Aldehyde in Antigonon leptopus Tea]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep035v1?rss=1">
<title><![CDATA[Cupping for Treating Pain: A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep035v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to assess the evidence for or against the effectiveness of cupping as a treatment option for pain. Fourteen databases were searched. Randomized clinical trials (RCTs) testing cupping in patients with pain of any origin were considered. Trials using cupping with or without drawing blood were included, while trials comparing cupping with other treatments of unproven efficacy were excluded. Trials with cupping as concomitant treatment together with other treatments of unproven efficacy were excluded. Trials were also excluded if pain was not a central symptom of the condition. The selection of studies, data extraction and validation were performed independently by three reviewers. Seven RCTs met all the inclusion criteria. Two RCTs suggested significant pain reduction for cupping in low back pain compared with usual care (<I>P</I> &lt; 0.01) and analgesia (<I>P</I> &lt; 0.001). Another two RCTs also showed positive effects of cupping in cancer pain (<I>P</I> &lt; 0.05) and trigeminal neuralgia (<I>P</I> &lt; 0.01) compared with anticancer drugs and analgesics, respectively. Two RCTs reported favorable effects of cupping on pain in brachialgia compared with usual care (<I>P</I> = 0.03) or heat pad (<I>P</I> &lt; 0.001). The other RCT failed to show superior effects of cupping on pain in herpes zoster compared with anti-viral medication (<I>P</I> = 0.065). Currently there are few RCTs testing the effectiveness of cupping in the management of pain. Most of the existing trials are of poor quality. Therefore, more rigorous studies are required before the effectiveness of cupping for the treatment of pain can be determined.</p>
]]></description>
<dc:creator><![CDATA[Kim, J.-I., Lee, M. S., Lee, D.-H., Boddy, K., Ernst, E.]]></dc:creator>
<dc:date>2009-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep035</dc:identifier>
<dc:title><![CDATA[Cupping for Treating Pain: A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep037v1?rss=1">
<title><![CDATA[Understanding Oriental Medicine Using a Systems Approach]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep037v1?rss=1</link>
<description><![CDATA[
<p>Two international meetings, the International Physiome Symposium 2008 and the Workshop on Systems Biology (SB) and Oriental Medicine (OM), were held to discuss the most appropriate scientific tools to research OM. Participants agreed that since OM is holistic medicine it needs a systems approach such as SB. However, SB itself is still a long way from identifying the high-level organization processes in the biological system that might correlate with concepts in OM. As such, a modest goal of launching a project to examine the problems of translation and interpretation of OM concepts would be the first step.</p>
]]></description>
<dc:creator><![CDATA[Kim, J. Y., Pham, D. D.]]></dc:creator>
<dc:date>2009-04-29</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep037</dc:identifier>
<dc:title><![CDATA[Understanding Oriental Medicine Using a Systems Approach]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-29</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep028v1?rss=1">
<title><![CDATA[The Neuroprotective Effect of Methanol Extract of Gagamjungjihwan and Fructus Euodiae on Ischemia-Induced Neuronal and Cognitive Impairment in the Rat]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep028v1?rss=1</link>
<description><![CDATA[
<p><I>Gagamjungjihwan</I> (GJ), a decoction consisting of five herbs including <I>ginseng</I>, <I>Acori Graminei Rhizoma</I>, <I>Uncariae Ramulus et Uncus</I>, <I>Polygalae Radic</I> and <I>Frustus Euodiae</I> (FE), has been widely used as herbal treatment for ischemia. In order to investigate the neuroprotective action of this novel prescription, we examined the influence of GJ and FE on learning and memory using the Morris water maze and studied their affects on the central cholinergic system in the hippocampus with neuronal and cognitive impairment. After middle cerebral artery occlusion was applied for 2 h, rats were administered GJ (200 mg kg<sup>&ndash;1</sup>, p.o.) or FE (200 mg kg<sup>&ndash;1</sup>, p.o.) daily for 2 weeks, followed by training and performance of the Morris water maze tasks. Rats with ischemic insults showed impaired learning and memory of the tasks. Pre-treatment with GJ and FE produced improvement in the escape latency to find the platform. Pre-treatments with GJ and FE also reduced the loss of cholinergic immunoreactivity in the hippocampus. The results demonstrated that GJ and FE have a protective effect against ischemia-induced neuronal and cognitive impairment. Our results suggest that GJ and FE might be useful in the treatment of vascular dementia.</p>
]]></description>
<dc:creator><![CDATA[Lee, B., Choi, E.-J., Lee, E.-J., Han, S.-M., Hahm, D.-H., Lee, H.-J., Shim, I.]]></dc:creator>
<dc:date>2009-04-24</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep028</dc:identifier>
<dc:title><![CDATA[The Neuroprotective Effect of Methanol Extract of Gagamjungjihwan and Fructus Euodiae on Ischemia-Induced Neuronal and Cognitive Impairment in the Rat]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep033v1?rss=1">
<title><![CDATA[Antidiabetic Properties of Azardiracta indica and Bougainvillea spectabilis: In Vivo Studies in Murine Diabetes Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep033v1?rss=1</link>
<description><![CDATA[
<p>Diabetes mellitus is a metabolic syndrome characterized by an increase in the blood glucose level. Treatment of diabetes is complicated due to multifactorial nature of the disease. <I>Azadirachta indica Adr. Juss</I> and <I>Bougainvillea spectabilis</I> are reported to have medicinal values including antidiabetic properties. In the present study using <I>in&nbsp;vivo</I> diabetic murine model, <I>A. indica</I> and <I>B. spectabilis</I> chloroform, methanolic and aqueous extracts were investigated for the biochemical parameters important for controlling diabetes. It was found that <I>A. indica</I> chloroform extract and <I>B. spectabilis</I> aqueous, methanolic extracts showed a good oral glucose tolerance and significantly reduced the intestinal glucosidase activity. Interestingly, <I>A. indica</I> chloroform and <I>B. spectabilis</I> aqueous extracts showed significant increase in glucose-6-phosphate dehydrogenase activity and hepatic, skeletal muscle glycogen content after 21 days of treatment. In immunohistochemical analysis, we observed a regeneration of insulin-producing cells and corresponding increase in the plasma insulin and c-peptide levels with the treatment of <I>A. indica</I> chloroform and <I>B. spectabilis</I> aqueous, methanolic extracts. Analyzing the results, it is clear that <I>A. indica</I> chloroform and <I>B. spectabilis</I> aqueous extracts are good candidates for developing new neutraceuticals treatment for diabetes.</p>
]]></description>
<dc:creator><![CDATA[Bhat, M., Kothiwale, S. K., Tirmale, A. R., Bhargava, S. Y., Joshi, B. N.]]></dc:creator>
<dc:date>2009-04-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep033</dc:identifier>
<dc:title><![CDATA[Antidiabetic Properties of Azardiracta indica and Bougainvillea spectabilis: In Vivo Studies in Murine Diabetes Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep030v1?rss=1">
<title><![CDATA[Lyprinol--is it a Useful Anti-inflammatory Agent?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep030v1?rss=1</link>
<description><![CDATA[
<p>The New Zealand green lipped mussel preparation Lyprinol is available without a prescription from a supermarket, pharmacy or Web. The Food and Drug Administration have recently warned Lyprinol USA about their extravagant anti-inflammatory claims for Lyprinol appearing on the web. These claims are put to thorough review. Lyprinol does have anti-inflammatory mechanisms, and has anti-inflammatory effects in some animal models of inflammation. Lyprinol may have benefits in dogs with arthritis. There are design problems with the clinical trials of Lyprinol in humans as an anti-inflammatory agent in osteoarthritis and rheumatoid arthritis, making it difficult to give a definite answer to how effective Lyprinol is in these conditions, but any benefit is small. Lyprinol also has a small benefit in atopic allergy. As anti-inflammatory agents, there is little to choose between Lyprinol and fish oil. No adverse effects have been reported with Lyprinol. Thus, although it is difficult to conclude whether Lyprinol does much good, it can be concluded that Lyprinol probably does no major harm.</p>
]]></description>
<dc:creator><![CDATA[Doggrell, S. A.]]></dc:creator>
<dc:date>2009-04-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep030</dc:identifier>
<dc:title><![CDATA[Lyprinol--is it a Useful Anti-inflammatory Agent?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-21</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep034v1?rss=1">
<title><![CDATA[Temperament and Character Profiles of Sasang Typology in an Adult Clinical Sample]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep034v1?rss=1</link>
<description><![CDATA[
<p>The purpose of this study was to examine the biopsychological personality profiles of traditional Korean <I>Sasang</I> typology based on the Temperament and Character Inventory (TCI) in a Korean adult clinical sample. A total of 97 adults completed the Korean version of the TCI. The participants were classified as one of three traditional Korean <I>Sasang</I> types (31 So-Yang, 41 Tae-Eum, 25 So-Eum) by three specialists in <I>Sasang</I> typology. The seven dimensions of TCI were compared between the different <I>Sasang</I> types using analysis of variance (ANOVA) and profile analysis. There were no significant differences in age, gender and education across the <I>Sasang</I> types. The TCI profile for each of the <I>Sasang</I> types was significantly different (profile analysis, df = 5.038, <I>F</I> = 3.546, <I>P</I> = 0.004). There were significant differences in the temperament dimensions of Novelty Seeking (<I>F</I> = 3.43, <I>P</I> = 0.036) and Harm Avoidance (<I>F</I> = 5.43, <I>P</I> = 0.006) among the <I>Sasang</I> types. The Novelty Seeking score of the So-Yang type (31.90 &plusmn; 9.87) was higher than that of the So-Eum type (25.24 &plusmn; 9.21; <I>P</I> = 0.019) while the So-Eum type (44.64 &plusmn; 8.47) scored higher on the Harm Avoidance score compared to the So-Yang type (35.16 &plusmn; 11.50; <I>P</I> = 0.003). There were no significant differences in the temperament dimension of Reward Dependence and Persistence, and the three character dimensions of Self-Directedness, Cooperativeness and Self-Transcendence. Results demonstrated distinct temperament traits associated with traditional Korean <I>Sasang</I> types using an objective biopsychological personality inventory. With further study, the <I>Sasang</I> typology may lead to enhanced clinical safety and efficacy as part of personalized medicine with traditional medicine.</p>
]]></description>
<dc:creator><![CDATA[Park, S. H., Kim, M.-g., Lee, S. J., Kim, J. Y., Chae, H.]]></dc:creator>
<dc:date>2009-04-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep034</dc:identifier>
<dc:title><![CDATA[Temperament and Character Profiles of Sasang Typology in an Adult Clinical Sample]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep032v1?rss=1">
<title><![CDATA[Informed Consent in Complementary and Alternative Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep032v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to examine complementary and alternative medicine (CAM) practitioners&rsquo; (i) attitudes toward informed consent and (ii) to assess whether standards of practice exist with respect to informed consent, and what these standards look like. The design and setting of the study constituted <b>f</b>ace-to-face qualitative interviews with 28 non-MD, community-based providers representing 11 different CAM therapeutic modalities. It was found that there is great deal of variability with respect to the informed consent process in CAM across providers and modalities. No unique profession-based patterns were identified. The content analysis yielded five major categories related to (i) general attitude towards the informed consent process, (ii) type and amount of information exchange during that process, (iii) disclosure of risks, (iv) discussions of alternatives, and (v) potential benefits. There is a widespread lack of standards with respect to the practice of informed consent across a broad range of CAM modalities. Addressing this problem requires concerted and systematic educational, ethical and judicial remedial actions. Informed consent, which is often viewed as a pervasive obligation is medicine, must be reshaped to have therapeutic value. Acknowledging current conceptions and misconception surrounding the practice of informed consent may help to bring about this change. More translational research is needed to guide this process.</p>
]]></description>
<dc:creator><![CDATA[Caspi, O., Shalom, T., Holexa, J.]]></dc:creator>
<dc:date>2009-04-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep032</dc:identifier>
<dc:title><![CDATA[Informed Consent in Complementary and Alternative Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep031v1?rss=1">
<title><![CDATA[Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep031v1?rss=1</link>
<description><![CDATA[
<p>Serum from men undergoing a low-fat, high-fiber diet and exercise intervention has previously been shown to decrease growth and increase apoptosis in serum-stimulated, androgen-dependent LNCaP cells associated with a reduction in serum IGF-I. Here we sought to determine the underlying mechanisms for these anticancer effects. Again, the intervention slowed growth and increased apoptosis in LNCaP cells; responses that were eliminated when IGF-I was added back to the post-intervention samples. The p53 protein content was increased and NFkB activation reduced in the post serum-stimulated LNCaP cells. Similar results were observed when the IGF-I receptor was blocked in the pre-intervention serum. In androgen-independent PC-3 cells, growth was reduced while none of the other factors were changed by the intervention. We conclude that diet and exercise intervention might help prevent clinical PCa as well as aid in the treatment of PCa during the early stages of development.</p>
]]></description>
<dc:creator><![CDATA[Soliman, S., Aronson, W. J., Barnard, R. J.]]></dc:creator>
<dc:date>2009-04-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep031</dc:identifier>
<dc:title><![CDATA[Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep029v1?rss=1">
<title><![CDATA[Royal Jelly Facilitates Restoration of the Cognitive Ability in Trimethyltin-Intoxicated Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep029v1?rss=1</link>
<description><![CDATA[
<p>Trimethyltin (TMT) is a toxic organotin compound that induces acute neuronal death selectively in the hippocampal dentate gyrus (DG) followed by cognition impairment; however the TMT-injured hippocampal DG itself is reported to regenerate the neuronal cell layer through rapid enhancement of neurogenesis. Neural stem/progenitor cells (NS/NPCs) are present in the adult hippocampal DG, and generate neurons that can function for the cognition ability. Therefore, we investigated whether royal jelly (RJ) stimulates the regenerating processes of the TMT-injured hippocampal DG, and found that orally administered RJ significantly increased the number of DG granule cells and simultaneously improved the cognitive impairment. Furthermore, we have already shown that RJ facilitates neurogenesis of cultured NS/NPCs. These present results, taken together with previous observations, suggest that the orally administered RJ may be a promising avenue for ameliorating neuronal function by regenerating hippocampal granule cells that function in the cognition process.</p>
]]></description>
<dc:creator><![CDATA[Hattori, N., Ohta, S., Sakamoto, T., Mishima, S., Furukawa, S.]]></dc:creator>
<dc:date>2009-04-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep029</dc:identifier>
<dc:title><![CDATA[Royal Jelly Facilitates Restoration of the Cognitive Ability in Trimethyltin-Intoxicated Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep024v1?rss=1">
<title><![CDATA[Brazilian Propolis Suppresses Angiogenesis by Inducing Apoptosis in Tube-forming Endothelial Cells through Inactivation of Survival Signal ERK1/2]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep024v1?rss=1</link>
<description><![CDATA[
<p>We recently reported that propolis suppresses tumor-induced angiogenesis through tube formation inhibition and apoptosis induction in endothelial cells. However, molecular mechanisms underlying such angiogenesis suppression by propolis have not been fully elucidated. The aim of this study was to investigate the effects of ethanol extract of Brazilian propolis (EEBP) on two major survival signals, extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt, and to elucidate whether changes in these signals were actually involved in antiangiogenic effects of the propolis. Detection by western blotting revealed that EEBP suppressed phosphorylation of ERK1/2, but not that of Akt. Pharmacological inhibition by U0126 demonstrated that ERK1/2 inactivation alone was enough to inhibit tube formation and induce apoptosis. It was also shown that EEBP and U0126 similarly induced activation of caspase-3 and cleavage of poly ADP-ribose polymerase (PARP) and lamin A/C, all of which are molecular markers of apoptosis. These results indicate that inhibition of survival signal ERK1/2, and subsequent induction of apoptosis, is a critical mechanism of angiogenesis suppression by EEBP.</p>
]]></description>
<dc:creator><![CDATA[Kunimasa, K., Ahn, M.-R., Kobayashi, T., Eguchi, R., Kumazawa, S., Fujimori, Y., Nakano, T., Nakayama, T., Kaji, K., Ohta, T.]]></dc:creator>
<dc:date>2009-04-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep024</dc:identifier>
<dc:title><![CDATA[Brazilian Propolis Suppresses Angiogenesis by Inducing Apoptosis in Tube-forming Endothelial Cells through Inactivation of Survival Signal ERK1/2]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep022v1?rss=1">
<title><![CDATA[Quality of Reporting of Randomized Clinical Trials in Tai Chi Interventions--A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep022v1?rss=1</link>
<description><![CDATA[
<p><b>Objectives:</b> To evaluate the reporting quality of published randomized clinical trials (RCTs) in the Tai Chi literature following the publication of the CONSORT guidelines in 2001.</p>
<p><b>Data sources:</b> The OVID MEDLINE and PUBMED databases</p>
<p><b>Review methods:</b> To survey the general characteristics of Tai Chi RCTs in the literature, we included any report if (i) it was an original report of the trial; (ii) its design was RCT; (iii) one of the treatments being tested was Tai Chi; and (iv) it was in English. In addition, we assessed the reporting quality of RCTs that were published between 2002 and 2007, using a modified CONSORT checklist of 40 items. The adequate description of Tai Chi interventions in these trials was examined against a 10-item checklist adapted from previous reviews.</p>
<p><b>Results:</b> The search yielded 31 Tai Chi RCTs published from 2002 to 2007 and only 11 for 1992&ndash;2001. Among trials published during 2002&ndash;2007, the most adequately reported criteria were related to background, participant eligibility and interpretation of the study results. Nonetheless, the most poorly reported items were associated with randomization allocation concealment, implementation of randomization and the definitions of period of recruitment and follow-up. In addition, only 23% of RCTs provided adequate details of Tai Chi intervention used in the trials.</p>
<p><b>Conclusion:</b> The findings in this review indicated that the reporting quality of Tai Chi intervention trials is sub-optimal. Substantial improvement is required to meet the CONSORT guidelines and allow assessment of the quality of evidence. We believe that not only investigators, but also journal editors, reviewers and funding agencies need to follow the CONSORT guidelines to improve the standards of research and strengthen the evidence base for Tai Chi and for complementary and alternative medicine.</p>
]]></description>
<dc:creator><![CDATA[Li, J.-Y., Zhang, Y.-F., Smith, G. S., Xue, C.-J., Luo, Y.-N., Chen, W.-H., Skinner, C. J., Finkelstein, J.]]></dc:creator>
<dc:date>2009-04-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep022</dc:identifier>
<dc:title><![CDATA[Quality of Reporting of Randomized Clinical Trials in Tai Chi Interventions--A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep027v1?rss=1">
<title><![CDATA[Analgesic Effects and the Mechanisms of Anti-Inflammation of Hispolon in Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep027v1?rss=1</link>
<description><![CDATA[
<p>Hispolon, an active ingredient in the fungi <I>Phellinus linteus</I> was evaluated with analgesic and anti-inflammatory effects. Treatment of male ICR mice with hispolon (10 and 20 mg/kg) significantly inhibited the numbers of acetic acid-induced writhing response. Also, our result showed that hispolon (20 mg/kg) significantly inhibited the formalin-induced pain in the later phase (<I>P</I> <I>&lt;</I> 0.01). In the anti-inflammatory test, hispolon (20 mg/kg) decreased the paw edema at the fourth and fifth hour after -carrageenin (Carr) administration, and increased the activities of superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione reductase (GRx) in the liver tissue. We also demonstrated that hispolon significantly attenuated the malondialdehyde (MDA) level in the edema paw at the fifth hour after Carr injection. Hispolon (10 and 20 mg/kg) decreased the nitric oxide (NO) levels on both the edema paw and serum level at the fifth hour after Carr injection. Also, hispolon (10 and 20 mg/kg) diminished the serum TNF- at the fifth hour after Carr injection. The anti-inflammatory mechanisms of hispolon might be related to the decrease in the level of MDA in the edema paw by increasing the activities of SOD, GPx and GRx in the liver. It probably exerts anti-inflammatory effects through the suppression of TNF- and NO.</p>
]]></description>
<dc:creator><![CDATA[Chang, H.-Y., Sheu, M.-J., Yang, C.-H., Lu, T.-C., Chang, Y. S., Peng, W.-H., Huang, S.-S., Huang, G.-J.]]></dc:creator>
<dc:date>2009-04-06</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep027</dc:identifier>
<dc:title><![CDATA[Analgesic Effects and the Mechanisms of Anti-Inflammation of Hispolon in Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep025v1?rss=1">
<title><![CDATA[San-Huang-Xie-Xin-Tang Protects Against Activated Microglia- and 6-OHDA-induced Toxicity in Neuronal SH-SY5Y Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep025v1?rss=1</link>
<description><![CDATA[
<p>San-Huang-Xie-Xin-Tang (SHXT), composed of <I>Coptidis rhizoma</I>, <I>Scutellariae radix</I> and <I>Rhei rhizoma</I>, is a traditional Chinese herbal medicine used to treat gastritis, gastric bleeding and peptic ulcers. This study investigated the neuroprotective effects of SHXT on microglia-mediated neurotoxicity using co-cultured lipopolysaccharide (LPS)-activated microglia-like BV-2 cells with neuroblastoma SH-SY5Y cells. Effects of SHXT on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity were also examined in SH-SY5Y cells. Results indicated SHXT inhibited LPS-induced inflammation of BV-2 cells by downregulation of iNOS, NO, COX-2, PGE<SUB>2</SUB>, gp91<sup>phox</sup>, iROS, TNF-, IL-1&beta;, inhibition of IB degradation and upregulation of HO-1. In addition, SHXT increased cell viability and down regulated nNOS, COX-2 and gp91<sup>phox</sup> of SH-SY5Y cells co-cultured with LPS activated BV-2 cells. SHXT treatment increased cell viability and mitochondria membrane potential (MMP), decreased expression of nNOS, COX-2, gp91<sup>phox</sup> and iROS, and inhibited IB degradation in 6-OHDA-treated SH-SY5Y cells. SHXT also attenuated LPS activated BV-2 cells- and 6-OHDA-induced cell death in differentiated SH-SY5Y cells with db-cAMP. Furthermore, SHXT-inhibited nuclear translocation of p65 subunit of NF-B in LPS treated BV-2 cells and 6-OHDA treated SH-SY5Y cells. In conclusion, SHXT showed protection from activated microglia- and 6-OHDA-induced neurotoxicity by attenuating inflammation and oxidative stress.</p>
]]></description>
<dc:creator><![CDATA[Shih, Y.-T., Chen, I.-J., Wu, Y.-C., Lo, Y.-C.]]></dc:creator>
<dc:date>2009-04-01</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep025</dc:identifier>
<dc:title><![CDATA[San-Huang-Xie-Xin-Tang Protects Against Activated Microglia- and 6-OHDA-induced Toxicity in Neuronal SH-SY5Y Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep023v1?rss=1">
<title><![CDATA[Allopathic Versus Homeopathic Strategies and the Recurrence of Prescriptions: Results from a Pharmacoeconomic Study in Italy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep023v1?rss=1</link>
<description><![CDATA[
<p>This is a pharmaeconomic study to assess the impact of different, cost-specific pharmacological strategies on the recurrence rate of prescriptions in the treatment of cold symptoms. Data were obtained from a prospective cohort study reporting individual prescriptions histories of subjects experiencing cold symptoms, obtained by a stratified random sample of 316 subjects, clustered into 139 Italian families, followed up for 40 months. Costs of homeopathic and allopathic treatments were recorded within each prescription. A Cox proportional hazards model with random effects was exploited to regress time elapsed between subsequent prescriptions over the relative difference between homeopathic- and allopathic-related costs, adjusting for age and gender and accounting for unobserved individual heterogeneity. Relative risks of event (prescription) re-occurrence have been estimated. The recurrence rate of prescriptions raise when allopathic strategies are preferred to homeopathic alternatives. No significant differences were observed between gender groups, while age was marginally significant. Inter-subjects heterogeneity was not significant.</p>
]]></description>
<dc:creator><![CDATA[Basili, A., Lagona, F., Roberti di Sarsina, P., Basili, C., Valeria Paterna, T.]]></dc:creator>
<dc:date>2009-04-01</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep023</dc:identifier>
<dc:title><![CDATA[Allopathic Versus Homeopathic Strategies and the Recurrence of Prescriptions: Results from a Pharmacoeconomic Study in Italy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep018v1?rss=1">
<title><![CDATA[Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep018v1?rss=1</link>
<description><![CDATA[
<p>Chinese herbal medicine (CHM) has been commonly used for treating insomnia in Asian countries for centuries. The aim of this study was to conduct a large-scale pharmaco-epidemiologic study and evaluate the frequency and patterns of CHM use in treating insomnia. We obtained the traditional Chinese medicine (TCM) outpatient claims from the National Health Insurance in Taiwan for the year 2002. Patients with insomnia were identified from the diagnostic code of International Classification of Disease among claimed visiting files. Corresponding prescription files were analyzed, and an association rule was applied to evaluate the co-prescription of CHM. Results showed that there were 16 134 subjects who visited TCM clinics for insomnia in Taiwan during 2002 and received a total of 29 801 CHM prescriptions. Subjects between 40 and 49 years of age comprised the largest number of those treated (25.3%). In addition, female subjects used CHMs for insomnia more frequently than male subjects (female:male = 1.94:1). There was an average of 4.8 items prescribed in the form of either an individual Chinese herb or formula in a single CHM prescription for insomnia. Shou-wu-teng (<I>Polygonum multiflorum</I>) was the most commonly prescribed single Chinese herb, while Suan-zao-ren-tang was the most commonly prescribed Chinese herbal formula. According to the association rule, the most commonly prescribed CHM drug combination was Suan-zao-ren-tang plus Long-dan-xie-gan-tang, while the most commonly prescribed triple drug combination was Suan-zao-ren-tang, <I>Albizia julibrissin</I>, and <I>P. multiflorum</I>. Nevertheless, further clinical trials are needed to evaluate the efficacy and safety of these CHMs for treating insomnia.</p>
]]></description>
<dc:creator><![CDATA[Chen, F.-P., Jong, M.-S., Chen, Y.-C., Kung, Y.-Y., Chen, T.-J., Chen, F.-J., Hwang, S.-J.]]></dc:creator>
<dc:date>2009-04-01</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep018</dc:identifier>
<dc:title><![CDATA[Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep026v1?rss=1">
<title><![CDATA[A Chinese Herbal Medicine, Tokishakuyakusan, Reduces the Worsening of Impairments and Independence After Stroke: A 1-year Randomized, Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep026v1?rss=1</link>
<description><![CDATA[
<p>In post-stroke patients, the recurrence of stroke and progression of impairments lead to a bedridden state and dementia. As for their treatments, only anti-hypertension and anti-coagulation therapies to prevent the recurrence of stroke are available. In Asia, post-stroke patients with impairments are often treated with herbal medicine. The present study evaluated the effectiveness of tokishakuyakusan (TS) in improving the impairment and independence in post-stroke patients. Thirty-one post-stroke patients (mean age = 81.4 years) were recruited and enrolled. Participants were randomly assigned to the TS group (<I>n</I>=16) or non-treatment (control) group (<I>n</I>=15) and treated for 12 months. Impairments were assessed using the Stroke Impairment Assessment Set (SIAS). Independence was evaluated using the functional independence measure (FIM). For each outcome measure, mean change was calculated every 3 months. The results were that impairments according to SIAS did not significantly change in the TS group. In contrast, SIAS significantly worsened in the control group. There was a significant difference between the two groups. In each term of SIAS, affected lower extremity scores, abdominal muscle strength, function of visuospatial perception, etc. in the TS group were better than those in the control group. Independence according to FIM did not change significantly in the TS group. In contrast, FIM significantly worsened in the control group. There was also a significant difference between the two groups. In conclusion, TS was considered to suppress the impairments of lower limbs and to exert a favorable effect on cerebral function for post-stroke patients.</p>
]]></description>
<dc:creator><![CDATA[Goto, H., Satoh, N., Hayashi, Y., Hikiami, H., Nagata, Y., Obi, R., Shimada, Y.]]></dc:creator>
<dc:date>2009-03-30</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep026</dc:identifier>
<dc:title><![CDATA[A Chinese Herbal Medicine, Tokishakuyakusan, Reduces the Worsening of Impairments and Independence After Stroke: A 1-year Randomized, Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep021v1?rss=1">
<title><![CDATA[Gingyo-San Enhances Immunity and Potentiates Infectious Bursal Disease Vaccination]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep021v1?rss=1</link>
<description><![CDATA[
<p>The purpose of the present study was to investigate the effects of Gingyo-san (GGS), a traditional Chinese medical formula, on peripheral lymphocyte proliferation and serum antibody titers in chickens vaccinated against the infectious bursal disease (IBD) virus. Treatment groups were fed one of three doses of GGS in their diet (0.5%, 1.0% and 2.0%, w/w), and the IBD vaccine was administered at 1 and 3 weeks of age. At Weeks 8, 12 and 16, changes in serum IBD antibody titers were measured via the micro-method and T cell proliferation. In gene expression experiments, GGS-treated peripheral T lymphocytes were stimulated with concanavalin A (ConA) for 24 h. The mRNA expression of interleukin-2 (IL-2), interferon- (IFN-), interleukin-4 (IL-4) and interleukin-12 (IL-12) was determined using a semi-quantitative RT&ndash;PCR assay. The results showed that a low dose of GGS could significantly raise the antibody titers. Medium and high doses of GGS enhanced IL-2 and IFN- production. GGS altered the expression of IL-4 and IL-12 in T lymphocytes. CD4<sup>+</sup> T lymphocyte development was also skewed towards the Th1 phenotype. GGS enhanced cell-mediated immunity and augmented the effects of IBD vaccination in strengthening subsequent anti-viral responses.</p>
]]></description>
<dc:creator><![CDATA[Hung, C.-M., Yeh, C.-C., Chong, K.-Y., Chen, H.-L., Chen, J.-Y., Kao, S.-T., Yen, C.-C., Yeh, M.-H., Lin, M.-S., Chen, C.-M.]]></dc:creator>
<dc:date>2009-03-22</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep021</dc:identifier>
<dc:title><![CDATA[Gingyo-San Enhances Immunity and Potentiates Infectious Bursal Disease Vaccination]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep020v1?rss=1">
<title><![CDATA[Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-methyl-l,3-benzodioxole Isolated from the Fruiting Body of Antrodia camphorate]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep020v1?rss=1</link>
<description><![CDATA[
<p>In this study, 4,7-dimethoxy-5-methyl-l,3-benzodioxole (SY-1) was isolated from three different sources of dried fruiting bodies of <I>Antrodia camphorate</I> (<I>AC</I>). <I>AC</I> is a medicinal mushroom that grows on the inner heartwood wall of <I>Cinnamomum kanehirai Hay</I> (<I>Lauraceae</I>), an endemic species that is used in Chinese medicine for its anti-tumor and immunomodulatory properties. In this study, we demonstrated that SY-1 profoundly decreased the proliferation of human colon cancer cells (COLO 205) through G0/G1 cell-cycle arrest (50&ndash;150 &micro;M) and induction of apoptosis (&gt;150 &micro;M). Cell-cycle arrest induced by SY-1 was associated with a significant increase in levels of p53, p21/Cip1 and p27/Kip1, and a decrease in cyclins D1, D3 and A. In contrast, SY-1 treatment did not induce significant changes in G0/G1 phase cell-cycle regulatory proteins in normal human colonic epithelial cells (FHC). The cells were cultured in soft agar to evaluate anchorage-independent colony formation, and we found that the number of transformed colonies was significantly reduced in the SY-1-treated COLO 205 cells. These findings demonstrate for the first time that SY-1 inhibits human colon cancer cell proliferation through inhibition of cell growth and anchorage-independent colony formation in soft agar. However, the detailed mechanisms of these processes remain unclear and will require further investigation.</p>
]]></description>
<dc:creator><![CDATA[Lien, H.-M., Lin, H.-W., Wang, Y.-J., Chen, L.-C., Yang, D.-Y., Lai, Y.-Y., Ho, Y.-S.]]></dc:creator>
<dc:date>2009-03-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep020</dc:identifier>
<dc:title><![CDATA[Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-methyl-l,3-benzodioxole Isolated from the Fruiting Body of Antrodia camphorate]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep019v1?rss=1">
<title><![CDATA[Integration of Complementary and Alternative Medicine into Family Practices in Germany: Results of a National Survey]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep019v1?rss=1</link>
<description><![CDATA[
<p>More than two-thirds of patients in Germany use complementary and alternative medicine (CAM) provided either by physicians or non-medical practitioners (&lsquo;Heilpraktiker&rsquo;). There is little information about the number of family physicians (FPs) providing CAM. Given the widespread public interest in the use of CAM, this study aimed to ascertain the use of and attitude toward CAM among FPs in Germany. A postal questionnaire developed based on qualitatively derived data was sent to 3000 randomly selected FPs in Germany. A reminder letter including a postcard (containing a single question about CAM use in practice and reasons for non-particpation in the survey) was sent to all FPs who had not returned the questionnaire. Of the 3000 FPs, 1027 (34%) returned the questionnaire and 444 (15%) returned the postcard. Altogether, 886 of the 1471 responding FPs (60%) reported using CAM in their practice. A positive attitude toward CAM was indicated by 503 FPs (55%), a rather negative attitude by 127 FPs (14%). Chirotherapy, relaxation and neural therapy were rated as most beneficial CAM therapies by FPs, whereas neural therapy, phytotherapy and acupuncture were the most commonly used therapies in German family practices. This survey clearly demonstrates that CAM is highly valued by many FPs and is already making a substantial contribution to first-contact primary care in Germany. Therefore, education and research about CAM should be increased. Furthermore, with the provision of CAM by FPs, the role of non-medical CAM practitioners within the German healthcare system is to be questioned.</p>
]]></description>
<dc:creator><![CDATA[Joos, S., Musselmann, B., Szecsenyi, J.]]></dc:creator>
<dc:date>2009-03-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep019</dc:identifier>
<dc:title><![CDATA[Integration of Complementary and Alternative Medicine into Family Practices in Germany: Results of a National Survey]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep014v2?rss=1">
<title><![CDATA[Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep014v2?rss=1</link>
<description><![CDATA[
<p>The composition of a Brazilian green propolis ethanolic extract (Et-Bra) and its effect on <I>Trypanosoma cruzi</I> trypomastigotes and other pathogenic microorganisms have already been reported. Here, we further investigated Et-Bra targets in <I>T. cruzi</I> and its effect on experimental infection of mice. The IC<SUB>50</SUB>/4 days for inhibition of amastigote proliferation was 8.5 &plusmn; 1.8 &micro;g ml<sup>&ndash;1</sup>, with no damage to the host cells. In epimastigotes Et-Bra induced alterations in reservosomes, Golgi complex and mitochondrion. These effects were confirmed by flow cytometry analysis. In trypomastigotes, Et-Bra led to the loss of plasma membrane integrity. The <I>in vitro</I> studies indicate that Et-Bra interferes in the functionality of the plasma membrane in trypomastigotes and of reservosomes and mitochondrion in epimastigotes. Acutely infected mice were treated orally with Et-Bra and the parasitemia, mortality and GPT, GOT, CK and urea levels were monitored. The extract (25&ndash;300 mg kg<sup>&ndash;1</sup> body weight/day for 10 days) reduced the parasitemia, although not at significant levels; increased the survival of the animals and did not induce any hepatic, muscular lesion or renal toxicity. Since Et-Bra was not toxic to the animals, it could be assayed in combination with other drugs. Et-Bra could be a potential metacyclogenesis blocker, considering its effect on reservosomes, which are an important energy source during parasite differentiation.</p>
]]></description>
<dc:creator><![CDATA[Salomao, K., de Souza, E. M., Henriques-Pons, A., Barbosa, H. S., de Castro, S. L.]]></dc:creator>
<dc:date>2009-03-11</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep014</dc:identifier>
<dc:title><![CDATA[Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-11</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep015v1?rss=1">
<title><![CDATA[Wound Healing Activity of Topical Application Forms Based on Ayurveda]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep015v1?rss=1</link>
<description><![CDATA[
<p>The traditional Indian medicine&mdash;Ayurveda, describes various herbs, fats, oils and minerals with anti-aging as well as wound healing properties. With aging, numerous changes occur in skin, including decrease in tissue cell regeneration, decrease in collagen content, loss of skin elasticity and mechanical strength. We prepared five topical anti-aging formulations using cow ghee, flax seed oil, <I>Phyllanthus emblica</I> fruits, <I>Shorea robusta</I> resin, <I>Yashada bhasma</I> as study materials. For preliminary efficacy evaluation of the anti-aging activity we chose excision and incision wound healing animal models and studied the parameters including wound contraction, collagen content and skin breaking strength which in turn is indicative of the tissue cell regeneration capacity, collagenation capacity and mechanical strength of skin. The group treated with the formulations containing <I>Yashada bhasma</I> along with <I>Shorea robusta</I> resin and flax seed oil showed significantly better wound contraction (<I>P</I>&lt;0.01), higher collagen content (<I>P</I> &lt; 0.05) and better skin breaking strength (<I>P</I>&lt;0.01) as compared to control group; thus proposing them to be effective prospective anti-aging formulations.</p>
]]></description>
<dc:creator><![CDATA[Datta, H. S., Mitra, S. K., Patwardhan, B.]]></dc:creator>
<dc:date>2009-02-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep015</dc:identifier>
<dc:title><![CDATA[Wound Healing Activity of Topical Application Forms Based on Ayurveda]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep010v1?rss=1">
<title><![CDATA[Acupuncture's Effects in Treating the Sequelae of Acute and Chronic Spinal Cord Injuries: A Review of Allopathic and Traditional Chinese Medicine Literature]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep010v1?rss=1</link>
<description><![CDATA[
<p>Each year, there are an estimated 12 000 individuals who sustain a spinal cord injury (SCI) in the United States. Improved understanding of the pathophysiology of SCI and its sequelae has over the past 50 years led to the development of medical treatments (especially urologic) that have enhanced short- and long-term survival from these injuries. The prevalence of individuals with SCI in this country is ~250 000 individuals; and beyond the incalculable personal consequences of these devastating neurologic injuries, substantial direct and indirect societal costs result from the sequelae of SCI including paralysis, sensory loss, chronic pain, decubiti and bladder and/or bowel incontinence. The purpose of this treatise is to review the allopathic and traditional Chinese medicine (TCM) literature available through MEDLINE, PubMed and eCAM search engines that discuss the potential uses of acupuncture to treat acute and chronic spinal cord injuries and their sequelae, and present the neurophysiologic mechanisms for acupuncture's beneficial effects. There is evidence that use of electroacupuncture in acute SCI may significantly improve long-term neurologic recovery from these injuries both in terms of motor, sensory and bowel/bladder function with essentially no risk. Acupuncture may even improve neurourologic function in individuals with chronic SCI, and help with management with chronic pain associated with these injuries.</p>
]]></description>
<dc:creator><![CDATA[Dorsher, P. T., McIntosh, P. M.]]></dc:creator>
<dc:date>2009-02-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep010</dc:identifier>
<dc:title><![CDATA[Acupuncture's Effects in Treating the Sequelae of Acute and Chronic Spinal Cord Injuries: A Review of Allopathic and Traditional Chinese Medicine Literature]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-25</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen090v1?rss=1">
<title><![CDATA[Evidences of Protective Potentials of Microdoses of Ultra-high Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen090v1?rss=1</link>
<description><![CDATA[
<p>The present study was undertaken to examine if microdoses of ultra-high diluted arsenic trioxide (a potentized homeopathic remedy, Arsenicum Album 200C, diluted 10<sup>&ndash;400</sup> times) have hepatoprotective potentials in mice subjected to repeated injections of arsenic trioxide. Arsenic intoxicated mice were divided into: (i) those receiving Arsenicum Album-200C daily, (ii) those receiving the same dose of diluted succussed alcohol (Alc 200C) and (iii) another group receiving neither drug nor succussed alcohol. Two other control groups were also maintained: one fed normal diet only and the other receiving normal diet and Alc-200C. Toxicity biomarkers like aspartate and alanine aminotransferases, glutathione reductase, catalase, succinate dehydrogenase, superoxide dismutase and reduced glutathione contents were periodically assayed keeping the observer &lsquo;blinded&rsquo;. Additionally, electron microscopic studies and gelatin zymography for matrix metalloproteinases of liver tissues were made at day 90 and 120. Blood glucose, hemoglobin, estradiol and testosterone contents were also studied. Compared to controls, Arsenicum Album-200C fed mice showed positive modulations of all parameters studied, thereby providing evidence of protective potentials of the homeopathic drug against chronic arsenic poisoning.</p>
]]></description>
<dc:creator><![CDATA[Banerjee, P., Bhattacharyya, S. S., Pathak, S., Boujedaini, N., Belon, P., Khuda-Bukhsh, A. R.]]></dc:creator>
<dc:date>2009-02-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen090</dc:identifier>
<dc:title><![CDATA[Evidences of Protective Potentials of Microdoses of Ultra-high Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep006v2?rss=1">
<title><![CDATA[WHO Standard Acupuncture Point Locations]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep006v2?rss=1</link>
<description><![CDATA[
<p><b>&lsquo;</b><I>WHO Standard Acupuncture Point Locations in the Western Pacific Region</I> (WHO Standard) was released in 2008. Initially, there were 92/361 controversial acupuncture points (acupoints). Through seven informal consultations and four task force team meetings, 86 points were agreed upon among the 92 controversial acupoints, leaving 6 remaining controversial acupoints, demanding active research in the future. This will enhance the reproducibility and validity of acupuncture studies. It will also lead to a better understanding of acupuncture mechanisms in order to optimize its clinical efficacy for a range of diseases and syndromes. This book has two parts: General Guidelines for Acupuncture Point Locations and WHO Standard Acupuncture Point Locations. First of all, familiarity with the General Guidelines for Acupuncture Point Locations in this book can help the reader to understand and use the contents of this book in depth. I would like to thank all of the participating experts and scholars for this great work, who have overcome the limits of previous acupuncture references. I also appreciate the dedicated effort and harmonious leadership of Dr Choi Seung-hoon, former Regional Adviser in Traditional Medicine of Western Pacific Office, WHO.</p>
]]></description>
<dc:creator><![CDATA[Lim, S.]]></dc:creator>
<dc:date>2009-02-24</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep006</dc:identifier>
<dc:title><![CDATA[WHO Standard Acupuncture Point Locations]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-24</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep011v1?rss=1">
<title><![CDATA[Garlic Increases Antioxidant Levels in Diabetic and Hypertensive Rats Determined by a Modified Peroxidase Method]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep011v1?rss=1</link>
<description><![CDATA[
<p>Oxidative damage by free radicals has been implicated in the pathogenesis of vascular disease in diabetes and hypertension. In the present study, the total antioxidant status in diabetic and hypertensive rats before and after treatment with garlic (<I>Allium sativum</I>) was determined. The total serum antioxidants were measured by a modified method reported earlier by Miller and coworkers. The reproducibility of the assay was confirmed by determining standard curves for the known antioxidants: trolox (a stable analog of vitamin E), glutathione and vitamin C with interassay correlation coefficients (<I>R<sup>2</sup></I>, <I>n</I> = 10 in triplicate) of 0.9984, 0.9768 and 0.987, respectively, confirming the reliability and reproducibility of the assay. This assay was then used to determine total serum antioxidant levels of streptozotocin-induced diabetic rats and two-kidney one-clip hypertensive rats both before and after 3 weeks of treatment with an aqueous extract of garlic (500 mg/kg IP daily). The serum antioxidant levels of rats after 3 weeks of treatment were significantly higher (<I>P</I> &lt; 0.001) than the pretreatment levels in both diabetic and hypertensive rats. The increased serum antioxidant levels were paralleled by a decrease in serum glucose in the garlic-treated diabetic rats and lowered systolic blood pressure in the garlic-treated hypertensive rats. We conclude from our study that (i) total antioxidants can be measured by a simple, reproducible, reliable assay and (ii) the total antioxidant status can be significantly improved by treatment with garlic.</p>
]]></description>
<dc:creator><![CDATA[Drobiova, H., Thomson, M., Al-Qattan, K., Peltonen-Shalaby, R., Al-Amin, Z., Ali, M.]]></dc:creator>
<dc:date>2009-02-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep011</dc:identifier>
<dc:title><![CDATA[Garlic Increases Antioxidant Levels in Diabetic and Hypertensive Rats Determined by a Modified Peroxidase Method]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep005v1?rss=1">
<title><![CDATA[Theories and Management of Aging: Modern and Ayurveda Perspectives]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep005v1?rss=1</link>
<description><![CDATA[
<p>Aging is a complex phenomenon, a sum total of changes that occur in a living organism with the passage of time and lead to decreasing ability to survive stress, increasing functional impairment and growing probability of death. There are many theories of aging and skin remains the largest organ of the study. Skin aging is described as a consequence of intrinsic and extrinsic factors. The most common amongst visible signs of skin aging are wrinkles and there are various therapies including antiaging cosmeceuticals, sunscreens, chemical peeling, injectable agents, such as botox, fibrel, autologous fat grafting as also few surgical procedures have been used. Ayurveda, the Indian traditional medicine, describes aging with great details. This review provides modern and Ayurvedic perspectives on theories and management of aging.</p>
]]></description>
<dc:creator><![CDATA[Datta, H. S., Mitra, S. K., Paramesh, R., Patwardhan, B.]]></dc:creator>
<dc:date>2009-02-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep005</dc:identifier>
<dc:title><![CDATA[Theories and Management of Aging: Modern and Ayurveda Perspectives]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-20</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep004v1?rss=1">
<title><![CDATA[A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep004v1?rss=1</link>
<description><![CDATA[
<p>Dang Gui Bu Xue Tang (DBT), a Chinese medicinal decoction contains Radix <I>Angelicae sinensis</I> (Danggui) and Radix Astragali (Huangqi) at a ratio of 1:5, is used commonly for treating women's ailments. This study was conducted to explore the effects of this preparation on insulin resistance in rats fed with 6-week diet containing 60% fructose. Similar to the action of rosiglitazone (4 mg kg<sup>&ndash;1</sup> per day by an oral administration), repeated oral administration of DBT (2.5 g kg<sup>&ndash;1</sup> per day) for 14 days was found to significantly alleviate the hyperglycemia but made no influence on plasma lipid profiles nor weight gain in fructose chow-fed rats. Also, the higher degree of insulin resistance as measured by homeostasis model assessment of basal insulin resistance in fructose chow-fed rats was significantly decreased by repeated DBT treatment. DBT displays the characteristic of rosiglitazone by increasing the whole-body insulin sensitivity in fructose chow-fed rats after 2-week treatment, as evidenced by the marked elevation of composite whole-body insulin sensitivity index during the oral glucose tolerance test. DBT improves insulin sensitivity through increased post-receptor insulin signaling mediated by enhancements in insulin receptor substrate-1-associated phosphatidylinositol 3-kinase step and glucose transporter subtype 4 translocation in soleus muscles of animals exhibiting insulin resistance. DBT is therefore proposed as potentially useful adjuvant therapy for patients with insulin resistance and/or the patients who wish to increase insulin sensitivity.</p>
]]></description>
<dc:creator><![CDATA[Liu, I-M., Tzeng, T.-F., Liou, S.-S.]]></dc:creator>
<dc:date>2009-02-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep004</dc:identifier>
<dc:title><![CDATA[A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep007v1?rss=1">
<title><![CDATA[Triterpenic Acids Present in Hawthorn Lower Plasma Cholesterol by Inhibiting Intestinal ACAT Activity in Hamsters]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep007v1?rss=1</link>
<description><![CDATA[
<p>Hawthorn (<I>Crataegus pinnatifida</I>) is an edible fruit used in traditional Chinese medicine to lower plasma lipids. This study explored lipid-lowering compounds and underlying mechanisms of action of hawthorn. Hawthorn powder extracts inhibited acylCoA:cholesterol acyltransferase (ACAT) activity in Caco-2 cells. The inhibitory activity was positively associated with triterpenic acid [i.e. oleanolic acid (OA) and ursolic acid (UA)] contents in the extracts. Cholesterol lowering effects of hawthorn and its potential additive effect in combination with plant sterol esters (PSE) were further studied in hamsters. Animals were fed a semi-synthetic diet containing 0.08% (w/w) cholesterol (control) or the same diet supplemented with (i) 0.37% hawthorn dichloromethane extract, (ii) 0.24% PSE, (iii) hawthorn dichloromethane extract (0.37%) plus PSE (0.24%) or (iv) OA/UA mixture (0.01%) for 4 weeks. Compared to the control diet, hawthorn, PSE, hawthorn plus PSE and OA/UA significantly lowered plasma non-HDL (VLDL + LDL) cholesterol concentrations by 8%, 9%, 21% and 6% and decreased hepatic cholesterol ester content by 9%, 23%, 46% and 22%, respectively. The cholesterol lowering effects of these ingredients were conversely associated with their capacities in increasing fecal neutral sterol excretion. In conclusion, OA and UA are responsible for the cholesterol lowering effect of hawthorn by inhibiting intestinal ACAT activity. In addition, hawthorn and particularly its bioactive compounds (OA and UA) enhanced the cholesterol lowering effect of plant sterols.</p>
]]></description>
<dc:creator><![CDATA[Lin, Y., Vermeer, M. A., A. Trautwein, E.]]></dc:creator>
<dc:date>2009-02-19</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep007</dc:identifier>
<dc:title><![CDATA[Triterpenic Acids Present in Hawthorn Lower Plasma Cholesterol by Inhibiting Intestinal ACAT Activity in Hamsters]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep009v1?rss=1">
<title><![CDATA[Acupuncture at 'Zusanli' (St.36) and 'Sanyinjiao' (SP.6) Points on the Gastrointestinal Tract: A Study of the Bioavailability of 99mTc-Sodium Pertechnetate in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep009v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study is to investigate the differences of acupuncture effect between the Zusanli (St.36) and Sanyinjiao (SP.6) points on the gastrointestinal-tract (GIT) segment performed by the bioavailability of <sup>99m</sup>Tc-sodium-pertechnetate (Na<sup>99m</sup>TcO<SUB>4</SUB>) in rats. Male Wistar rats (<I>n</I> = 21) were allocated into three groups of seven each. Group 1 was treated by acupuncture bilaterally at St.36; Group 2 at SP.6; and Group 3 was untreated (control). After 10 min of needle insertion in anesthetized rats, 0.3 ml of Na<sup>99m</sup>TcO<SUB>4</SUB> (7.4 MBq) was injected via ocular-plexus. After 20 min, the exitus of animals was induced by cervical-dislocation and GIT organs isolated. However, immediately before the exitus procedure, blood was collected by cardiac-puncture for blood radio-labeling (BRL).The radioactivity uptake of the blood constituents was calculated together with the GIT organs by a well gamma counter. The percentage of injected dose per gram of tissue (%ID/g) of Na<sup>99m</sup>TcO<SUB>4</SUB> was calculated for each GIT organs, while BRL was calculated in%ID. According to the one-way ANOVA, the stomach, jejunum, ileum from the treated groups (Group 1 and Group 2) had significant differences compared to the controls (Group 3). However, between the treated groups (Group 1 and Group 2), there were significant differences (<I>P</I> &lt; 0.05) in the stomach, jejunum, ileum, cecum, transverse and rectum. In BRL analysis, Group 2 showed significant increase and decrease of the insoluble and soluble fractions of the blood cells, respectively (<I>P</I> &lt; 0.0001). The authors suggest that St.36 may have a tendency of up-regulation effect on GIT, whereas SP.6, down-regulation effect. However, further rigorous experimental studies to examine the effectiveness of acupuncture in either acupuncture points need to be carried out.</p>
]]></description>
<dc:creator><![CDATA[Senna-Fernandes, V., Franca, D. L. M., de Souza, D., Santos, K. C. M., Sousa, R. S., Manoel, C. V., Santos-Filho, S. D., Bernardo-Filho, M., Guimaraes, M. A. M.]]></dc:creator>
<dc:date>2009-02-12</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep009</dc:identifier>
<dc:title><![CDATA[Acupuncture at 'Zusanli' (St.36) and 'Sanyinjiao' (SP.6) Points on the Gastrointestinal Tract: A Study of the Bioavailability of 99mTc-Sodium Pertechnetate in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep012v1?rss=1">
<title><![CDATA[Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep012v1?rss=1</link>
<description><![CDATA[
<p>&lsquo;Boiogito&rsquo; is a Kampo preparation which has been used since ancient times in patients with obesity of the &lsquo;asthenic constitution&rsquo; type, so-called &lsquo;watery obesity&rsquo;, and its effect has been recognized clinically. In this study, we investigated the anti-obesity effect of Boiogito in the TSOD (Tsumura Suzuki Obese Diabetes) mouse, a model of spontaneous obese type II diabetes mellitus. Boiogito showed a significant anti-obesity effect in TSOD mice by suppressing body weight gain in a dosage-dependent manner. In addition, Boiogito showed significant ameliorative effects on features of metabolic syndrome such as hyperinsulinemia, fasting hyperglycemia and abnormal lipid metabolism. Regarding lipid accumulation in TSOD mice, Boiogito showed a significant suppressive effect on accumulation of subcutaneous fat, but the effect on the visceral fat accumulation that constitutes the basis of metabolic syndrome was weak, and the suppressive effect on insulin resistance was also weak. Furthermore, Boiogito did not alleviate the abnormal glucose tolerance, the hypertension or the peripheral neuropathy characteristically developed in the TSOD mice. In contrast, in the TSNO (Tsumura Suzuki Non-Obesity) mice used as controls, Boiogito suppressed body weight gain and accumulation of subcutaneous and visceral fat. The above results suggested that Boiogito is effective as an anti-obesity drug against obesity of the &lsquo;asthenic constitution&rsquo; type in which subcutaneous fat accumulates, but cannot be expected to exert a preventive effect against various symptoms of metabolic syndrome that are based on visceral fat accumulation.</p>
]]></description>
<dc:creator><![CDATA[Shimada, T., Akase, T., Kosugi, M., Aburada, M.]]></dc:creator>
<dc:date>2009-02-10</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep012</dc:identifier>
<dc:title><![CDATA[Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep013v1?rss=1">
<title><![CDATA[Protective Effects of Chinese Traditional Medicine Buyang Huanwu Decoction on Myocardial Injury]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep013v1?rss=1</link>
<description><![CDATA[
<p>Many clinical studies have reported that Buyang Huanwu Decoction (BYHWD) has a protective effect on ischemic heart disease (IHD). In the present study, the protective effect of BYHWD on myocardial ischemia was investigated. Different doses of BYHWD and Compound Danshen Dropping Pills (CDDP) were lavaged to rats respectively, isoproterenol (ISO) was intraperitoneally injected in to all animals to induce myocardial ischemia except the control group. Electrocardiogram (ECG) of each animal was recorded; activities of lactate dehydrogenase (LDH), creatine kinase (CK) and aspartate aminotransferase (AST) in serum were detected. As the results of ECG showed, pre-treatment with BYHWD inhibited ischemic myocardial injury, and the activities of LDH, CK and AST were lower than those in the myocardial ischemia model group, which suggests that BYHWD rescues the myocardium from ischemia status. To research the potential mechanism, the level of nitric oxide (NO), nitric oxide syntheses (NOS) and inducible nitric oxide syntheses (iNOS), the expression of iNOS and ligand of cluster of differentiation 40 (CD40L) were detected. The results revealed that BYHWD significantly decreased the level of NO, NOS and iNOS in serum. Moreover, BYHWD decreased the expression of iNOS and CD40L in myocardial tissues. These results indicate that the protective effect of BYHWD on myocardial ischemia and mechanism are associated with inhibition of iNOS and CD40L expression.</p>
]]></description>
<dc:creator><![CDATA[Yang, G., Fang, Z., Liu, Y., Zhang, H., Shi, X., Ji, Q., Lin, Q., Lin, R.]]></dc:creator>
<dc:date>2009-02-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep013</dc:identifier>
<dc:title><![CDATA[Protective Effects of Chinese Traditional Medicine Buyang Huanwu Decoction on Myocardial Injury]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen089v1?rss=1">
<title><![CDATA[Winnowing the Chaff of Charlatanism from the Wheat of Science]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen089v1?rss=1</link>
<description><![CDATA[
<p>Experts and lay people alike can sometimes find it difficult to demarcate the absurd. Here I propose a set of criteria that may be helpful in achieving this in the realm of healthcare: falsifiability, plausibility and some hallmarks of pseudoscience. Applying this method is unlikely to be fool-proof but it might be a valuable aid in discriminating credible from incredible health claims.</p>
]]></description>
<dc:creator><![CDATA[Ernst, E.]]></dc:creator>
<dc:date>2009-02-06</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen089</dc:identifier>
<dc:title><![CDATA[Winnowing the Chaff of Charlatanism from the Wheat of Science]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-06</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep003v1?rss=1">
<title><![CDATA[Antioxidant and Preventive Effects of Extract from Nymphaea candida Flower on In vitro Immunological Liver Injury of Rat Primary Hepatocyte Cultures]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep003v1?rss=1</link>
<description><![CDATA[
<p><I>Nymphaea candida</I> is traditional Uighur medicine that is commonly used to treat head pains, cough, hepatitis and hypertension in Xinjiang of China. In this article, the extract of <I>N. candida</I> was measured for antioxidant activity, using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals scavenging assay and reducing power determination, and compared with those of the positive controls of butylated hydroxytoluene (BHT) and gallic acid (GA). The active extract was further purified by liquid&ndash;liquid partition to afford four fractions, of which the ethyl acetate-soluble (EA) fraction (NCE) exhibited the strongest antioxidant capacity with IC<SUB>50</SUB> value of 12.6 &micro;g/ml for DPPH&middot;. Thirteen phenolic compounds were isolated from this fraction, and they all showed significant antioxidant activities in DPPH model system. Furthermore, NCE showed potent antioxidant capacity with IC<SUB>50</SUB> value of 59.32 &micro;g/ml, 24.48 &micro;g/ml and 86.85 &micro;g/ml, for O<SUB>2</SUB><sup>&ndash;</sup>,&middot;OH and H<SUB>2</SUB>O<SUB>2</SUB> radicals, respectively. Moreover, NCE on BCG plus LPS-induced immunological liver injury was evaluated using primary cultured rat hepatocytes. NCE produced significant hepatoprotective effects as evidenced by decreased supernatant enzyme activities (AST&mdash;aspartate transaminase, <I>P</I> &lt; 0.01; ALT&mdash;alanine transferase, <I>P</I> &lt; 0.01) and nitric oxide (NO, <I>P</I> &lt; 0.01) production. These results revealed the <I>in vitro</I> antioxidant and hepatoprotective activities of NCE against immunological liver injury. Further investigations are necessary to verify these activities <I>in vivo</I>.</p>
]]></description>
<dc:creator><![CDATA[Zhao, J., Liu, T., Ma, L., Yan, M., Gu, Z., Huang, Y., Xu, F., Zhao, Y.]]></dc:creator>
<dc:date>2009-02-05</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep003</dc:identifier>
<dc:title><![CDATA[Antioxidant and Preventive Effects of Extract from Nymphaea candida Flower on In vitro Immunological Liver Injury of Rat Primary Hepatocyte Cultures]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-05</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep002v1?rss=1">
<title><![CDATA[Alstonine as an Antipsychotic: Effects on Brain Amines and Metabolic Changes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep002v1?rss=1</link>
<description><![CDATA[
<p>Managing schizophrenia has never been a trivial matter. Furthermore, while classical antipsychotics induce extrapyramidal side effects and hyperprolactinaemia, atypical antipsychotics lead to diabetes, hyperlipidaemia, and weight gain. Moreover, even with newer drugs, a sizable proportion of patients do not show significant improvement. Alstonine is an indole alkaloid identified as the major component of a plant-based remedy used in Nigeria to treat the mentally ill. Alstonine presents a clear antipsychotic profile in rodents, apparently with differential effects in distinct dopaminergic pathways. The aim of this study was to complement the antipsychotic profile of alstonine, verifying its effects on brain amines in mouse frontal cortex and striatum. Additionally, we examined if alstonine induces some hormonal and metabolic changes common to antipsychotics. HPLC data reveal that alstonine increases serotonergic transmission and increases intraneuronal dopamine catabolism. In relation to possible side effects, preliminary data suggest that alstonine does not affect prolactin levels, does not induce gains in body weight, but prevents the expected fasting-induced decrease in glucose levels. Overall, this study reinforces the proposal that alstonine is a potential innovative antipsychotic, and that a comprehensive understanding of its neurochemical basis may open new avenues to developing newer antipsychotic medications.</p>
]]></description>
<dc:creator><![CDATA[Linck, V. M., Herrmann, A. P., Piato, A. L., Detanico, B. C., Figueiro, M., Florio, J., Iwu, M. M., Okunji, C. O., Leal, M. B., Elisabetsky, E.]]></dc:creator>
<dc:date>2009-02-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep002</dc:identifier>
<dc:title><![CDATA[Alstonine as an Antipsychotic: Effects on Brain Amines and Metabolic Changes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nep001v1?rss=1">
<title><![CDATA[Acupuncture and Auricular Acupressure in Relieving Menopausal Hot Flashes of Bilaterally Ovariectomized Chinese Women: A Randomized Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nep001v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study is to explore the effects of acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized Chinese women. Between May 2006 and March 2008, 46 bilaterally ovariectomized Chinese women were randomized into an acupuncture and auricular acupressure group (<I>n</I> = 21) and a hormone replacement therapy (HRT) group (Tibolone, <I>n</I> = 25). Each patient was given a standard daily log and was required to record the frequency and severity of hot flashes and side effects of the treatment felt daily, from 1 week before the treatment started to the fourth week after the treatment ended. The serum levels of follicle stimulating hormone (FSH), LH and E<SUB>2</SUB> were detected before and after the treatment. After the treatment and the follow-up, both the severity and frequency of hot flashes in the two groups were relieved significantly when compared with pre-treatment (<I>P</I> &lt; 0.05). There was no significant difference in the severity of hot flashes between them after treatment (<I>P</I> &gt; 0.05), while after the follow-up, the severity of hot flashes in the HRT group was alleviated more. After the treatment and the follow-up, the frequency of menopausal hot flashes in the HRT group was reduced more (<I>P</I> &lt; 0.05). After treatment, the levels of FSH decreased significantly and the levels of E<SUB>2</SUB> increased significantly in both groups (<I>P</I> &lt; 0.05), and they changed more in the HRT group (<I>P</I> &lt; 0.05). Acupuncture and auricular acupressure can be used as alternative treatments to relieve menopausal hot flashes for those bilaterally ovariectomized women who are unable or unwilling to receive HRT.</p>
]]></description>
<dc:creator><![CDATA[Zhou, J., Qu, F., Sang, X., Wang, X., Nan, R.]]></dc:creator>
<dc:date>2009-02-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep001</dc:identifier>
<dc:title><![CDATA[Acupuncture and Auricular Acupressure in Relieving Menopausal Hot Flashes of Bilaterally Ovariectomized Chinese Women: A Randomized Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-02-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen091v1?rss=1">
<title><![CDATA[Filtrate of Phellinus linteus Broth Culture Reduces Infarct Size Significantly in a Rat Model of Permanent Focal Cerebral Ischemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen091v1?rss=1</link>
<description><![CDATA[
<p><I>Phellinus linteus</I>, a natural growing mushroom, has been known to exhibit anti-tumor, anti-inflammatory, anti-allergic and anti-oxidant effects. Aiming to exploit the neuroprotective effects of <I>P. linteus</I>, we evaluated its effects on infarct volume reduction in a rat model of focal cerebral ischemia. Male Sprague&ndash;Dawley rats were subjected to right middle cerebral artery occlusion. Filtrate of <I>P. linteus</I> broth culture (various doses), fractionated filtrate (based on molecular weight) or control medium was administered intraperitoneally to rats before or after ischemia induction. Rats were killed at 24 h after the stroke surgery. Cortical and caudoputaminal infarct volumes were determined separately using an image analysis program following staining with 2,3,5-triphenyltetrazolium chloride. Significant cortical infarct volume reductions were found in the pre-treatment groups (30 and 60 min before onset of cerebral ischemia) compared with the control group, showing dose dependence. Posttreatment (30 min after ischemic onset) also significantly reduced cortical infarct volume. Furthermore, the higher molecular weight (&ge;12 000) fraction of the culture filtrate was more effective compared with the lower molecular weight fraction. The present findings suggest that <I>P. linteus</I> may be a new promising approach for the treatment of focal cerebral ischemia, with the additional benefit of a wide therapeutic time window since significant infarct volume reduction is obtained by administration even after the ischemic event. Our finding that the higher molecular weight fraction of the <I>P. linteus</I> culture filtrate demonstrated more prominent effect may provide a clue to identify the neuroprotective substances and mechanisms.</p>
]]></description>
<dc:creator><![CDATA[Suzuki, S., Kawamata, T., Okada, Y., Kobayashi, T., Nakamura, T., Hori, T.]]></dc:creator>
<dc:date>2009-01-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen091</dc:identifier>
<dc:title><![CDATA[Filtrate of Phellinus linteus Broth Culture Reduces Infarct Size Significantly in a Rat Model of Permanent Focal Cerebral Ischemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen074v3?rss=1">
<title><![CDATA[A Standardized Transcutaneous Electric Acupoint Stimulation for Relieving Tobacco Urges in Dependent Smokers]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen074v3?rss=1</link>
<description><![CDATA[
<p>The efficacy of acupuncture in smoking cessation, and its effect on the urge to smoke are unclear. We evaluated the effect of a standardized protocol of transcutaneous electric acupoint stimulations (TEAS) on alleviating the urge to smoke. Ninety-eight smokers were recruited in two double-blind studies. Participants abstained from smoking for 26 h, and were randomized to receive TEAS alternating between 2 and 100 Hz at four acupoints (LI4 and PC8, PC6 and TE5) at four different intensities (10, 5, Intermittent 5 or 0 mA). The urge to smoke was assessed by the Questionnaire of Smoking Urges (QSU-Brief). In Experiment 1, the 10 mA group (<I>n</I> = 20) was compared with the 5 mA group (<I>n</I> = 20); the increase in smoking urges did not differ significantly. Considering the possibility that 5 mA may be an active intervention, in Experiment 2, a true placebo (0 mA), and a proxy of placebo [Intermittent 5 mA (i5 mA)] were compared with 10 mA TEAS. In this experiment, 10 mA (<I>n</I> = 20) TEAS showed a tendency to alleviate smoking urges compared with 0 mA (<I>n</I> = 16), and i5 mA (<I>n</I> = 19) TEAS. Only when the data of smokers with Fagerst&ouml;m Test for Nicotine Dependence score &ge;5 were analyzed that the difference between the 10 mA group and the control group (0 and i5 mA) became significant. Based on these preliminary findings, we conclude that TEAS applied on the skin may antagonize the increase in urge to smoke in abstinent-dependent smokers. It seems warranted to assess the efficacy of TEAS in smoking cessation clinical trials involving a larger population of dependent smokers.</p>
]]></description>
<dc:creator><![CDATA[Lambert, C., Berlin, I., Lee, T.-L., Hee, S. W., Tan, A. S. L., Picard, D., Han, J. S.]]></dc:creator>
<dc:date>2009-01-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen074</dc:identifier>
<dc:title><![CDATA[A Standardized Transcutaneous Electric Acupoint Stimulation for Relieving Tobacco Urges in Dependent Smokers]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen088v1?rss=1">
<title><![CDATA[Forgotten Features of Head Zones and Their Relation to Diagnostically Relevant Acupuncture Points]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen088v1?rss=1</link>
<description><![CDATA[
<p>In the 1890s Sir Henry Head discovered certain areas of the skin that develop tenderness (allodynia) in the course of visceral disease. These areas were later termed &lsquo;Head zones&rsquo;. In addition, he also emphasized the existence of specific points within these zones, that he called &lsquo;maximum points&rsquo;, a finding that seems to be almost forgotten today. We hypothesized that two important groups of acupuncture points, the diagnostically relevant Mu and Shu points, spatially and functionally coincide with these maximum points to a large extent. A comparison of Head's papers with the Huang Di Neijing (Yellow Thearch's Inner Classic) and the Zhen Jiu Jia Yi Jing (Systematic Classic of Acupuncture and Moxibustion), two of the oldest still extant Chinese sources on acupuncture, revealed astonishing parallels between the two concepts regarding both point locations and functional aspects. These findings suggest that the Chinese discovery of viscerocutaneous reflexes preceded the discovery in the West by more than 2000 years. Furthermore, the fact that Chinese medicine uses Mu and Shu points not only diagnostically but also therapeutically may give us new insights into the underlying mechanisms of acupuncture.</p>
]]></description>
<dc:creator><![CDATA[Beissner, F., Henke, C., Unschuld, P. U.]]></dc:creator>
<dc:date>2009-01-12</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen088</dc:identifier>
<dc:title><![CDATA[Forgotten Features of Head Zones and Their Relation to Diagnostically Relevant Acupuncture Points]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen086v1?rss=1">
<title><![CDATA[Jungle Honey Enhances Immune Function and Antitumor Activity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen086v1?rss=1</link>
<description><![CDATA[
<p>Jungle honey (JH) is collected from timber and blossom by wild honey bees that live in the tropical forest of Nigeria. JH is used as a traditional medicine for colds, skin inflammation and burn wounds as well as general health care. However, the effects of JH on immune functions are not clearly known. Therefore, we investigated the effects of JH on immune functions and antitumor activity in mice. Female C57BL/6 mice were injected with JH (1 mg/mouse/day, seven times intra-peritoneal). After seven injections, peritoneal cells (PC) were obtained. Antitumor activity was assessed by growth of Lewis Lung Carcinoma/2 (LL/2) cells. PC numbers were increased in JH-injected mice compared to control mice. In Dot Plot analysis by FACS, a new cell population appeared in JH-injected mice. The percent of Gr-1 surface antigen and the intensity of Gr-1 antigen expression of PC were increased in JH-injected mice. The new cell population was neutrophils. JH possessed chemotactic activity for neutrophils. Tumor incidence and weight were decreased in JH-injected mice. The ratio of reactive oxygen species (ROS) producing cells was increased in JH-injected mice. The effective component in JH was fractionized by gel filtration using HPLC and had an approximate molecular weight (MW) of 261. These results suggest that neutrophils induced by JH possess potent antitumor activity mediated by ROS and the effective immune component of JH is substrate of MW 261.</p>
]]></description>
<dc:creator><![CDATA[Fukuda, M., Kobayashi, K., Hirono, Y., Miyagawa, M., Ishida, T., Ejiogu, E. C., Sawai, M., Pinkerton, K. E., Takeuchi, M.]]></dc:creator>
<dc:date>2009-01-12</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen086</dc:identifier>
<dc:title><![CDATA[Jungle Honey Enhances Immune Function and Antitumor Activity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen087v1?rss=1">
<title><![CDATA[Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea corylifolia L. Seeds]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen087v1?rss=1</link>
<description><![CDATA[
<p><I>Psoralea corylifolia</I> L. (Fabaceae) is a widely used medical plant in China. This study was designed to screen and identify bioactive compounds with anticancer activity from the seeds of <I>Psoralea corylifolia</I> L. One volatile fraction (fraction I) and three other fractions (fraction II, III, IV) from methanol extraction of <I>P. corylifolia</I> L. were obtained. Bioactivities of these fractions were evaluated by the cytotoxicity on KB, KBv200, K562, K562/ADM cancer cells with MTT assay. Major components in the active fraction were identified by HPLC/MS<sup>n</sup>. Fraction IV significantly inhibits the growth of cancer cells in a dose-dependent manner. The IC<SUB>50</SUB> values were 21.6, 24.4, 10.0 and 26.9, respectively. Psoralen and isopsoralen, isolated from fraction IV, were subject to bioactive assay and presented a dose-dependent anticancer activity in four cancer cell lines (KB, KBv200, K562 and K562/ADM). The IC<SUB>50</SUB> values of psoralen were 88.1, 86.6, 24.4 and 62.6, which of isopsoralen were 61.9, 49.4, 49.6 and 72.0, respectively. Apoptosis of tumor cell significantly increased after treated with psoralen and isopsoralen. Induction of apoptotic activity was confirmed by flow cytometry after staining with Annexin V/PI. These results suggested psoralen and isopsoralen contribute to anticancer effect of <I>P. corylifolia</I> L.</p>
]]></description>
<dc:creator><![CDATA[Wang, Y., Hong, C., Zhou, C., Xu, D., Qu, H.-b., Cheng, Y.]]></dc:creator>
<dc:date>2009-01-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen087</dc:identifier>
<dc:title><![CDATA[Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea corylifolia L. Seeds]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen085v1?rss=1">
<title><![CDATA[A Chinese Herbal Decoction, Danggui Buxue Tang, Stimulates Proliferation, Differentiation and Gene Expression of Cultured Osteosarcoma Cells: Genomic Approach to Reveal Specific Gene Activation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen085v1?rss=1</link>
<description><![CDATA[
<p>Danggui Buxue Tang (DBT), a Chinese herbal decoction used to treat ailments in women, contains Radix Astragali (Huangqi; RA) and Radix Angelicae Sinensis (Danggui; RAS). When DBT was applied onto cultured MG-63 cells, an increase of cell proliferation and differentiation of MG-63 cell were revealed: both of these effects were significantly higher in DBT than RA or RAS extract. To search for the biological markers that are specifically regulated by DBT, DNA microarray was used to reveal the gene expression profiling of DBT in MG-63 cells as compared to that of RA- or RAS-treated cells. Amongst 883 DBT-regulated genes, 403 of them are specifically regulated by DBT treatment, including CCL-2, CCL-7, CCL-8 and galectin-9. The signaling cascade of this DBT-regulated gene expression was also elucidated in cultured MG-63 cells. The current results reveal the potential usage of this herbal decoction in treating osteoporosis and suggest the uniqueness of Chinese herbal decoction that requires a well-defined formulation. The DBT-regulated genes in the culture could serve as biological responsive markers for quality assurance of the herbal preparation.</p>
]]></description>
<dc:creator><![CDATA[Choi, R. C. Y., Gao, Q. T., Cheung, A. W. H., Zhu, J. T. T., Lau, F. T. C., Li, J., Li, W. Z. M., Chu, G. K. Y., Duan, R., Cheung, J. K. H., Ding, A. W., Zhao, K. J., Dong, T. T. X., Tsim, K. W. K.]]></dc:creator>
<dc:date>2009-01-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen085</dc:identifier>
<dc:title><![CDATA[A Chinese Herbal Decoction, Danggui Buxue Tang, Stimulates Proliferation, Differentiation and Gene Expression of Cultured Osteosarcoma Cells: Genomic Approach to Reveal Specific Gene Activation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen084v1?rss=1">
<title><![CDATA[Cordycepin Induced MA-10 Mouse Leydig Tumor Cell Apoptosis through Caspase-9 Pathway]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen084v1?rss=1</link>
<description><![CDATA[
<p>In the present study, the apoptotic effect of cordycepin on MA-10 cells, a mouse Leydig tumor cell line, was investigated. Results demonstrated that the number of rounding-up cell increased by cordycepin (10 &micro;M to 5 mM for 24 h), and cells with plasma membrane blebbing could be observed by 100 &micro;M cordycepin. In viability test, MA-10 cell surviving rate significantly decreased as the dosage (10 &micro;M to 5 mM) and duration (3&ndash;24 h) of cordycepin treatment increased (<I>P</I> &lt; 0.05). Cordycepin at 100 &micro;M and 1 mM for 24 h treatment induced significant DNA fragmentation (<I>P</I> &lt; 0.05). In addition, the percentage of G1 and G2/M phase cell significantly declined by cordycepin (100 &micro;M and 1 mM) for 24 h treatment, while the percentages of subG1 phase cell increased by 100 &micro;M and/or 1 mM cordycepin in 6, 12 and 24 h treatments (<I>P</I> &lt; 0.05), respectively, which highly suggested that cordycepin induced MA-10 cell apoptosis. In mechanism study with the treatments of caspases, c-Jun NH<SUB>2</SUB> terminal kinase (JNK) or reactive oxygen species (ROS) inhibitors plus cordycepin for 24 h, only caspases inhibitor suppressed subG1 phase in MA-10 cells. Moreover, western blotting results showed that cordycepin induced caspase-9, -3 and -7 protein expressions, but not caspase-8, in time- and dose-dependent manners. In conclusion, cordycepin induced apoptosis in MA-10 mouse Leydig tumor cells through a caspase-9 and -3 and -7 dependent pathway.</p>
]]></description>
<dc:creator><![CDATA[Jen, C.-Y., Lin, C.-Y., Leu, S.-F., Huang, B.-M.]]></dc:creator>
<dc:date>2009-01-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen084</dc:identifier>
<dc:title><![CDATA[Cordycepin Induced MA-10 Mouse Leydig Tumor Cell Apoptosis through Caspase-9 Pathway]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen081v1?rss=1">
<title><![CDATA[Suppressive Effect of Juzen-Taiho-To on Lung Metastasis of B16 Melanoma Cells in vivo]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen081v1?rss=1</link>
<description><![CDATA[
<p>Juzen-Taiho-To (JTT) is well known to be one of Kampo (Japanese herbal) medicine consisted of 10 component herbs and used for the supplemental therapy of cancer patients with remarkably success. However, the precise mechanisms by which JTT could favorably modify the clinical conditions of cancer patients are not well defined. The present study, therefore, was undertaken to examine the possible mechanisms of JTT on prevention of cancer metastasis using experimental mouse model. JTT was well mixed with rodent chow at concentrations of either 0.2 or 1.0%, and administered orally <I>ad libitum</I>, which was started 1 week before tumor cell injection and continue throughout the experiment. Oral administration of JTT at concentration 0.2 and 1.0% into C57BL/6 male mice significantly inhibited tumor metastasis in lungs, which was induced by the intravenous injection of 2 <FONT FACE="arial,helvetica">x</FONT> 10<sup>5</sup> B16 melanoma cell. JTT at a concentration of 1.0% also significantly suppressed lung metastasis of B16 melanoma cell from hind footpad in C57BL/6 mice. In the second part of experiments, the influence of the depression of natural killer (NK) cell, natural killer T (NKT) cell and several types of cytokines on JTT-mediated inhibition of tumor cell metastasis. Intraperitoneal injection of anti asialo-GM1 antibody against NK cells and anti NK-1.1 monoclonal antibody (mAb) to NKT cells abrogated the inhibitory action of JTT on lung metastasis of B16 melanoma cells. Although intraperitoneal administration of anti-IFN- mAb scarcely affected the inhibitory action of JTT on tumor cell metastasis, injection of amrinone, which used for IL-12 suppression, significantly decreased the ability of JTT to prevent tumor cell metastasis. These results strongly suggest that oral administration of JTT caused increase in the production of IL-12, which is responsible for the activation of both NK cell and NKT cell, in the lungs and results in inhibition of B16 melanoma cell metastasis in the lungs.</p>
]]></description>
<dc:creator><![CDATA[Matsuda, T., Maekawa, K., Asano, K., Hisamitsu, T.]]></dc:creator>
<dc:date>2009-01-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen081</dc:identifier>
<dc:title><![CDATA[Suppressive Effect of Juzen-Taiho-To on Lung Metastasis of B16 Melanoma Cells in vivo]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen083v2?rss=1">
<title><![CDATA[A Milestone in Codifying the Wisdom of Traditional Oriental Medicine: TCM, Kampo, TKM, TVM--WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen083v2?rss=1</link>
<description><![CDATA[
<p>The WHO published a dictionary-type book entitled &lsquo;WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region&rsquo; which has a total of 3259 technical terms which have been commonly used in traditional Chinese (TCM), Japanese (Kampo), Korean (TKM) and Vietnamese (TVM) medicines. In this comprehensive guide, each term has the English expression, the original Chinese character and a concise English definition. The book covers 3106 terms from basic theories, diagnostics, diseases, various therapeutics including acupuncture and moxibustion and even the English wording of 153 titles which are considered the most important traditional medical classics published in these four countries. A prominent feature of the compilation is the codification format that assigns numbers in hundred decimal units for each category of the section. This type of coding system provides the flexibility for adding more terminologies in the future and is useful for constructing a database for the retrieval of various published scientific articles. Overall, the usage of these standard terminologies is highly desirable to deliver accurate meanings, and ultimately to avoid a variety of expressions for a single term in different scientific manuscripts on Oriental medicine.</p>
]]></description>
<dc:creator><![CDATA[Choi, S.-H., Chang, I.-M.]]></dc:creator>
<dc:date>2009-01-06</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen083</dc:identifier>
<dc:title><![CDATA[A Milestone in Codifying the Wisdom of Traditional Oriental Medicine: TCM, Kampo, TKM, TVM--WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-06</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen082v1?rss=1">
<title><![CDATA[Evaluation of Oxygen Radical Absorbance Capacity in Kampo Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen082v1?rss=1</link>
<description><![CDATA[
<p>Antioxidant capacity of food has come to be shown in terms of oxygen radical absorbance capacity (ORAC) mainly on vegetables or fruit. However, the evaluation of Kampo in terms of ORAC has not yet been accomplished. It is important that such an investigation is also conducted for Kampo medicine. We measured the ORAC value of almost all the available Kampo formulas used in the Japanese National health insurance system and examined the ORAC value both for the daily prescription, and also the crude herb ingredients. The ORAC value of Kampo medicine ranged 4.65&ndash;5913 units/day. The ORAC value was high in Kampo formulas including Rhei Rhizoma, and was relatively high in Kampo formulas including anti-inflammatory herbs other than Rhei Rhizoma. The ORAC value was also high in Kampo formulas including crude herbs that have relaxation effects. The ORAC value of a crude herb would seem to not be fixed but be dependent on combination with other crude herbs from the comparison of different herbs added to the basic Kampo medicine. These results suggest variability and complexity of the antioxidant capacity of Kampo medicine within the similar range of food. On the other hand, investigation of the compound changes of various crude herbs with ORAC may lead to the elucidation of the action mechanism of Kampo medicine.</p>
]]></description>
<dc:creator><![CDATA[Nishimura, K., Osawa, T., Watanabe, K.]]></dc:creator>
<dc:date>2009-01-06</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen082</dc:identifier>
<dc:title><![CDATA[Evaluation of Oxygen Radical Absorbance Capacity in Kampo Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen080v1?rss=1">
<title><![CDATA[Delayed Effect of Acupuncture Treatment in OA of the Knee: A Blinded, Randomized, Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen080v1?rss=1</link>
<description><![CDATA[
<p>To assess the efficacy in providing improved function and pain relief by administering 8 weeks of acupuncture as adjunctive therapy to standard care in elderly patients with OA of the knee. This randomized, controlled, blinded trial was conducted on 55 patients with OA of the knee. Forty-one patients completed the study (26 females, 15 males, mean age &plusmn; SD 71.7 &plusmn; 8.6 years). Patients were randomly divided into an intervention group that received biweekly acupuncture treatment (<I>n</I> = 28) and a control group that received sham acupuncture (<I>n</I> = 27), both in addition to standard therapy, e.g. NSAIDS, cyclooxygenase-2 inhibitors, acetaminophen, intra-articular hyaluronic acid and steroid injections. Primary outcomes measures were changes in the Knee Society Score (KSS) knee score and in KSS function and pain ratings at therapy onset, at 8 weeks (closure of study) and at 12 weeks (1 month after last treatment). Secondary outcomes were patient satisfaction and validity of sham acupuncture. There was significant improvement in all three scores in both groups after 8 and 12 weeks compared with baseline (<I>P</I>&lt;0.05). Significant differences between the intervention and control groups in the KSS knee score (<I>P</I> = 0.036) was apparent only after 12 weeks. Patient satisfaction was higher in the intervention group. Adjunctive acupuncture treatment seems to provide added improvement to standard care in elderly patients with OA of the knee. Future research should determine the optimal duration of acupuncture treatment in the context of OA.</p>
]]></description>
<dc:creator><![CDATA[Miller, E., Maimon, Y., Rosenblatt, Y., Mendler, A., Hasner, A., Barad, A., Amir, H., Dekel, S., Lev-Ari, S.]]></dc:creator>
<dc:date>2009-01-05</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen080</dc:identifier>
<dc:title><![CDATA[Delayed Effect of Acupuncture Treatment in OA of the Knee: A Blinded, Randomized, Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-01-05</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen079v1?rss=1">
<title><![CDATA[Complementary and Alternative Medicine: Comparison of Current Knowledge, Attitudes and Interest among German Medical Students and Doctors]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen079v1?rss=1</link>
<description><![CDATA[
<p>Although it has been agreed that complementary and alternative medicine (CAM) should be included in the German medical curriculum, there is no consensus on which methods and how it should be taught. This study aimed to assess needs for CAM education by evaluating current knowledge, attitudes and interests of medical students, general physicians and gynecologists. Two instruments based on established and validated questionnaires were developed. One was given to seventh semester medical students and the other to office-based doctors. Data were analyzed by bivariate correlation and cross-tabulation. Altogether 550 questionnaires were distributed&mdash;280 to doctors and 270 to medical students. Completed questionnaires were returned by 80.4% of students and 78.2% of doctors. Although 73.8% (160/219) of doctors and 40% (87/217) of students had already informed themselves about CAM, neither group felt that they knew much about CAM. Doctors believed that CAM was most useful in general medicine, supportive oncology, pediatrics, dermatology and gynecology, while students believed that dermatology, general medicine, psychiatry and rheumatology offered opportunities; both recommended that CAM should be taught in these areas. Both groups believed that CAM should be included in medical education; however, they believed that CAM needed more investigation and should be taught &lsquo;critically&rsquo;. German doctors and students would like to be better informed about CAM. An approach which teaches fundamental competences to students, chooses specific content based on evidence, demographics and medical conditions and provides students with the skills they need for future learning should be adopted.</p>
]]></description>
<dc:creator><![CDATA[Munstedt, K., Harren, H., von Georgi, R., Hackethal, A.]]></dc:creator>
<dc:date>2008-12-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen079</dc:identifier>
<dc:title><![CDATA[Complementary and Alternative Medicine: Comparison of Current Knowledge, Attitudes and Interest among German Medical Students and Doctors]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen066v1?rss=1">
<title><![CDATA[The Biological Safety of Stainless Steel Needles Used in Warm-needling]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen066v1?rss=1</link>
<description><![CDATA[
<p>Warm-needling (also called thermo-acupuncture) is a combination of acupuncture and moxibustion. Due to the intense heat involved, there have been concerns over the biological safety of the acuneedles used in the treatment. This paper reports two phases of a safety test. For a preliminary test, we compared the temperature change patterns of stainless steel (SS304) needles and traditional gold alloy needles, which have been increasingly replaced by the former. To verify the effects of the presence of coating materials, the main test involved three different kinds of SS304: silicone-coated, salicylic acid-coated and non-coated needles. Each group of needles was tested for pH level, heavy metals and UV absorbance spectrum along with biological tests on the cytotoxicity and hemolysis of the needle. All the tests on the extractants from the needles were negative. In the biological tests, each test result showed a significant difference from the positive control samples, while no significant difference was observed compared with the negative control samples. In the hemolysis tests, all samples satisfied the Korean Government Standards. All the results suggest that SS304 needles are biologically safe to be used in warm-needling, though they can be improved to perform as well as the gold alloy needles in terms of temperature fluctuations.</p>
]]></description>
<dc:creator><![CDATA[Lim, S., Lee, S., Yi, S.-H., Son, Y.-S., Choi, S.-m., Kim, Y.-K.]]></dc:creator>
<dc:date>2008-12-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen066</dc:identifier>
<dc:title><![CDATA[The Biological Safety of Stainless Steel Needles Used in Warm-needling]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen078v1?rss=1">
<title><![CDATA[Mediation of Endogenous {beta}-Endorphin in the Plasma Glucose-lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen078v1?rss=1</link>
<description><![CDATA[
<p>Recently, there have been advances in the development of new substances effective in managing diabetic disorders. Opioid receptors couple multiple systems to result in various biological effects, although opioids are best known for analgesia. In the present review, we used our recent data to describe the advance in plasma glucose-lowering action of herbal products, especially the mediation of &beta;-endorphin in glucose homeostasis of insulin-deficient diabetes. In type 1-like streptozotocin-induced diabetic rats, we identified many products purified from herbs that show a dose-dependent plasma glucose-lowering action. Increase in &beta;-endorphin secretion from the adrenal gland may activate peripheral opioid &micro;-receptors (MOR) to enhance the expression of muscle glucose transporters and/or to reduce hepatic gluconeogenesis at the gene level, thereby leading to improved glucose utilization in peripheral tissues for amelioration of severe hyperglycemia. It has also been observed that stimulation of <SUB>1</SUB>-adrenoceptors (<SUB>1</SUB>-ARs) in the adrenal gland by some herbal products is responsible for the increase in &beta;-endorphin secretion via a phospholipase C-protein kinase dependent pathway. However, an increase in &beta;-endorphin secretion from the adrenal gland by herbal products can function via another receptor. New insights into the mediation of endogenous &beta;-endorphin activation of peripheral MOR by herbal products for regulation of glucose homeostasis without the presence of insulin have been established. Therefore, an increase in &beta;-endorphin secretion and/or direct stimulation of peripheral MOR via an insulin-independent action might serve as the potential target for development of a therapeutic agent or promising adjuvant in intensive plasma glucose control.</p>
]]></description>
<dc:creator><![CDATA[Liu, I. M., Cheng, J. T.]]></dc:creator>
<dc:date>2008-12-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen078</dc:identifier>
<dc:title><![CDATA[Mediation of Endogenous {beta}-Endorphin in the Plasma Glucose-lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-17</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen077v1?rss=1">
<title><![CDATA[Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen077v1?rss=1</link>
<description><![CDATA[
<p>Bioassay-guided fractionation of the chloroform extract of <I>Byrsonima fagifolia</I> leaves led to the isolation of active antitubercular compounds alkane dotriacontane (Minimal Inhibitory Concentration&mdash;MIC, 62.5 &micro;g ml<sup>&ndash;1</sup>), triterpenoids as bassic acid (MIC = 2.5 &micro;g ml<sup>&ndash;1</sup>), -amyrin acetate (MIC = 62.5 &micro;g ml<sup>&ndash;1</sup>), a mixture of lupeol, - and &beta;-amyrin (MIC = 31.5 &micro;g ml<sup>&ndash;1</sup>) and a mixture of lupeol, and acetates of - and &beta;-amyrin (MIC = 31.5 &micro;g ml<sup>&ndash;1</sup>). The antimycobacterial activity was determined by the Microplate Alamar Blue Assay (MABA) and the structures of promising compounds were determined by spectroscopic analysis. This investigation constitutes the first report of a chemical and antitubercular study of apolar compounds from <I>B. fagifolia</I> Niedenzu (IK).</p>
]]></description>
<dc:creator><![CDATA[Higuchi, C. T., Sannomiya, M., Pavan, F. R., Leite, S. R. A., Sato, D. N., Franzblau, S. G., Sacramento, L. V. S., Vilegas, W., Leite, C. Q. F.]]></dc:creator>
<dc:date>2008-12-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen077</dc:identifier>
<dc:title><![CDATA[Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen075v1?rss=1">
<title><![CDATA[The Knowledge, Attitudes and Usage of Complementary and Alternative Medicine of Medical Students]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen075v1?rss=1</link>
<description><![CDATA[
<p>The increasing use of CAM by patients has led to an increase in teaching about CAM in medical school in the US. In preparation for initiation of a new curriculum in Integrative Medicine at the David Geffen School of Medicine at UCLA a cross sectional survey was used to assess medical students&rsquo;: (i) familiarity, (ii) opinions, (iii) personal use and (iv) willingness to recommend specific CAM modalities, using a five point Likert scale of an established measure. A total of 263 first, second and third year medical students at UCLA completed surveys. Third year students reported less personal use of CAM and less favorable attitudes towards CAM than first year students. Since this was a cross-sectional rather than longitudinal study this may be a cohort effect. However, it may reflect the increased curricular emphasis on evidenced-based medicine, and subsequent student dependence on randomized clinical trials to influence and guide practice. This will need to be addressed in curricular efforts to incorporate Integrative Medicine.</p>
]]></description>
<dc:creator><![CDATA[DeSylvia, D., Stuber, M., Fung, C. C., Bazargan-Hejazi, S., Cooper, E.]]></dc:creator>
<dc:date>2008-12-10</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen075</dc:identifier>
<dc:title><![CDATA[The Knowledge, Attitudes and Usage of Complementary and Alternative Medicine of Medical Students]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-12-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen070v1?rss=1">
<title><![CDATA[N-Acetylcysteine an Allium plant compound improves high-sucrose diet-induced obesity and related effects]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen070v1?rss=1</link>
<description><![CDATA[
<p>This study was designed to determine whether <I>N</I>-acetylcysteine (NAC, C<SUB>5</SUB>H<SUB>9</SUB>&ndash;NO<SUB>3</SUB>S), a compound from <I>Allium</I> species may be used as a complementary therapeutic agent, to inhibit high-sucrose induced-obesity and its effects on glucose tolerance, <I>in vivo</I> low-density lipoprotein (LDL)-oxidation and serum oxidative stress in rats. Initially, 24 male Wistar rats were divided into two groups: controls receiving standard chow (C, <I>n</I>=6) and those receiving high-sucrose diet (HS, <I>n</I> = 18). After 22 days, (HS) group was divided into three groups (<I>n</I> = 6/group); (HS-HS) continued to eat high-sucrose diet and water; (HS-N) continued to eat high-sucrose diet and received 2 mg l<sup>&ndash;1</sup>-NAC in its drinking water; (HS-CN) changing high-sucrose to standard chow and receiving 2 mg l<sup>&shy;1</sup>-NAC in its drinking water. After 22 days of the HS-group division (44 days of experimental period) body weight, body mass index and surface area were enhanced in HS-HS rats (<I>P</I> &lt; 0.001). HS-HS rats had glucose intolerance, increased serum triacylglycerol (TG), very low-density lipoprotein (VLDL), oxidized-LDL (ox-LDL) and lipid-hydroperoxide (LH) than the others (<I>P</I> &lt; 0.01). NAC in HS-N and HS-CN rats reduced the obesity markers, feed efficiency, LH and ox-LDL, as well normalized glucose response, TG and VLDL (<I>P</I> &lt; 0.01) in these groups compared with HS-HS. Total antioxidant substances, GSH/GSSG ratio and glutathione-reductase, were higher in HS-N than in HS-HS (<I>P</I> &lt; 0.01). In conclusion, NAC improved high-sucrose diet-induced obesity and its effects on glucose tolerance, lipid profile, <I>in vivo</I> LDL-oxidation and serum oxidative stress, enhancing antioxidant defences. The application of this agent may be feasible and beneficial for high-sucrose diet-induced obesity, which certainly would bring new insights on obesity-related adverse effects control.</p>
]]></description>
<dc:creator><![CDATA[Souza, G. A., Ebaid, G. X., Seiva, F. R. F., Rocha, K. H. R., Galhardi, C. M., Mani, F., Novelli, E. L. B.]]></dc:creator>
<dc:date>2008-11-11</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen070</dc:identifier>
<dc:title><![CDATA[N-Acetylcysteine an Allium plant compound improves high-sucrose diet-induced obesity and related effects]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-11</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen068v1?rss=1">
<title><![CDATA[Carthamus Tinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen068v1?rss=1</link>
<description><![CDATA[
<p><I>Carthamus tinctorius</I> (CT), also named safflower, is a traditional Chinese medicine widely used to improve blood circulation. CT also has been studied for its antitumor activity in certain cancers. To investigate the effects of CT on the dendritic cell (DC)-based vaccine in cancer treatment, cytokine secretion of mouse splenic T lymphocytes and the maturation of DCs in response to CT were analyzed. To assess the antitumor activity of CT extract on mouse CD117<sup>+</sup> (c-kit)-derived DCs pulsed with JC mammal tumor antigens, the JC tumor was challenged by the CT-treated DC vaccine <I>in vivo</I>. CT stimulated IFN- and IL-10 secretion of splenic T lymphocytes and enhanced the maturation of DCs by enhancing immunological molecule expression. When DC vaccine was pulsed with tumor antigens along with CT extract, the levels of TNF- and IL-1&beta; were dramatically increased with a dose-dependent response and more immunologic and co-stimulatory molecules were expressed on the DC surface. In addition, CT-treated tumor lysate-pulsed DC vaccine reduced the tumor weight in tumor-bearing mice by 15.3% more than tumor lysate-pulsed DC vaccine without CT treatment. CT polarized cytokine secretion toward the Th1 pathway and also increased the population of cytotoxic T lymphocytes <I>ex vivo</I>. In conclusion, CT activates DCs might promote the recognition of antigens and facilitate antigen presentation to Th1 immune responses.</p>
]]></description>
<dc:creator><![CDATA[Chang, J.-M., Hung, L.-M., Chyan, Y.-J., Cheng, C.-M., Wu, R.-Y.]]></dc:creator>
<dc:date>2008-11-11</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen068</dc:identifier>
<dc:title><![CDATA[Carthamus Tinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-11</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen072v1?rss=1">
<title><![CDATA[Mumijo Traditional Medicine: Fossil Deposits from Antarctica (Chemical Composition and Beneficial Bioactivity)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen072v1?rss=1</link>
<description><![CDATA[
<p>Mumijo is a widely used traditional medicine, especially in Russia, Altai Mountains, Mongolia, Iran Kasachstan and in Kirgistan. Mumijo preparations have been successfully used for the prevention and treatment of infectious diseases; they display immune-stimulating and antiallergic activity as well. In the present study, we investigate the chemical composition and the biomedical potential of a Mumijo(-related) product collected from the Antarctica. The yellow material originates from the snow petrels, <I>Pagodroma nivea</I>. Extensive purification and chemical analysis revealed that the fossil samples are a mixture of glycerol derivatives. <I>In vitro</I> experiments showed that the Mumijo extract caused in cortical neurons a strong neuroprotective effect against the apoptosis-inducing amyloid peptide fragment &beta;-fragment 25&ndash;35 (A&beta;25&ndash;35). In addition, the fraction rich in glycerol ethers/wax esters displayed a significant growth-promoting activity in permanent neuronal PC12 cells. It is concluded that this new Mumijo preparation has distinct and marked neuroprotective activity, very likely due to the content of glycerol ether derivatives.</p>
]]></description>
<dc:creator><![CDATA[Aiello, A., Fattorusso, E., Menna, M., Vitalone, R., Schroder, H. C., Muller, W. E. G.]]></dc:creator>
<dc:date>2008-11-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen072</dc:identifier>
<dc:title><![CDATA[Mumijo Traditional Medicine: Fossil Deposits from Antarctica (Chemical Composition and Beneficial Bioactivity)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen069v1?rss=1">
<title><![CDATA[Dietary Soy Supplement on Fibromyalgia Symptoms: A Randomized, Double-blind, Placebo-controlled, Early Phase Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen069v1?rss=1</link>
<description><![CDATA[
<p>Most patients with fibromyalgia use complementary and alternative medicine (CAM). Properly designed controlled trials are necessary to assess the effectiveness of these practices. This study was a randomized, double-blind, placebo-controlled, early phase trial. Fifty patients seen at a fibromyalgia outpatient treatment program were randomly assigned to a daily soy or placebo (casein) shake. Outcome measures were scores of the Fibromyalgia Impact Questionnaire (FIQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) at baseline and after 6 weeks of intervention. Analysis was with standard statistics based on the null hypothesis, and separation test for early phase CAM comparative trials. Twenty-eight patients completed the study. Use of standard statistics with intent-to-treat analysis showed that total FIQ scores decreased by 14% in the soy group (<I>P</I> = 0.02) and by 18% in the placebo group (<I>P</I>&lt;0.001). The difference in change in scores between the groups was not significant (<I>P</I> = 0.16). With the same analysis, CES-D scores decreased in the soy group by 16% (<I>P</I> = 0.004) and in the placebo group by 15% (<I>P</I> = 0.05). The change in scores was similar in the groups (<I>P</I> = 0.83). Results of statistical analysis using the separation test and intent-to-treat analysis revealed no benefit of soy compared with placebo. Shakes that contain soy and shakes that contain casein, when combined with a multidisciplinary fibromyalgia treatment program, provide a decrease in fibromyalgia symptoms. Separation between the effects of soy and casein (control) shakes did not favor the intervention. Therefore, large&ndash;sample studies using soy for patients with fibromyalgia are probably not indicated.</p>
]]></description>
<dc:creator><![CDATA[Wahner-Roedler, D. L., Thompson, J. M., Luedtke, C. A., King, S. M., Cha, S. S., Elkin, P. L., Bruce, B. K., Townsend, C. O., Bergeson, J. R., Eickhoff, A. L., Loehrer, L. L., Sood, A., Bauer, B. A.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen069</dc:identifier>
<dc:title><![CDATA[Dietary Soy Supplement on Fibromyalgia Symptoms: A Randomized, Double-blind, Placebo-controlled, Early Phase Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen034v2?rss=1">
<title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture Part 3: A Short Review of Animal Experiments]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen034v2?rss=1</link>
<description><![CDATA[
<p>High-tech acupuncture research has been performed for 10 years at the Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine at the Medical University of Graz. This article as a part of a series comprises animal experiments in the field of needle and laser acupuncture. The investigations presented in this article were performed in pigs, dogs and sheep. In all studies sedative stimulation effects of the acupoint Yintang are described using different measurement parameters (EEG-bispectral index, EEG spectral edge frequency and metabolic parameters).</p>
]]></description>
<dc:creator><![CDATA[Litscher, G.]]></dc:creator>
<dc:date>2008-11-05</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen034</dc:identifier>
<dc:title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture Part 3: A Short Review of Animal Experiments]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-05</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen071v1?rss=1">
<title><![CDATA[Sustainable Traditional Medicine: Taking the Inspirations from Ancient Veterinary Science]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen071v1?rss=1</link>
<description><![CDATA[
<p>Rapid reduction in natural resources as a consequence to the expanded urbanization, global warming and reduced natural habitat posed a considerable threat to the sustainability of traditional medicine. Being completely dependent upon natural resources like herbs, minerals and animal products, traditional medicine would possibly rank first in order of extinction of heritage if an alternative way is not considered well in time. In reference to the use of animal products, Ayurveda presents some unique examples where animals are used without causing harm to them and so without posing a threat to their existence. In the current context, when natural resources are facing a threat to their existence, a revisit to these ideas may give us a new insight to refine our look at natural resources used in traditional medicine.</p>
]]></description>
<dc:creator><![CDATA[Rastogi, S., Kaphle, K.]]></dc:creator>
<dc:date>2008-11-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen071</dc:identifier>
<dc:title><![CDATA[Sustainable Traditional Medicine: Taking the Inspirations from Ancient Veterinary Science]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-11-02</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen067v1?rss=1">
<title><![CDATA[Weight Loss in Animals and Humans Treated with 'Weighlevel', a Combination of Four Medicinal Plants Used In Traditional Arabic and Islamic Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen067v1?rss=1</link>
<description><![CDATA[
<p>Weighlevel, a mixture of extract of four plants used in traditional Arabic and Islamic medicine as well as in European herbal medicine, was prepared and assessed for its safety and efficacy in weight loss. Leaves of <I>Alchemilla vulgaris</I>, <I>Olea europaea</I> and <I>Mentha longifolia</I> L., as well as seeds of <I>Cuminum cyminum</I>, were used. Cultured human fibroblasts treated with Weighlevel did not exhibit any sign of toxicity as evidenced by lactate dehydrogenase release. These results were confirmed in experimental studies on rats where an LD<SUB>50</SUB> of 15.3 g kg<sup>&ndash;1</sup> was observed. Significant antioxidant properties were seen at very low concentrations of Weighlevel (10 &micro;g ml<sup>&ndash;1</sup>) as measured by the lipid peroxidation method. Progressive and significant weight loss was observed in chickens given this mixture weekly for 4 weeks compared with controls. Furthermore, a 3-fold increase in the thermogenesis was seen in rat interscapular brown adipose tissue following exposure to different concentrations of Weighlevel extract as determined by measurement of increased oxygen consumption. In addition, a clinical study was carried out among 80 human volunteers with a body mass index (BMI) of 30.67 &plusmn; 2.14 kg m<sup>&ndash;</sup><sup>2</sup>. All 80 subjects were asked to continue their usual diet but to eat only three main meals daily and to take one Weighlevel tablet 30 min before each meal. Fourteen subjects were excluded for not following the protocol, and 66 subjects were all evaluated for efficacy and tolerability of Weighlevel monthly for 3 months. Weighlevel was well tolerated by all subjects, and no side effects were reported. A progressive and significant weight loss was seen in these subjects during the whole study period. Higher levels of weight loss were seen in people with BMI of 25&ndash;30 kg m<sup>&ndash;</sup><sup>2</sup> (overweight) compared to people with BMI &gt;30 kg m<sup>&ndash;</sup><sup>2</sup> (obese). The BMI was reduced after 3 months from 28.5 &plusmn; 1.2 and 32.1 &plusmn; 1.8 kg m<sup>&ndash;</sup><sup>2</sup> to 24.5 &plusmn; 1.4 and 27.5 &plusmn; 2.2 kg m<sup>&ndash;</sup><sup>2</sup> in overweight and obese group, respectively. Results indicate safety, tolerability and efficacy of Weighlevel.</p>
]]></description>
<dc:creator><![CDATA[Said, O., Saad, B., Fulder, S., Khalil, K., Kassis, E.]]></dc:creator>
<dc:date>2008-10-24</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen067</dc:identifier>
<dc:title><![CDATA[Weight Loss in Animals and Humans Treated with 'Weighlevel', a Combination of Four Medicinal Plants Used In Traditional Arabic and Islamic Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen062v1?rss=1">
<title><![CDATA[Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen062v1?rss=1</link>
<description><![CDATA[
<p>Abnormal Savda Munziq (ASMq) is a traditional Uighur medicinal herbal preparation, commonly used for the treatment and prevention of cancer. We tested the effects of ethanol extract of ASMq on cultured human hepatoma cells (HepG2) to explore the mechanism of its putative anticancer properties, using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) bromide, neutral red and lactate dehydrogenase (LDH) leakage assays, testing the incorporation of <sup>3</sup>[H]-leucine and <sup>3</sup>[H]-nucleosides into protein, DNA and RNA, and quantifying the formation of malondialdehyde&ndash;thiobarbituric acid (MDA) adducts. ASMq ethanol extract significantly inhibited the growth of HepG2 and cell viability, increased the leakage of LDH after 48 h or 72 h treatment, in a concentration- and time-dependent manner (<I>P</I> &lt; 0.05). Cellular protein, DNA and RNA synthesis were inhibited in a concentration- and time-dependent manner (<I>P</I> &lt; 0.05). No significant MDA release in culture medium and no lipid peroxidation in cells were observed. The results suggest that the cytotoxic effects of ASMq ethanol extract might be related to inhibition of cancer cell growth, alteration of cell membrane integrity and inhibition of cellular protein, DNA and RNA synthesis.</p>
]]></description>
<dc:creator><![CDATA[Upur, H., Yusup, A., Baudrimont, I., Umar, A., Berke, B., Yimit, D., Lapham, J. C., Creppy, E. E., Moore, N.]]></dc:creator>
<dc:date>2008-10-15</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen062</dc:identifier>
<dc:title><![CDATA[Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-15</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen063v1?rss=1">
<title><![CDATA[Aqueous Extract of Black Maca (Lepidium meyenii) on Memory Impairment Induced by Ovariectomy in Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen063v1?rss=1</link>
<description><![CDATA[
<p>The present study aims to test two different doses of aqueous extract of black maca on learning and memory in ovariectomized (OVX) mice and their relation with malonalehyde (MDA), acetylcholinesterase (Ache) and monoamine oxidase (MAO) brain levels. Female mice were divided into five groups: (i) naive (control), (ii) sham, (iii) OVX mice and OVX mice treated with (iv) 0.50 g kg<sup>&ndash;1</sup> and (v) 2.00 g kg<sup>&ndash;1</sup> black maca. Mice were orally treated with distilled water or black maca during 35 days starting 7 days after surgery. Memory and learning were assessed using the water Morris maze (from day 23&ndash;27) and the step-down avoidance test (days 34 and 35). At the end of each treatment, mice were sacrificed by decapitation and brains were dissected out for MDA, Ache and MAO determinations. Black maca (0.5 and 2.0 g/kg) increased step-down latency when compared to OVX control mice. Black maca decreased MDA and Ache levels in OVX mice; whereas, no differences were observed in MAO levels. Finally, black maca improved experimental memory impairment induced by ovariectomy, due in part, by its antioxidant and Ache inhibitory activities.</p>
]]></description>
<dc:creator><![CDATA[Rubio, J., Qiong, W., Liu, X., Jiang, Z., Dang, H., Chen, S.-L., Gonzales, G. F.]]></dc:creator>
<dc:date>2008-10-09</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen063</dc:identifier>
<dc:title><![CDATA[Aqueous Extract of Black Maca (Lepidium meyenii) on Memory Impairment Induced by Ovariectomy in Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-09</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen065v1?rss=1">
<title><![CDATA[An International Comparison of Attitudes Toward Traditional and Modern Medicine in a Chinese and an American Clinic Setting]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen065v1?rss=1</link>
<description><![CDATA[
<p>Introduction: International comparative research on traditional medicine (TM) offers a useful method for examining differences in patient characteristics and can provide insight into: (i) more universal characteristics which may cross cultures and international borders; (ii) unique characteristics influenced by regional/national factors; and (iii) cultural values of immigrant populations. To explore these issues TM patients from the United States and China were compared. Methods: Data collection took place at two TM college clinics. A convenience sample of 128 patients in China and 127 patients in the United States completed a 28-item questionnaire. Results: There was a marked similarity between the two patient groups in terms of the biological characteristics of age and gender. Musculoskeletal issues were the most common presenting complaints in the United States; while, in China TM was used for a more diverse array of conditions. The majority of patients in both countries had initially used allopathic medicine (AM); significantly, more of the United States respondents stopped allopathic treatment after beginning traditional treatment. In comparing the two countries, patients in China were significantly more satisfied with AM and American patients significantly more satisfied with TM. In comparing the two medicines, the patient samples in both countries were significantly more satisfied with TM than AM. Discussion: Although treatment often originated with allopathic providers, many patients sought alternatives presumably to find the best solution to their problems. This tendency toward self-assignment suggests that a pluralistic healthcare system may provide the greatest satisfaction resulting from personal choice and improved outcomes.</p>
]]></description>
<dc:creator><![CDATA[Burke, A., Kuo, T., Harvey, R., Wang, J.]]></dc:creator>
<dc:date>2008-10-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen065</dc:identifier>
<dc:title><![CDATA[An International Comparison of Attitudes Toward Traditional and Modern Medicine in a Chinese and an American Clinic Setting]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen064v1?rss=1">
<title><![CDATA[Electroacupuncture Delays Hypertension Development through Enhancing NO/NOS Activity in Spontaneously Hypertensive Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen064v1?rss=1</link>
<description><![CDATA[
<p>Using spontaneously hypertensive rats (SHR), this study investigated whether electroacupuncture (EA) could reduce early stage hypertension by examining nitric oxide (NO) levels in plasma and nitric oxide synthase (NOS) levels in the mesenteric resistance artery. EA was applied to the acupuncture point Governor Vessel 20 (GV20) or to a non-acupuncture point in the tail twice weekly for 3 weeks under anesthesia. In conscious SHR and normotensive Wistar Kyoto (WKY) rats, blood pressure was determined the day after EA treatment by the tail-cuff method. We measured plasma NO concentration, and evaluated endothelial NO syntheses (eNOS) and neuronal NOS (nNOS) protein expression in the mesenteric artery. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were lower after 3 weeks of GV20 treatment than EA at non-acupuncture point and no treatment control in SHR. nNOS expression by EA was significantly different between both WKY and no treatment SHR control, and EA at GV20 in SHR. eNOS expression was significantly high in EA at GV 20 compared with no treatment control. In conclusion, EA could attenuate the blood pressure elevation of SHR, along with enhancing NO/NOS activity in the mesenteric artery in SHR.</p>
]]></description>
<dc:creator><![CDATA[Hwang, H. S., Kim, Y. S., Ryu, Y. H., Lee, J. E., Lee, Y. S., Yang, E. J., Lee, M. S., Choi, S.-M.]]></dc:creator>
<dc:date>2008-10-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen064</dc:identifier>
<dc:title><![CDATA[Electroacupuncture Delays Hypertension Development through Enhancing NO/NOS Activity in Spontaneously Hypertensive Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-10-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen061v1?rss=1">
<title><![CDATA[The Influence of Acupressure at Extra 1 Acupuncture Point on the Spectral Entropy of the EEG and the LF/HF Ratio of Heart Rate Variability]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen061v1?rss=1</link>
<description><![CDATA[
<p>Acupressure applied on the Extra 1 acupuncture point results in sedation, thereby reducing bispectral index (BIS) values. Mental status and hypnotic agents influence the autonomic nervous system. We hypothesized that acupressure at the Extra 1 point would induce sedation and change sympatho&ndash;parasympathetic nerve balance. We investigated the effect of acupressure at the Extra 1 point on the EEG spectral entropy values and heart rate variability (HRV). Forty-eight volunteers (24 males and 24 females) were randomly assigned to the control or Extra 1 group. The control group received acupressure at a sham point and the Extra 1 group received acupressure at the Extra 1 point. Acupressure was applied for 5 min. The record of the EEG spectral entropy values and HRV started 5 min before acupressure and stopped 5 min after acupressure. Acupressure significantly reduced the EEG spectral entropy values in both groups, but the values of the Extra 1 group were significantly smaller than those of the control group (<I>P</I> &lt; 0.01). Acupressure significantly decreased the LF/HF ratio of HRV in both groups (<I>P</I> &lt; 0.05). When divided upon gender, although acupressure tended to decrease the LF/HF ratio, the ratio significantly decreased during and after acupressure only in females of the Extra 1 group (<I>P</I> &lt; 0.05). We concluded that acupressure on the Extra 1 point significantly reduced the EEG spectral entropy in both the genders, but affected the LF/HF ratio of HRV only in females.</p>
]]></description>
<dc:creator><![CDATA[Arai, Y.-C. P, Ushida, T., Matsubara, T., Shimo, K., Ito, H., Sato, Y., Wakao, Y., Komatsu, T.]]></dc:creator>
<dc:date>2008-09-30</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen061</dc:identifier>
<dc:title><![CDATA[The Influence of Acupressure at Extra 1 Acupuncture Point on the Spectral Entropy of the EEG and the LF/HF Ratio of Heart Rate Variability]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen060v1?rss=1">
<title><![CDATA[A Chinese Herbal Preparation Containing Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneolum Syntheticum Reduces Circulating Adhesion Molecules]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen060v1?rss=1</link>
<description><![CDATA[
<p>Circulating adhesion molecules (CAMs), surface proteins expressed in the vascular endothelium, have emerged as risk factors for cardiovascular disease (CVD). CAMs are involved in intercellular communication that are believed to play a role in atherosclerosis. A Chinese medicine, the &lsquo;Dantonic Pill&rsquo; (DP) (also known as the &lsquo;Cardiotonic Pill&rsquo;), containing three Chinese herbal material medica, Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneolum Syntheticum, has been used in China for the prevention and management of CVD. Previous laboratory and animal studies have suggested that this preparation reduces both atherogenesis and adhesion molecule expression. A parallel double blind randomized placebo-controlled study was conducted to assess the effects of the DP on three species of CAM [intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 and endothelial cell selectin (E-selectin)] in participants with mild&ndash;moderate hypercholesterolemia. Secondary endpoints included biochemical and hematological variables and clinical effects. Forty participants were randomized to either treatment or control for 12 weeks. Treatment with DP was associated with a statistically significant decrease in ICAM-1 (9% decrease, <I>P</I> = 0.03) and E-Selectin (15% decrease, <I>P</I> = 0.004). There was no significant change in renal function tests, liver function tests, glucose, lipids or C-reactive protein levels and clinical adverse effects did not differ between the active and the control groups. There were no relevant changes in participants receiving placebo. These results suggest that this herbal medicine may contribute to the development of a novel approach to cardiovascular risk reduction.</p>
]]></description>
<dc:creator><![CDATA[O'Brien, K. A., Ling, S., Abbas, E., Dai, A., Zhang, J., Wang, W. C., Bensoussan, A., Luo, R., Guo, Z.-X., Komesaroff, P. A.]]></dc:creator>
<dc:date>2008-09-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen060</dc:identifier>
<dc:title><![CDATA[A Chinese Herbal Preparation Containing Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneolum Syntheticum Reduces Circulating Adhesion Molecules]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen058v1?rss=1">
<title><![CDATA[Spirulina in Clinical Practice: Evidence-Based Human Applications]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen058v1?rss=1</link>
<description><![CDATA[
<p><I>Spirulina</I> or <I>Arthrospira</I> is a blue-green alga that became famous after it was successfully used by NASA as a dietary supplement for astronauts on space missions. It has the ability to modulate immune functions and exhibits anti-inflammatory properties by inhibiting the release of histamine by mast cells. Multiple studies investigating the efficacy and the potential clinical applications of <I>Spirulina</I> in treating several diseases have been performed and a few randomized controlled trials and systematic reviews suggest that this alga may improve several symptoms and may even have an anticancer, antiviral and antiallergic effects. Current and potential clinical applications, issues of safety, indications, side-effects and levels of evidence are addressed in this review. Areas of ongoing and future research are also discussed.</p>
]]></description>
<dc:creator><![CDATA[Karkos, P. D., Leong, S. C., Karkos, C. D., Sivaji, N., Assimakopoulos, D. A.]]></dc:creator>
<dc:date>2008-09-14</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen058</dc:identifier>
<dc:title><![CDATA[Spirulina in Clinical Practice: Evidence-Based Human Applications]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-14</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen056v1?rss=1">
<title><![CDATA[Hypericum triquetrifolium--Derived Factors Downregulate the Production Levels of LPS-Induced Nitric Oxide and Tumor Necrosis Factor-{alpha} in THP-1 Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen056v1?rss=1</link>
<description><![CDATA[
<p>Based on knowledge from traditional Arab herbal medicine, this <I>in vitro</I> study aims to examine the anti-inflammatory mechanism of <I>Hypericum triquetrifolium</I> by measuring the expression and release of pro-inflammatory cytokines, tumor necrosis factor- (TNF-) and interleukine-6 (IL-6), and inducible nitric oxide synthase (iNOS) in human monocytic cells, THP-1. The effects were assessed by measuring the levels of secretory proteins and mRNA of TNF- and IL-6, the levels of nitric oxide (NO) secretion and the expression of iNOS in THP-1 cells. Cells were treated with 5 &micro;g lipopolysaccharide/ml (LPS) in the presence and absence of increasing concentrations of extracts from the aerial parts of <I>H. triquetrifolium</I>. During the entire experimental period, we used extract concentrations (up to 250 &micro;g ml<sup>&ndash;1</sup>) that had no cytotoxic effects, as measured with MTT and LDH assays. <I>Hypericum triquetrifolium</I> extracts remarkably suppressed the LPS-induced NO release, significantly attenuated the LPS-induced transcription of iNOS and inhibited in a dose-dependent manner the expression and release of TNF-. No significant effects were observed on the release of IL-6. Taken together, these results suggest that <I>H. triquetrifolium</I> probably exerts anti-inflammatory effects through the suppression of TNF- and iNOS expressions.</p>
]]></description>
<dc:creator><![CDATA[Saad, B., AbouAtta, B. S., Basha, W., Hmade, A., Kmail, A., Khasib, S., Said, O.]]></dc:creator>
<dc:date>2008-09-14</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen056</dc:identifier>
<dc:title><![CDATA[Hypericum triquetrifolium--Derived Factors Downregulate the Production Levels of LPS-Induced Nitric Oxide and Tumor Necrosis Factor-{alpha} in THP-1 Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-14</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen059v1?rss=1">
<title><![CDATA[Science Across Borders: 5th Annual Natural Health Product Research Conference--March 26-29, 2008, Toronto, Canada]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen059v1?rss=1</link>
<description><![CDATA[
<p>Canada is experiencing a growing interest in the use of alternative therapies and products particularly natural health products (NHP). In 1997, Canadians spent around C$ 2 billion on NHP. In an attempt to catch with this popularity of NHP use, Canadian researchers and administrators from academia, industry and government jointly established the Natural Health Product Research Society of Canada (NHPRS). Since its formation, NHPRS has been organizing an annual meeting which brings together world renowned researchers and experts in the area of NHP research. For 2008, the annual NHPRS meeting took place in Toronto from the 26th to 29th of March with a focus on &lsquo;Science Across Borders: Global Natural Health Products Research&rsquo;. The scientific program was spread into three days of plenary lectures and oral presentations. The different sessions containing these talks were on: ethnobotany around the world; chemical analysis of NHP; product standards and quality control; ethnomedicine; novel analytical approaches; systemic research, nutrisciences and molecular medicine; and drug development from NHP. The meeting proved to be a great success in terms of the speakers that were invited and based on the data that was presented which highlighted recent research taking place in the field of NHP not only in Canada but from many parts of the world.</p>
]]></description>
<dc:creator><![CDATA[Ghayur, M. N.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen059</dc:identifier>
<dc:title><![CDATA[Science Across Borders: 5th Annual Natural Health Product Research Conference--March 26-29, 2008, Toronto, Canada]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-04</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen057v1?rss=1">
<title><![CDATA[An Extract of Antrodia camphorata Mycelia Attenuates the Progression of Nephritis in Systemic Lupus Erythematosus-Prone NZB/W F1 Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen057v1?rss=1</link>
<description><![CDATA[
<p><I>Antrodia camphorata</I> is used in folk medicine for the treatment of inflammation syndromes and liver-related diseases in Taiwan. The goal of this study was to evaluate the efficacy of the mycelial extract of <I>A. camphorata</I> (ACE) for the treatment of systemic lupus erythematosus (SLE) in SLE-prone NZB/W F1 mice. After antibodies against double-stranded DNA appeared in NZB/W mice, the mice were orally administered varying dosages of ACE (100, 200 and 400 mg kg<sup>&ndash;1</sup>) for 5 consecutive days per week for 12 weeks via gavage. To assess the efficacy of ACE, we measured SLE-associated biochemical and histopathological biomarkers levels of blood urine nitrogen (BUN), blood creatinine, urine protein and urine creatinine and thickness of the kidney glomerular basement membrane by staining with periodic acid&ndash;Schiff. Antroquinonol, an active component of ACE, was investigated for anti-inflammation activity in lipopolysaccharide-induced RAW 267.4 cells.ACE at 400 mg kg<sup>&ndash;1</sup> significantly suppressed urine protein and serum BUN levels and decreased the thickness of the kidney glomerular basement membrane. Antroquinonol significantly inhibited the production of tumor necrosis factor- and interleukin-1&beta; by 75 and 78%, respectively. In conclusion, ACE reduced urine protein and creatinine levels and suppressed the thickening of the kidney glomerular basement membrane, suggesting that ACE protects the kidney from immunological damage resulting from autoimmune disease.</p>
]]></description>
<dc:creator><![CDATA[Chang, J.-M., Lee, Y.-R., Hung, L.-M., Liu, S.-Y., Kuo, M.-T., Wen, W.-C., Chen, P.]]></dc:creator>
<dc:date>2008-09-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen057</dc:identifier>
<dc:title><![CDATA[An Extract of Antrodia camphorata Mycelia Attenuates the Progression of Nephritis in Systemic Lupus Erythematosus-Prone NZB/W F1 Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen052v1?rss=1">
<title><![CDATA[Comparative Analysis of Viperidae Venoms Antibacterial Profile: a Short Communication for Proteomics]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen052v1?rss=1</link>
<description><![CDATA[
<p>Bacterial infections involving multidrug-resistant strains are one of the ten leading causes of death and an important health problem in need for new antibacterial sources and agents. Herein, we tested and compared four snake venoms (<I>Agkistrodon rhodostoma, Bothrops jararaca, B. atrox and Lachesis muta</I>) against 10 Gram-positive and Gram-negative drug-resistant clinical bacteria strains to identify them as new sources of potential antibacterial molecules. Our data revealed that, as efficient as some antibiotics currently on the market [minimal inhibitory concentration (MIC) = 1&ndash;32 &micro;g ml<sup>&ndash;1</sup>], <I>A. rhodostoma</I> and <I>B. atrox</I> venoms were active against <I>Staphylococcus epidermidis</I> and <I>Enterococcus faecalis</I> (MIC = 4.5 &micro;g ml<sup>&ndash;1</sup>), while <I>B. jararaca</I> inhibited <I>S. aureus</I> growth (MIC = 13 &micro;g ml<sup>&ndash;1</sup>). As genomic and proteomic technologies are improving and developing rapidly, our results suggested that <I>A. rhodostoma, B. atrox</I> and <I>B. jararaca</I> venoms and glands are feasible sources for searching antimicrobial prototypes for future design new antibiotics against drug-resistant clinical bacteria. They also point to an additional perspective to fully identify the pharmacological potential of these venoms by using different techniques.</p>
]]></description>
<dc:creator><![CDATA[Ferreira, B. L., Santos, D. O., Santos, A. L. d., Rodrigues, C. R., de Freitas, C. C., Cabral, L. M., Castro, H. C.]]></dc:creator>
<dc:date>2008-09-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen052</dc:identifier>
<dc:title><![CDATA[Comparative Analysis of Viperidae Venoms Antibacterial Profile: a Short Communication for Proteomics]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-09-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen055v1?rss=1">
<title><![CDATA[Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen055v1?rss=1</link>
<description><![CDATA[
<p>Many ethical concerns revolve around the four basic principles of research: merit and integrity, respect for human beings, weighting of risk&ndash;benefit and justice. These principles form the basis for any discussion concerning human research ethics and are applicable to all areas of research including acupuncture and Chinese herbal medicine. World Health Organisation document, <I>Guidelines for Clinical Research on Acupuncture</I>, states that &lsquo;consideration should be given to the different value systems that are involved in human rights such as social, cultural and historical issues&rsquo; and that &lsquo;further studies should be conducted in relation to ethical issues involved in clinical research on acupuncture&rsquo;. In addition to outlining the four basic principles, this paper will also examine the effect of Asian culture on Western human research ethics and how this may impact upon issues such as informed consent and weighting of risk&ndash;benefit.</p>
]]></description>
<dc:creator><![CDATA[Zaslawski, C.]]></dc:creator>
<dc:date>2008-08-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen055</dc:identifier>
<dc:title><![CDATA[Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-08-21</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen051v2?rss=1">
<title><![CDATA[Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen051v2?rss=1</link>
<description><![CDATA[
<p>David Geffen School of Medicine faculty, representing a wide range of disciplines, engaged speakers nationally known for their expertise on complementary, alternative and integrative medicine (CAIM) and its investigation at a January, 2008 symposium on the campus of the University of California, Los Angeles. The forum was created to educate the UCLA Institutional Review Board (IRB), and lively participation by School of Medicine faculty helped bring IRB members up to speed on controversies surrounding CAIM research. The symposium demonstrated that academics who are neither proponents nor detractors of CAIM can facilitate cross talk between opposing camps, elucidating questions important to its evaluation by those charged with protecting research subjects. It also brought attention to the universality of quandaries facing CAIM investigators and to the ingenuity with which they have addressed many of them.</p>
]]></description>
<dc:creator><![CDATA[Logue, E. H.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen051</dc:identifier>
<dc:title><![CDATA[Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-08-13</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen053v1?rss=1">
<title><![CDATA[An Antioxidant Phytotherapy to Rescue Neuronal Oxidative Stress]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen053v1?rss=1</link>
<description><![CDATA[
<p>Oxidative stress is involved in the pathogenesis of ischemic neuronal injury. A Chinese herbal formula composed of <I>Poria cocos</I> (Chinese name: <I>Fu Ling</I>), <I>Atractylodes macrocephala</I> (Chinese name: <I>Bai Zhu</I>) and <I>Angelica sinensis</I> (Chinese names: <I>Danggui, Dong quai, Donggui</I>; Korean name: <I>Danggwi</I>) (FBD), has been proved to be beneficial in the treatment of cerebral ischemia/reperfusion (I/R).This study was carried out to evaluate the protective effect of FBD against neuronal oxidative stress <I>in vivo</I> and <I>in vitro</I>. Rat I/R were established by middle cerebral artery occlusion (MCAO) for 1 h, followed by 24 h reperfusion. MCAO led to significant depletion in superoxide dismutase and glutathione and rise in lipid peroxidation (LPO) and nitric oxide in brain. The neurological deficit and brain infarction were also significantly elevated by MCAO as compared with sham-operated group. All the brain oxidative stress and damage were significantly attenuated by 7 days pretreatment with the aqueous extract of FBD (250 mg kg<sup>&ndash;1</sup>, p.o.). Moreover, cerebrospinal fluid sampled from FBD-pretreated rats protected PC12 cells against oxidative insult induced by 0.2 mM hydrogen peroxide, in a concentration and time-dependent manner (IC<SUB>50</SUB> 10.6%, ET<SUB>50</SUB> 1.2 h). However, aqueous extract of FBD just slightly scavenged superoxide anion radical generated in xanthine&ndash;xanthine oxidase system (IC<SUB>50</SUB> 2.4 mg ml<sup>&ndash;1</sup>) and hydroxyl radical generated in Fenton reaction system (IC<SUB>50</SUB> 3.6 mg ml<sup>&ndash;1</sup>). In conclusion, FBD was a distinct antioxidant phytotherapy to rescue neuronal oxidative stress, through blocking LPO, restoring endogenous antioxidant system, but not scavenging free radicals.</p>
]]></description>
<dc:creator><![CDATA[Lin, Z., Zhu, D., Yan, Y., Yu, B., Wang, Q., Shen, P., Ruan, K.]]></dc:creator>
<dc:date>2008-08-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen053</dc:identifier>
<dc:title><![CDATA[An Antioxidant Phytotherapy to Rescue Neuronal Oxidative Stress]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-08-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen050v1?rss=1">
<title><![CDATA[Addition of Fructooligosaccharides and Dried Plum to Soy-based Diets Reverses Bone Loss in the Ovariectomized Rat]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen050v1?rss=1</link>
<description><![CDATA[
<p>Dietary bioactive components that play a role in improving skeletal health have received considerable attention in complementary and alternative medicine practices as a result of their increased efficacy to combat chronic diseases. The objectives of this study were to evaluate the additive or synergistic effects of dried plum and fructooligosaccharides (FOS) and to determine whether dried plum and FOS or their combination in a soy protein-based diet can restore bone mass in ovarian hormone deficient rats. For this purpose, 72 3-month-old female Sprague-Dawley rats were divided into six groups (<I>n</I> = 12) and either ovariectomized (Ovx, five groups) or sham-operated (sham, one group). The rats were maintained on a semipurified standard diet for 45 days after surgery to establish bone loss. Thereafter, the rats were placed on one of the following dietary treatments for 60 days: casein-based diet (Sham and Ovx), soy-based diet (Ovx+soy) or soy-based diet with dried plum (Ovx+soy+plum), FOS (Ovx+soy+FOS) and combination of dried plum and FOS (Ovx+soy+plum+FOS). Soy protein in combination with the test compounds significantly improved whole-body bone mineral density (BMD). All test compounds in combination with soy protein significantly increased femoral BMD but the combination of soy protein, dried plum and FOS had the most pronounced effect in increasing lumbar BMD. Similarly, all of the test compounds increased ultimate load, indicating improved biomechanical properties. The positive effects of these test compounds on bone may be due to their ability to modulate bone resorption and formation, as shown by suppressed urinary deoxypyridinoline excretion and enhanced alkaline phosphatase activity.</p>
]]></description>
<dc:creator><![CDATA[Johnson, C. D., Lucas, E. A., Hooshmand, S., Campbell, S., Akhter, M. P., Arjmandi, B. H.]]></dc:creator>
<dc:date>2008-07-30</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen050</dc:identifier>
<dc:title><![CDATA[Addition of Fructooligosaccharides and Dried Plum to Soy-based Diets Reverses Bone Loss in the Ovariectomized Rat]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen047v1?rss=1">
<title><![CDATA[Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen047v1?rss=1</link>
<description><![CDATA[
<p>Proanthocyanidins, compounds highly concentrated in dietary fruits, such as cranberries and grapes, demonstrate significant cancer prevention potential against many types of cancer. The objective of this study was to evaluate cranberry and grape seed extracts to quantitate and compare their anti-proliferative effects on the most common type of oral cancer, oral squamous cell carcinoma. Using two well-characterized oral squamous cell carcinoma cell lines, CAL27 and SCC25, assays were performed to evaluate the effects of cranberry and grape seed extract on phenotypic behaviors of these oral cancers. The proliferation of both oral cancer cell lines was significantly inhibited by the administration of cranberry and grape seed extracts, in a dose-dependent manner. In addition, key regulators of apoptosis, caspase-2 and caspase-8, were concomitantly up-regulated by these treatments. However, cranberry and grape seed extracts elicited differential effects on cell adhesion, cell morphology, and cell cycle regulatory pathways. This study represents one of the first comparative investigations of cranberry and grape seed extracts and their anti-proliferative effects on oral cancers. Previous findings using purified proanthocyanidin from grape seed extract demonstrated more prominent growth inhibition, as well as apoptosis-inducing, properties on CAL27 cells. These observations provide evidence that cranberry and grape seed extracts not only inhibit oral cancer proliferation but also that the mechanism of this inhibition may function by triggering key apoptotic regulators in these cell lines. This information will be of benefit to researchers interested in elucidating which dietary components are central to mechanisms involved in the mediation of oral carcinogenesis and progression.</p>
]]></description>
<dc:creator><![CDATA[Chatelain, K., Phippen, S., McCabe, J., Teeters, C. A., O'Malley, S., Kingsley, K.]]></dc:creator>
<dc:date>2008-07-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen047</dc:identifier>
<dc:title><![CDATA[Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen037v2?rss=1">
<title><![CDATA[Public Status and Prevalence of Acupuncture in Japan]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen037v2?rss=1</link>
<description><![CDATA[
<p>Acupuncture originated in China and is widespread throughout Asia. It is expected that a higher utilization of this remedy exists in these countries compared to Western countries. We conducted annual nationwide surveys from 2003 through 2006 on the utilization of acupuncture in Japan. Face-to-face interviews were conducted with 2000 individuals randomly chosen from the resident database. Annual utilization percentages, based on the number of respondents, from 2003 to 2006 were 6.5%, 4.8%, 6.4%, and 6.7%, respectively, while lifetime experiences determined in each surveys were estimated as 26.7, 19.4, 24.4 and 25.4, respectively. Respondents who had utilized acupuncture and/or moxibustion tended to be older than those who had no experience. Acupuncture was mainly used for musculoskeletal symptoms, and a detailed breakdown of the musculoskeletal symptoms identified in the 2005 survey showed 50.9% for low back pain, 35.9% for shoulder stiffness and 12.0% for knee pain. Reasons given for continuing therapy included the effective amelioration of symptoms, comfort of the procedure and low number of side-effects, while those who decided against continuing cited no improvement of symptoms, cost and lack of time for treatment. In conclusion, annual utilization of acupuncture and/or moxibustion was estimated at more than 6%, and the percentage of those with a lifetime experience was ~25%, thus demonstrating the relatively higher utilization of the remedy in Japan over utilization in western countries. Application of the treatment for musculoskeletal problems and utilization by the older population were specific standouts of the use of acupuncture and/or moxibustion in Japan.</p>
]]></description>
<dc:creator><![CDATA[Ishizaki, N., Yano, T., Kawakita, K.]]></dc:creator>
<dc:date>2008-07-19</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen037</dc:identifier>
<dc:title><![CDATA[Public Status and Prevalence of Acupuncture in Japan]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem182v3?rss=1">
<title><![CDATA[Group Music Intervention Reduces Aggression and Improves Self-esteem in Children with Highly Aggressive Behavior: A Pilot Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem182v3?rss=1</link>
<description><![CDATA[
<p>We investigated the effects of group music intervention on aggression and self-esteem in children with highly aggressive behavior. Forty-eight children were allocated to either a music intervention group or an untreated control group. The music intervention group received 50 min of music intervention twice weekly for 15 consecutive weeks. The outcome measures were Child Behavior Checklist Aggression Problems Scale (Parents), Child Aggression Assessment Inventory (Teachers) and Rosenberg Self-esteem Scale. After 15 weeks, the music intervention group showed significant reduction of aggression and improvement of self-esteem compared with the control group. All outcome measures were significantly lower in the music intervention group than prior to treatment, while there was no change in the control group. These findings suggest that music can reduce aggressive behavior and improve self-esteem in children with highly aggressive behavior. Music intervention is an easily accessible therapy for children and as such may be an effective intervention for aggressive behavior. Further more, objective and replicable measures are required from a randomized controlled trial with a larger sample size and active comparable control.</p>
]]></description>
<dc:creator><![CDATA[Choi, A.-N., Lee, M. S., Lee, J.-S.]]></dc:creator>
<dc:date>2008-07-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem182</dc:identifier>
<dc:title><![CDATA[Group Music Intervention Reduces Aggression and Improves Self-esteem in Children with Highly Aggressive Behavior: A Pilot Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen045v1?rss=1">
<title><![CDATA[Antidepressant-like Effect of l-perillaldehyde in Stress-induced Depression-like Model Mice through Regulation of the Olfactory Nervous System]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen045v1?rss=1</link>
<description><![CDATA[
<p>Perillae Herba (a leaf of <I>Perilla frutescens</I>) has been prescribed as one of the component herbs in certain Kampo (Japanese herbal) medicines that are used clinically for the improvement of depressive mood. <I>l</I>-Perillaldehyde (PAH) is a major component in the essential oil containing in Perillae Herba, but its antidepressant-like effect has not been reported. To clarify the antidepressant-like effect of PAH, the inhaled effect of PAH on stress-induced depression-like model mice prepared by subjection to a combination of forced swimming and chronic mild stresses was investigated. The degree of the depression-like state was measured by the animal's duration of immobility using a forced swimming test. Inhalation of PAH (0.0965 and 0.965 mg/mouse/day, 9 days) significantly shortened the duration of immobility of the depression-like model mice and did not affect locomotor activity. However, another odor substance, cinnamaldehyde containing in Cinnamomi Cortex, exhibited no reduction in the immobility. The reduction in the immobility induced by the inhalation of PAH was prevented on anosmia-induced mice prepared by intranasal irrigation with zinc sulfate. These results suggest that the inhalation of PAH shows antidepressant-like activity through the olfactory nervous function.</p>
]]></description>
<dc:creator><![CDATA[Ito, N., Nagai, T., Oikawa, T., Yamada, H., Hanawa, T.]]></dc:creator>
<dc:date>2008-07-16</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen045</dc:identifier>
<dc:title><![CDATA[Antidepressant-like Effect of l-perillaldehyde in Stress-induced Depression-like Model Mice through Regulation of the Olfactory Nervous System]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen049v1?rss=1">
<title><![CDATA[Assessment of the Mutagenic Activity of Extracts of Brazilian Propolis in Topical Pharmaceutical Formulations on Mammalian Cells In Vitro and In Vivo]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen049v1?rss=1</link>
<description><![CDATA[
<p>Propolis possesses various biological activities such as antibacterial, antifungal, anti-inflammatory, anesthetic and antioxidant properties. A topically applied product based on Brazilian green propolis was developed for the treatment of burns. For such substance to be used more safely in future clinical applications, the present study evaluated the mutagenic potential of topical formulations supplemented with green propolis extract (1.2, 2.4 and 3.6%) based on the analysis of chromosomal aberrations and of micronuclei. In the <I>in vitro</I> studies, 3-h pulse (G<SUB>1</SUB> phase of the cell cycle) and continuous (20 h) treatments were performed. In the <I>in vivo</I> assessment, the animals were injured on the back and then submitted to acute (24 h), subacute (7 days) and subchronic (30 days) treatments consisting of daily dermal applications of gels containing different concentrations of propolis. Similar frequencies of chromosomal aberrations were observed for cultures submitted to 3-h pulse and continuous treatment with gels containing different propolis concentrations and cultures not submitted to any treatment. However, in the continuous treatment cultures treated with the 3.6% propolis gel presented significantly lower mitotic indices than the negative control. No statistically significant differences in the frequencies of micronuclei were observed between animals treated with gels containing different concentrations of propolis and the negative control for the three treatment times. Under the present conditions, topical formulations containing different concentrations of green propolis used for the treatment of burns showed no mutagenic effect in either test system, but 3.6% propolis gel was found to be cytotoxic in the <I>in vitro</I> test.</p>
]]></description>
<dc:creator><![CDATA[Senedese, J. M., Rodrigues, A. R., Furtado, M. A., Faustino, V. D., Berretta, A. A., Marchetti, J. M., Tavares, D. C.]]></dc:creator>
<dc:date>2008-07-09</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen049</dc:identifier>
<dc:title><![CDATA[Assessment of the Mutagenic Activity of Extracts of Brazilian Propolis in Topical Pharmaceutical Formulations on Mammalian Cells In Vitro and In Vivo]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-09</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen044v1?rss=1">
<title><![CDATA[GP Participation and Recruitment of Patients to RCTs: Lessons from Trials of Acupuncture and Exercise for Low Back Pain in Primary Care]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen044v1?rss=1</link>
<description><![CDATA[
<p>The objective of this study was to identify factors associated with general practitioner (GP) participation and the recruitment of people to trials in primary care, based on data from two trials of interventions for treating chronic low back pain. The study was based on data from two randomized controlled trials (RCTs), one involving exercise, the other acupuncture, and subsequent reporting by GPs in a postal questionnaire. The exercise trial achieved 62% recruitment whereas the acupuncture trial achieved 100% recruitment. In both trials GPs most efficient at referring patients were those with a special interest in the subject area, and those known personally to the research team. A follow-up GP questionnaire found that both trials had maintained a high profile with over 80% of GPs, and successful recruitment strategies included project reminder letters, updates and personal contacts. Achieving target recruitment of patients in the acupuncture trial was aided by the deliberate application of lessons learned in the exercise trial, in particular the need to keep initial study entry criteria broad, with subsequent filtering undertaken by the study researcher. In addition the use of effective methods of maintaining the trial profile, the involvement of a GP advisor, the decision to maximize the recruitment of GPs early in the trial and the direct recruitment of interested individual GPs. The successful recruitment of patients to trials in primary care requires careful planning and continuous monitoring from the outset. Prior to starting recruitment, it is useful to identify previous trials in a similar environment in order to learn from their experience and optimize patient recruitment.</p>
]]></description>
<dc:creator><![CDATA[Bell-Syer, S. E. M., Thorpe, L. N., Thomas, K., MacPherson, H.]]></dc:creator>
<dc:date>2008-07-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen044</dc:identifier>
<dc:title><![CDATA[GP Participation and Recruitment of Patients to RCTs: Lessons from Trials of Acupuncture and Exercise for Low Back Pain in Primary Care]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem179v2?rss=1">
<title><![CDATA[Body Acupuncture for Nicotine Withdrawal Symptoms: A Randomized Placebo-controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem179v2?rss=1</link>
<description><![CDATA[
<p>This study evaluated whether improvements in nicotine withdrawal symptoms (NWS), depression and anxiety are greater for body acupuncture than for sham acupuncture. Smoking volunteers from the public were randomized to receive six sessions of either real or sham acupuncture for 2 weeks. The primary outcome measure was NWS measured by the Minnesota Nicotine Withdrawal Score, and the secondary measures were scores on the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). Eighty volunteers were randomized into real acupuncture (<I>n</I> = 38) and sham acupuncture (<I>n</I> = 42) groups, of which 46 subjects (22 and 24 in the real and sham acupuncture groups, respectively) completed the treatment and the 2-week follow-up. An intention-to-treat analysis revealed that the NWS did not differ significantly between the real and sham acupuncture groups immediately after the treatment (12.2 &plusmn; 9.7 and 12.8 &plusmn; 7.7, respectively; mean &plusmn; SD) and at the 2-week follow-up (11.7 &plusmn; 10.2 and 12.6 &plusmn; 7.8). Both groups also showed similar improvements in BDI and BAI scores. These results indicate that the real acupuncture treatment tested in this trial was no more effective than sham acupuncture at reducing NWS, depression and anxiety for smoking cessation.</p>
]]></description>
<dc:creator><![CDATA[Hyun, M.-K., Lee, M. S., Kang, K., Choi, S.-M.]]></dc:creator>
<dc:date>2008-07-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem179</dc:identifier>
<dc:title><![CDATA[Body Acupuncture for Nicotine Withdrawal Symptoms: A Randomized Placebo-controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen048v1?rss=1">
<title><![CDATA[Potential Benefits on Impairment of Endothelial Function after a High-fat Meal of 4 weeks of Flavonoid Supplementation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen048v1?rss=1</link>
<description><![CDATA[
<p>Studies with foods high in flavonoids have demonstrated improvement in endothelial function. We investigated whether 4 weeks of flavonoid supplementation would prevent an adverse impact on endothelial function of a high-fat meal. Endothelial function was measured by reactive hyperemia peripheral arterial tonometry (RH-PAT). The RH-PAT index was measured both before and 3 h after a high-fat meal, in 23 healthy volunteers. Subjects were randomized in a double-blind, cross-over design to 4 weeks of daily supplementation with OPC-3&reg;, or a matching placebo. RH-PAT index before and after the high-fat meal was measured at the beginning and end of each 4-week treatment phase. The high-fat meal caused a decline in endothelial function at baseline in the placebo (&ndash;10.71%, <I>P</I> = 0.006) and flavonoid [&ndash;9.97% (<I>P</I> = 0.077)] groups, and there was no difference in decline between arms (<I>P</I> = 0.906). The high-fat meal produced a decline after 4 weeks of placebo [&ndash;12.37% (<I>P</I> = 0.005)], but no decline after 4 weeks of flavonoid supplement [&ndash;3.16% (<I>P</I> = 0.663)], and the difference between the two responses was highly significant (<I>P</I> &lt; 0.0001). Within-group comparisons revealed no difference in endothelial function decline in the placebo arm between baseline and 4 weeks [&ndash;10.71% versus &ndash;12.37% (<I>P</I> = 0.758)]. In the flavonoid supplement arm, the difference in endothelial function decline between baseline and 4 weeks was &ndash;9.97% versus &ndash;3.16%, but did not reach statistical significance (<I>P</I> = 0.451). These results suggest that the flavonoid supplement used in this study mitigates the impairment of endothelial function caused by a high-fat meal. Whether certain subpopulations derive greater or lesser benefit remains unclear.</p>
]]></description>
<dc:creator><![CDATA[Barringer, T. A., Hatcher, L., Sasser, H. C.]]></dc:creator>
<dc:date>2008-07-03</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen048</dc:identifier>
<dc:title><![CDATA[Potential Benefits on Impairment of Endothelial Function after a High-fat Meal of 4 weeks of Flavonoid Supplementation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen040v1?rss=1">
<title><![CDATA[Antidiabetic Indian Plants: a Good Source of Potent Amylase Inhibitors]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen040v1?rss=1</link>
<description><![CDATA[
<p>Diabetes is known as a multifactorial disease. The treatment of diabetes (Type II) is complicated due to the inherent patho-physiological factors related to this disease. One of the complications of diabetes is post-prandial hyperglycemia (PPHG). Glucosidase inhibitors, particularly -amylase inhibitors are a class of compounds that helps in managing PPHG. Six ethno-botanically known plants having antidiabetic property namely, <I>Azadirachta indica</I> Adr. Juss.; <I>Murraya koenigii</I> (L.) Sprengel; <I>Ocimum tenuflorum</I> (L.) (syn: <I>Sanctum</I>); <I>Syzygium cumini</I> (L.) Skeels (syn: <I>Eugenia jambolana</I>); <I>Linum usitatissimum</I> (L.) and <I>Bougainvillea spectabilis</I> were tested for their ability to inhibit glucosidase activity. The chloroform, methanol and aqueous extracts were prepared sequentially from either leaves or seeds of these plants. It was observed that the chloroform extract of <I>O. tenuflorum; B. spectabilis; M. koenigii</I> and <I>S. cumini</I> have significant -amylase inhibitory property. Plants extracts were further tested against murine pancreatic, liver and small intestinal crude enzyme preparations for glucosidase inhibitory activity. The three extracts of <I>O. tenuflorum</I> and chloroform extract of <I>M. koenigi</I> showed good inhibition of murine pancreatic and intestinal glucosidases as compared with acarbose, a known glucosidase inhibitor.</p>
]]></description>
<dc:creator><![CDATA[Bhat, M., Zinjarde, S. S., Bhargava, S. Y., Kumar, A. R., Joshi, B. N.]]></dc:creator>
<dc:date>2008-06-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen040</dc:identifier>
<dc:title><![CDATA[Antidiabetic Indian Plants: a Good Source of Potent Amylase Inhibitors]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-06-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen036v1?rss=1">
<title><![CDATA[Therapeutic Potential of Plants as Anti-microbials for Drug Discovery]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen036v1?rss=1</link>
<description><![CDATA[
<p>The uses of traditional medicinal plants for primary health care have steadily increased worldwide in recent years. Scientists are in search of new phytochemicals that could be developed as useful anti-microbials for treatment of infectious diseases. Currently, out of 80% of pharmaceuticals derived from plants, very few are now being used as anti-microbials. Plants are rich in a wide variety of secondary metabolites that have found anti-microbial properties. This review highlights the current status of traditional medicine, its contribution to modern medicine, recent trends in the evaluation of anti-microbials with a special emphasis upon some tribal medicine, <I>in vitro</I> and <I>in vivo</I> experimental design for screening, and therapeutic efficacy in safety and human clinical trails for commercial outlet. Many of these commercially available compounds are crude preparations administered without performing human clinical trials. Recent methods are useful to standardize the extraction for scientific investigation of new phytochemicals and anti-microbials of traditionally used plants. It is concluded that once the local ethnomedical preparations of traditional sources are scientifically evaluated before dispensing they should replace existing drugs commonly used for the therapeutic treatment of infection. This method should be put into practice for future investigations in the field of ethnopharmacology, phytochemistry, ethnobotany and other biological fields for drug discovery.</p>
]]></description>
<dc:creator><![CDATA[Samy, R. P., Gopalakrishnakone, P.]]></dc:creator>
<dc:date>2008-06-24</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen036</dc:identifier>
<dc:title><![CDATA[Therapeutic Potential of Plants as Anti-microbials for Drug Discovery]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-06-24</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen042v1?rss=1">
<title><![CDATA[The World Summit of Harmonization on Traditional, Alternative and Complementary Medicine (TACM) in Lima, Peru]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen042v1?rss=1</link>
<description><![CDATA[
<p>The World Summit of Harmonization on Traditional, Alternative and Complementary Medicine (TACM) was held in Lima, Peru, November 7&ndash;11, 2007, with almost 600 worldwide participants. This meeting was organized by Peruvian Medical College, the institution that affiliates and authorizes all physicians to practice medicine in Peru. The meeting included seven sections starting with an overview on the current status of the TACM. The second section included experiences from different countries on regulations and quality control in products and services used in the TACM. The worldwide experience of education and training in TACM was a very important part of the meeting in which speakers from Spain, Germany, Argentina, Italy, Brazil, Cuba and Peru shared their experience. The meeting included topics on homeopathy, acupuncture, mind&ndash;body medicine, neural therapy, chiropraxis, among others. Two final sessions were related to the ways of linking Traditional medicine to the national Health Systems in the Latin America countries and also the association between bio-commerce and TACM including intellectual properties and bio-piracy.</p>
]]></description>
<dc:creator><![CDATA[Gonzales, G. F., Aguilar, J., Villar, M.]]></dc:creator>
<dc:date>2008-06-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen042</dc:identifier>
<dc:title><![CDATA[The World Summit of Harmonization on Traditional, Alternative and Complementary Medicine (TACM) in Lima, Peru]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-06-23</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen043v1?rss=1">
<title><![CDATA[Electroacupuncture of 2 Hz has a Rewarding Effect: Evidence from a Conditioned Place Preference Study in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen043v1?rss=1</link>
<description><![CDATA[
<p>Electroacupuncture (EA) has been used to suppress heroin craving in addicts and the conditioned place preference (CPP) for morphine in the rat. The question remained whether EA by itself will produce some rewarding effect. This was investigated using the CPP procedure in the present study. The results indicated that rats showed a significant preference to the 2 Hz EA-paired compartment. This rewarding effect of EA was prevented by pre-treatment with the opioid receptor antagonist naloxone [2 mg kg<sup>&ndash;1</sup>, intraperitoneally (i.p.)], CB1 cannabinoid antagonist AM251 (3 &micro;g per rat, intracerebroventricularly) or D1 dopamine receptor antagonist SCH23390 (0.1 mg kg<sup>&ndash;1</sup>, i.p.), respectively. It is concluded that 2 Hz EA is capable of inducing CPP in the rat via the activation of the endogenous opioid-, cannabinoid- and dopamine-systems.</p>
]]></description>
<dc:creator><![CDATA[Xia, W., Chu, N.-N., Liang, J., Li, Y.-J., Zhang, R., Han, J.-S., Cui, C.-L.]]></dc:creator>
<dc:date>2008-06-19</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen043</dc:identifier>
<dc:title><![CDATA[Electroacupuncture of 2 Hz has a Rewarding Effect: Evidence from a Conditioned Place Preference Study in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-06-19</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen041v1?rss=1">
<title><![CDATA[The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen041v1?rss=1</link>
<description><![CDATA[
<p>Maca, a plant native to the Peruvian highlands, contains (1R,3S)-1-methyl-1,2,3,4-tetrahydro-&beta;-carboline-3-carboxylic acid (MTCA). The family of the tetrahydro-&beta;-carbolines has been associated with both biologically helpful and harmful compounds. We present evidence that MTCA is a natural constituent of Maca, and on consumption no toxicity is found. This suggests that, when consumed as multi-component, MTCA may loose its adversity as drug action.</p>
]]></description>
<dc:creator><![CDATA[Gonzales, G. F., Gonzales-Castaneda, C.]]></dc:creator>
<dc:date>2008-06-19</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen041</dc:identifier>
<dc:title><![CDATA[The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-06-19</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen039v1?rss=1">
<title><![CDATA[Traditional Arabic and Islamic Medicine, a Re-emerging Health Aid]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen039v1?rss=1</link>
<description><![CDATA[
<p>Complementary medicine is a formal method of health care in most countries of the ancient world. It is expected to become more widely integrated into the modern medical system, including the medical curriculum. Despite the perception of modern medicine as more efficacious, traditional medicine continues to be practiced. More than 70% of the developing world's population still depends primarily on the complementary and alternative systems of medicine (CAM). In rural areas, cultural beliefs and practices often lead to self-care, home remedies or consultation with traditional healers. Herbal medicine can be broadly classified into four basic systems as follows: Traditional Chinese Herbalism, Ayurvedic Herbalism, Western Herbalism&mdash;which originally came from Greece and Rome to Europe and then spread to North and South America and Traditional Arabic and Islamic Medicine (TAIM). There is no doubt that today the concept of Arabic traditional herbal medicine is a part of modern life in the Middle East, and it is acquiring worldwide respect, with growing interest among traditional herbalists and the scientific community. TAIM therapies have shown remarkable success in healing acute as well as chronic diseases and have been utilized by people in most countries of the Mediterranean who have faith in spiritual healers. TAIM is the first choice for many in dealing with ailments such as infertility, epilepsy, psychosomatic troubles and depression. In parallel, issues of efficacy and safety of complementary medicine have become increasingly important and supervision of the techniques and procedures used is required for commercial as well as traditional uses. More research is therefore needed to understand this type of medicine and ensure its safe usage. The present review will discuss the status of traditional Arab medicine (particularly herbal medicine), including the efficacy and toxicity of specific medicinal preparations, with an emphasis on the modern <I>in vitro</I> and <I>in vivo</I> techniques.</p>
]]></description>
<dc:creator><![CDATA[Azaizeh, H., Saad, B., Cooper, E., Said, O.]]></dc:creator>
<dc:date>2008-06-13</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen039</dc:identifier>
<dc:title><![CDATA[Traditional Arabic and Islamic Medicine, a Re-emerging Health Aid]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-06-13</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen038v1?rss=1">
<title><![CDATA[Anti-oxidant and Anti-hypercholesterolemic Activities of Wasabia japonica]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen038v1?rss=1</link>
<description><![CDATA[
<p>The effects of <I>Wasabia japonica</I> (WJ) were investigated <I>in vitro</I> and <I>in vivo</I> for their anti-oxidant and anti-hypercholesterolemic activities. It was found that the aqueous extracts of WJ leaves (WJL) had strong scavenging activities towards 1,1-Diphenyl-2-picryhydrazyl (DPPH) and nitric oxide (NO) free radicals in cell free systems. WJL also inhibited NO production and the expressions of inducible NO synthase (iNOS) mRNA and enzyme protein, determined by Griess reactions, RT-PCR or Western blotting respectively in Lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages cells. The anti-hypercholesterolemic effects of WJ diet were investigated in hypercholesterolemia rats. Sprague-Dawley rats were divided into four groups and were fed with either normal diet (Group 1), or diet containing 1%(w/w) cholesterol (Groups 2, 3 and 4). After 4 weeks, Group 2 was changed to normal diet, Groups 3 and 4 were changed to the diet containing 5% WJ leaf and or 5% WJ root, respectively. 3 weeks after WJ diets, Serum HDL-cholesterol levels were significantly increased in WJ diet groups compared with the normal diet hypercholesterolemia rats. In contrast, the serum LDL-cholesterol levels and liver xanthine oxidase (XO) activity in WJ diet groups were significantly decreased. The results indicate that the WJ extracts have significant anti-oxidant activities, and the WJ diet exhibited anti-hypercholesterolemic action in high cholesterol diet rats, which was companied with modulations of cholesterol metabolism and decrease in liver XO activity.</p>
]]></description>
<dc:creator><![CDATA[Lee, Y. S., Yang, J. H., Bae, M. J., Yoo, W. K., Ye, S., Xue, C. C. L., Li, C. G.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen038</dc:identifier>
<dc:title><![CDATA[Anti-oxidant and Anti-hypercholesterolemic Activities of Wasabia japonica]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen032v1?rss=1">
<title><![CDATA[Macroscopic Quantum Coherence in Patient-Practitioner-Remedy Entanglement: The Quantized Fluctuation Field Perspective]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen032v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hankey, A.]]></dc:creator>
<dc:date>2008-05-14</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen032</dc:identifier>
<dc:title><![CDATA[Macroscopic Quantum Coherence in Patient-Practitioner-Remedy Entanglement: The Quantized Fluctuation Field Perspective]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-14</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen033v1?rss=1">
<title><![CDATA[The Role of Dual-trained Conventional/Complementary Physicians as Mediators of Integration in Primary Care]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen033v1?rss=1</link>
<description><![CDATA[
<p>A growing number of physicians study complementary and alternative medicine (CAM). Limited data are available on perspectives of physicians with dual training in conventional medicine and CAM, on issues of communication and collaboration with CAM practitioners (CAMPs). Questionnaires were administered to primary care physicians employed in the largest health maintenance organization (HMO) in Israel and to MD and non-MD CAM practitioners employed by a CAM-related agency of the same HMO. Data for statistical analysis were available from 333 primary care physicians (PCPs) and 241 CAM practitioners. Thirty-one of the 241 CAMPs were dual-trained physicians employed in a CAM-related agency as practitioners and/or triage-consultants. Dual trained physicians and CAMPs shared similar attitudes and supported, more so than PCPs, collaborative physician&ndash;CAM practitioner teamwork in clinical practice, medical education and research. Nevertheless, dual trained physicians supported a physician-dominant teamwork model (similar to the PCPs&rsquo; approach) in contrast to non-MD CAM practitioners who mainly supported a co-directed teamwork model. Compared to PCPs and non-MD CAM practitioners, dual trained physicians supported significantly more a medical/referral letter as the preferred means of doctor&ndash;CAM practitioner communication. Dual trained physicians have a unique outlook toward CAM integration and physician&ndash;practitioner collaboration, compared to non-MD CAM practitioners and PCPs. More studies are warranted to explore the role of dual trained physicians as mediators of integration.</p>
]]></description>
<dc:creator><![CDATA[Ben-Arye, E.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen033</dc:identifier>
<dc:title><![CDATA[The Role of Dual-trained Conventional/Complementary Physicians as Mediators of Integration in Primary Care]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen031v1?rss=1">
<title><![CDATA[Use, Attitudes and Knowledge of Complementary and Alternative Drugs (CADs) Among Pregnant Women: a Preliminary Survey in Tuscany]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen031v1?rss=1</link>
<description><![CDATA[
<p>To explore pregnant women's use, attitudes, knowledge and beliefs of complementary and alternative drugs (CADs) defined as products manufactured from herbs or with a natural origin. A preliminary survey was conducted among 172 pregnant women in their third trimester of pregnancy, consecutively recruited in two obstetrical settings; 15 women were randomly selected to compute a <I>test-to-retest</I> analysis. Response rate was 87.2%. <I>Test-to-retest</I> analysis showed a questionnaire's reproducibility exceeding a <I>K</I>-value of 0.7 for all items. Mean age was 32.4 &plusmn; 0.4 years; most women were nulliparae (62.7%). The majority of subjects (68%) declared to have used one or more CADs during their lifetime; 48% of pregnant women reported taking at least one CAD previously and during the current pregnancy. Women's habitual use of CADs meant they were at higher risk of taking CADs also during pregnancy (adjusted odds ratio = 10.8; 95% confidence interval: 4.7&ndash;25.0). Moreover, 59.1% of the subjects were unable to correctly identify the type of CADs they were using. The majority of women resorted to gynecologists as the primary information source for CADs during pregnancy, while they mainly referred to herbalists when not pregnant. Habitual use of CADs seems to be a strong predictor for their ingestion also during pregnancy; in addition most subjects were unable to correctly identify the products they were taking. In the light of the scanty data concerning the safety of CADs during pregnancy, these preliminary results confirm the need to investigate thoroughly the situation of pregnant women and CADs consumption.</p>
]]></description>
<dc:creator><![CDATA[Lapi, F., Vannacci, A., Moschini, M., Cipollini, F., Morsuillo, M., Gallo, E., Banchelli, G., Cecchi, E., Pirro, M. D., Giovannini, M. G., Cariglia, M. T., Gori, L., Firenzuoli, F., Mugelli, A.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen031</dc:identifier>
<dc:title><![CDATA[Use, Attitudes and Knowledge of Complementary and Alternative Drugs (CADs) Among Pregnant Women: a Preliminary Survey in Tuscany]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen029v1?rss=1">
<title><![CDATA[Physiological Adjustments to Stress Measures Following Massage Therapy: A Review of the Literature]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen029v1?rss=1</link>
<description><![CDATA[
<p>Use of massage therapy by the general public has increased substantially in recent years. In light of the popularity of massage therapy for stress reduction, a comprehensive review of the peer-reviewed literature is important to summarize the effectiveness of this modality on stress-reactive physiological measures. On-line databases were searched for articles relevant to both massage therapy and stress. Articles were included in this review if (i) the massage therapy account consisted of manipulation of soft tissues and was conducted by a trained therapist, and (ii) a dependent measure to evaluate physiological stress was reported. Hormonal and physical parameters are reviewed. A total of 25 studies met all inclusion criteria. A majority of studies employed a 20&ndash;30 min massage administered twice-weekly over 5 weeks with evaluations conducted pre-post an individual session (single treatment) or following a series of sessions (multiple treatments). Single treatment reductions in salivary cortisol and heart rate were consistently noted. A sustained reduction for these measures was not supported in the literature, although the single-treatment effect was repeatable within a study. To date, the research data is insufficient to make definitive statements regarding the multiple treatment effect of massage therapy on urinary cortisol or catecholamines, but some evidence for a positive effect on diastolic blood pressure has been documented. While significant improvement has been demonstrated following massage therapy, the general research body on this topic lacks the necessary scientific rigor to provide a definitive understanding of the effect massage therapy has on many physiological variables associated with stress.</p>
]]></description>
<dc:creator><![CDATA[Moraska, A., Pollini, R. A., Boulanger, K., Brooks, M. Z., Teitlebaum, L.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen029</dc:identifier>
<dc:title><![CDATA[Physiological Adjustments to Stress Measures Following Massage Therapy: A Review of the Literature]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen027v1?rss=1">
<title><![CDATA[Yoga Practice for the Management of Type II Diabetes Mellitus in Adults: A systematic review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen027v1?rss=1</link>
<description><![CDATA[
<p>The effect of practicing yoga for the management of type II Diabetes was assessed in this systematic review through searching related electronic databases and the grey literature to the end of May 2007 using Ovid. All randomized controlled clinical trials (RCTs) comparing yoga practice with other type of intervention or with regular practice or both, were included regardless of language or type of publication. Each study was assessed for quality by two independent reviewers. Mean difference was used for summarizing the effect of each study outcomes with 95% confidence intervals. Pooling of the studies did not take place due to the wide clinical variation between the studies. Publication bias was assessed by statistical methods. Five trials with 363 participants met the inclusion criteria with medium to high risk of bias and different intervention characteristics. The studies&rsquo; results show improvement in outcomes among patients with diabetes type II. These improvements were mainly among short term or immediate diabetes outcomes and not all were statistically significant. The results were inconclusive and not significant for the long-term outcomes. No adverse effects were reported in any of the included studies. Short-term benefits for patients with diabetes may be achieved from practicing yoga. Further research is needed in this area. Factors like quality of the trials and other methodological issues should be improved by large randomized control trials with allocation concealment to assess the effectiveness of yoga on diabetes type II. A definitive recommendation for physicians to encourage their patients to practice yoga cannot be reached at present.</p>
]]></description>
<dc:creator><![CDATA[Aljasir, B., Bryson, M., Al-shehri, B.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen027</dc:identifier>
<dc:title><![CDATA[Yoga Practice for the Management of Type II Diabetes Mellitus in Adults: A systematic review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen026v1?rss=1">
<title><![CDATA[Immunostimulation-Mediated Anti-tumor Activity of Bamboo (Sasa senanensis) Leaf Extracts Obtained Under 'Vigorous' Condition]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen026v1?rss=1</link>
<description><![CDATA[
<p>Traditional Japanese medicine uses the leaves of Kumaizasa bamboo extracted in hot water at 100&deg;C. For this study, we developed a new, &lsquo;vigorous&rsquo; extraction method involving steps at 100, 121 and 196&deg;C. This procedure not only yielded greater amounts of extract but also with significant increase in immunostimulating activity, which induces activation of human natural killer (NK) cells, macrophages and potent induction of IL-2, IL-12 and IFN- in tumor bearing mice. The efficacy of the extract to facilitate phagocytosis and nitric oxide production by mouse peritoneal macrophages was determined and compared with that of 1,3-&beta;-glucan. Anti-tumor activity was evaluated <I>in vivo</I> in several mouse tumor models (S-180, C38 and Meth-A). Oral administration of the extracts was carried out when tumor reached size of approximately 6 mm at concentrations of 0.05% or higher. The extracts significantly suppressed tumor growth in S-180 and C38 tumor models. Overall survival was significantly prolonged in the treatment group than that of control. Activation of macrophages and NK cells by the extracts suggests that the anti-tumor efficacy of the extract is mediated by immunopotentiation. The extracts resolved into three major fractions (F-I, F-II and F-III) in Sephadex gel chromatography. Fraction F-I consists of 1,3-&beta;-glucan and stimulated both macrophages and NK cells suggesting that it may be the primary immunopotentiating factor in suppressing cancer. Fraction F-III has potent free radical scavenging effects and may play an important role in cancer prevention. These results warrant further translation and clinical investigations.</p>
]]></description>
<dc:creator><![CDATA[Seki, T., Kida, K., Maeda, H.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen026</dc:identifier>
<dc:title><![CDATA[Immunostimulation-Mediated Anti-tumor Activity of Bamboo (Sasa senanensis) Leaf Extracts Obtained Under 'Vigorous' Condition]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen030v1?rss=1">
<title><![CDATA[In vitro anti-plasmodial activity of Trigonella foenum-graecum L.]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen030v1?rss=1</link>
<description><![CDATA[
<p>Developing countries, where malaria is one of the most prevalent diseases, still rely on traditional medicine as a source for the treatment of this disease. For the present study, <I>Trigonella foenum-graecum</I> L. (fenugreek) were collected from Coimbatore, Tamilnadu, India. The test plant has been used in India by traditional healers for the treatment of fever as well as other diseases. The active principle was extracted out in different solvent systems to assess the anti-plasmodial potential, with an aim that they can further be utilized to formulate drugs. <I>In vitro</I> anti-plasmodial assay of the extracted fractions of fenugreek leaves was carried out using laboratory adapted chloroquine sensitive and resistant <I>Plasmodium falciparum</I> isolates. Schizont maturation inhibition assay was adopted to analyze the potential of the extracts. Ethanol extract (50%) seemed to possess profound anti-plasmodial activity with IC<SUB>50</SUB> value of 8.75 &plusmn; 0.35 &micro;g ml<sup>&ndash;1</sup> and 10.25 &plusmn; 0.35 &micro;g ml<sup>&ndash;1</sup> against chloroquine sensitive and resistant <I>P. falciparum</I> isolates, respectively. Among the investigated six fractions of the plant extracts, two were found to have significant anti-plasmodial activity with IC<SUB>50</SUB> values &lt;10 &micro;g ml<sup>&ndash;1</sup>, namely ethanol and butanol extracts. Two extracts chloroform and ethyl acetate showed moderate activity with IC<SUB>50</SUB> values ranging from 10 to 20 &micro;g ml<sup>&ndash;1</sup>, and the other two extracts, hexane and water appeared to be inactive with IC<SUB>50</SUB> values &gt;85 &micro;g ml<sup>&ndash;1</sup>. In addition, preliminary phytochemical screening of the various extracts indicated the presence of alkaloids, saponin, tannin like phenolic compounds, flavonoids and steroids.</p>
]]></description>
<dc:creator><![CDATA[Palaniswamy, M., Pradeep, B. V., Sathya, R., Angayarkanni, J.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen030</dc:identifier>
<dc:title><![CDATA[In vitro anti-plasmodial activity of Trigonella foenum-graecum L.]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen028v1?rss=1">
<title><![CDATA['The Science of CAIM: What's Next for Complementary, Alternative and Integrative Medical Research?']]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen028v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Logue, E. H.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen028</dc:identifier>
<dc:title><![CDATA['The Science of CAIM: What's Next for Complementary, Alternative and Integrative Medical Research?']]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-02</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen025v1?rss=1">
<title><![CDATA[Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen025v1?rss=1</link>
<description><![CDATA[
<p>Mistletoe preparations such as Iscador are in common use as complementary/anthroposophic medications for many cancer indications, particularly for solid cancers. The efficacy is still discussed controversially. This paper presents an individual patient data meta-analysis of all published prospective matched-pair studies with breast cancer patients concerned with long-term application of a complementary/anthroposophic therapy with the mistletoe preparation Iscador. Six sets of data were available for individual patient meta-analysis of breast cancer patients, matched according to prognostic factors into pairs with and without mistletoe (Iscador) therapy. The main outcome measures were overall survival and psychosomatic self-regulation. Overall survival was almost significant in favor of the Iscador group in the combined data set of the randomized studies: estimate of the hazard ratio with 95% confidence interval 0.59 (0.34, 1.02). Overall survival was highly significant in the combined data set of the non-randomized studies: 0.43 (0.34, 0.56). In the combined analysis of the randomized studies, improvement of psychosomatic self-regulation, as a measure of autonomous coping with the disease, was highly significant in favor of the Iscador group: estimate of the median difference 0.45 (0.15, 0.80), <I>P</I> = 0.0051. The analyzed studies show that therapy with Iscador might prolong overall survival and improve psychosomatic self-regulation of breast cancer patients.</p>
]]></description>
<dc:creator><![CDATA[Ziegler, R., Grossarth-Maticek, R.]]></dc:creator>
<dc:date>2008-04-11</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen025</dc:identifier>
<dc:title><![CDATA[Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-04-11</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen024v1?rss=1">
<title><![CDATA[The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen024v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Feingold, E.]]></dc:creator>
<dc:date>2008-04-09</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen024</dc:identifier>
<dc:title><![CDATA[The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-04-09</prism:publicationDate>
<prism:section>Book Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen021v1?rss=1">
<title><![CDATA[Soybeans Ameliolate Diabetic Nephropathy in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen021v1?rss=1</link>
<description><![CDATA[
<p>Diabetic nephropathy is one of the most frequent and serious complications of diabetes mellitus. Soybeans have been shown to reduce urinary albumin excretion and total cholesterol in non-diabetic patients with nephrotic syndrome. However, reports focusing specifically on diabetic nephropathy are scarce and the available results are inconsistent. It was reported that soybean consumption reduced urinary protein excretion in type 1 diabetic patients with diabetic nephropathy, whereas it was found to elicit an increase in urinary protein excretion when soybeans were consumed by type 2 diabetic patients. This study aims to investigate the effects of soybean in diabetic nephropathy, particularly the effects of consuming soybeans on the histopathology of diabetic nephropathy, using aquaporin (AQP) and osteopontin (OPN) expression as diagnostic markers. Male Sprague-Dawley rats were assigned to one of three groups: control, diabetic with red chow diet and diabetic with soybean diet. For histological examination, the expression of OPN and AQP, renal function and hemoglobin A1c were evaluated at the end of the study. Improvements in glomerular and tubulointerstitial lesions were demonstrated in the diabetic rat group given a soybean diet. OPN and AQP expression were suppressed in the kidney specimens of diabetic rats with the soybean diet. In conclusion, soybeans may prevent the weight loss and morphological disruption of the kidney associated with diabetes mellitus. Soybeans also may improve glycemic control. It seems likely that long-term control of blood glucose levels using a soybean diet could prevent the progression of diabetes mellitus, and therefore, nephropathy could be prevented.</p>
]]></description>
<dc:creator><![CDATA[Choi, Y. E., Ahn, S. K., Lee, W. T., Lee, J. E., Park, S. H., Yoon, B. B., Park, K. A.]]></dc:creator>
<dc:date>2008-03-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen021</dc:identifier>
<dc:title><![CDATA[Soybeans Ameliolate Diabetic Nephropathy in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen020v1?rss=1">
<title><![CDATA[Summary of the American College for Advancement in Medicine November 2007 Conference on Integrative Medicine: Advancing Science and Clinical Practice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen020v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Speight, N., Hynote, E. D.]]></dc:creator>
<dc:date>2008-03-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen020</dc:identifier>
<dc:title><![CDATA[Summary of the American College for Advancement in Medicine November 2007 Conference on Integrative Medicine: Advancing Science and Clinical Practice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-20</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen019v1?rss=1">
<title><![CDATA[MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen019v1?rss=1</link>
<description><![CDATA[
<p>We examined the <I>in vitro</I> anti-human immunodeficiency virus (HIV) activity of MRN-100, an iron-based compound derived from bivalent and tervalent ferrates. MRN-100 action against HIV-1 (SF strain) was tested in primary cultures of peripheral blood mononuclear cells (MNC) by analyzing p24 antigen production and percent survival of MNC infected with HIV. MRN-100 at a concentration of 10% (v/v) inhibited HIV-1 replication in 11 out of 14 samples (79%). The percentage of suppression of p24 antigen was &ndash;12.3 to 100% at 10 days post-treatment. MRN-100 also exhibited a significant protective effect in the survival of HIV-1-infected MNC. MNC survival post-treatment was dose dependent, 70.4% &plusmn; 8.4, 83.6% &plusmn; 10.7 and 90% &plusmn; 11.4, at concentrations 2.5, 5 and 10% (v/v), respectively, as compared with 53% &plusmn; 4 for HIV-1-infected MNC without treatment. The effect was detected as early as 4 days and continued up to 11 days. Treatment with MRN-100 caused no significant change in proliferative response of MNC alone or cocultured with different mitogens: PHA and Con-A (activators of T cell function) and PWM (activator of CD4<sup>+</sup> T cell-dependent B cells). We concluded that MRN-100 possesses anti-HIV activity <I>in vitro</I> and without an increase in lymphocyte proliferation, MRN-100 may be a useful agent for treating patients with acquired immunodeficiency syndrome.</p>
]]></description>
<dc:creator><![CDATA[Ghoneum, M., Shaheen, M.]]></dc:creator>
<dc:date>2008-03-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen019</dc:identifier>
<dc:title><![CDATA[MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen023v1?rss=1">
<title><![CDATA[Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen023v1?rss=1</link>
<description><![CDATA[
<p>Complementary and Alternative Medicines (CAM) are used by an extensive number of patients in the UK and elsewhere. In order to understand this pattern of behavior, it is helpful to examine the characteristics of people who use CAM. This narrative review collates and evaluates the evidence concerning the demographic characteristics and health status factors associated with CAM use in community-based non-clinical populations. A systematic literature search of computerized databases was conducted, and published research papers which present evidence concerning associations between CAM use and demographic and health characteristics are discussed and evaluated. The evidence suggests that people who use CAM tend to be female, of middle age and have more education. In terms of their health, CAM users tend to have more than one medical condition, but might not be more likely than non-users to have specific conditions such as cancer or to rate their own general health as poor. The multivariate studies that have been conducted suggest that both demographic and health characteristics contribute independently to CAM use. In conclusion, demographic characteristics and factors related to an individual's health status are associated with CAM use. Future research is needed to address methodological limitations in existing studies.</p>
]]></description>
<dc:creator><![CDATA[Bishop, F. L., Lewith, G. T.]]></dc:creator>
<dc:date>2008-03-13</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen023</dc:identifier>
<dc:title><![CDATA[Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-13</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen022v1?rss=1">
<title><![CDATA[Prognostic Ability of Practitioners of Traditional Arabic Medicine: Comparison with Western Methods Through a Relative Patient Progress Scale]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen022v1?rss=1</link>
<description><![CDATA[
<p>The ancient Greek medical theory based on balance or imbalance of humors disappeared in the western world, but does survive elsewhere. Is this survival related to a certain degree of health care efficiency? We explored this hypothesis through a study of classical Greco-Arab medicine in Mauritania. Modern general practitioners evaluated the safety and effectiveness of classical Arabic medicine in a Mauritanian traditional clinic, with a prognosis/follow-up method allowing the following comparisons: (i) actual patient progress (clinical outcome) compared with what the traditional &lsquo;tabib&rsquo; had anticipated (= prognostic ability) and (ii) patient progress compared with what could be hoped for <I>if</I> the patient were treated by a modern physician in the same neighborhood. The practice appeared fairly safe and, on average, clinical outcome was similar to what could be expected with modern medicine. In some cases, patient progress was better than expected. The ability to correctly predict an individual's clinical outcome did not seem to be better along modern or Greco-Arab theories. Weekly joint meetings (modern and traditional practitioners) were spontaneously organized with a modern health centre in the neighborhood. Practitioners of a different medical system can predict patient progress. For the patient, avoiding false expectations with health care and ensuring appropriate referral may be the most important. Prognosis and outcome studies such as the one presented here may help to develop institutions where patients find support in making their choices, not only among several treatment options, but also among several medical systems.</p>
]]></description>
<dc:creator><![CDATA[Graz, B.]]></dc:creator>
<dc:date>2008-03-13</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen022</dc:identifier>
<dc:title><![CDATA[Prognostic Ability of Practitioners of Traditional Arabic Medicine: Comparison with Western Methods Through a Relative Patient Progress Scale]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-13</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen011v1?rss=1">
<title><![CDATA[Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen011v1?rss=1</link>
<description><![CDATA[
<p>High morbidity and mortality associated with oral squamous cell carcinoma (OSCC) are largely attributable to late stage diagnosis. Despite significant advances in therapeutic strategies, the five-year survival rate for oral cancer remains at about 50%. A chemopreventive approach may be an effective alternative or adjunct to current therapies. Previous studies have shown anti-tumor effects of isoflavones in several cancers, including oral cancer. However, their mechanisms of action are still unclear. We hypothesized that isoflavones inhibit multiple signaling pathways implicated in oral carcinogenesis. To address our hypothesis, we investigated the effects of three isoflavone derivatives, genistein, biochanin A and daidzein, on SCC15 and SCC25 squamous cell carcinoma cell lines. In cell proliferation experiments, we found that genistein and biochanin A inhibited SCC15 and SCC25 cell growth with an IC50 of 50 &micro;M. We also investigated the effect of isoflavones on ERK and Akt pathways. Our results, from western blot analysis, suggest that both genistein and biochanin A induced decreases in phosphorylation of ERK and Akt at treatment concentrations of 20, 50 and 100 &micro;M. Taken together, our results clearly demonstrate a differential regulation of signaling pathways by various isoflavones in OSCC cell lines. Thus, tumor progression models can be utilized to study the preventive and therapeutic roles of isoflavones in oral cancer cell lines.</p>
]]></description>
<dc:creator><![CDATA[Johnson, T. L., Lai, M. B., Lai, J. C. K., Bhushan, A.]]></dc:creator>
<dc:date>2008-02-29</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen011</dc:identifier>
<dc:title><![CDATA[Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen018v1?rss=1">
<title><![CDATA[Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen018v1?rss=1</link>
<description><![CDATA[
<p><I>Satureja khuzestanica</I> is an endemic plant of Iran that is widely distributed in the Southern part of the country. It has antioxidant properties and thus it seems to be useful in diseases related to oxidative stress such as diabetes and hyperlipidemia. The present study investigates the effect of <I>S. khuzestanica</I> supplement in metabolic parameters of hyperlipidemic patients with type 2 diabetes mellitus. Twenty-one hyperlipidemic patients with type 2 diabetes mellitus were randomized in a double blind, placebo controlled clinical trial to receive either <I>S. khuzestanica</I> (tablets contain 250 mg dried leaves) or placebo once a day for 60 days. Blood samples were obtained at baseline and at the end of the study. Samples were analyzed for levels of glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, creatinine, thiobarbituric acid reactive substances (TBARS) as marker of lipid peroxidation and ferric reducing ability (total antioxidant power, TAP). Treatment of patients by <I>S. khuzestanica</I> for 60 days induced significant decrease in total cholesterol (<I>P</I> = 0.008) and LDL-cholesterol (<I>P</I> = 0.03) while increased HDL-cholesterol (<I>P</I> = 0.02) and TAP (<I>P</I> = 0.007) in comparison with the baseline values. <I>S. khuzestanica</I> did not alter blood glucose, triglyceride, creatinin and TBARS levels. In comparison with baseline values, no significant change was observed in blood glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, creatinine, TBARS and TAP in placebo-treated group. Usage of <I>S. khuzestanica</I> as a supplement to drug regimen of diabetic type 2 patients with hyperlipidemia is recommended.</p>
]]></description>
<dc:creator><![CDATA[Vosough-Ghanbari, S., Rahimi, R., Kharabaf, S., Zeinali, S., Mohammadirad, A., Amini, S., Yasa, N., Salehnia, A., Toliat, T., Nikfar, S., Larijani, B., Abdollahi, M.]]></dc:creator>
<dc:date>2008-02-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen018</dc:identifier>
<dc:title><![CDATA[Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen017v1?rss=1">
<title><![CDATA[Traditional Chinese Medicine for Chronic Fatigue Syndrome]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen017v1?rss=1</link>
<description><![CDATA[
<p>More and more patients have been diagnosed as having chronic fatigue syndrome (CFS) in recent years. Western drug use for this syndrome is often associated with many side-effects and little clinical benefit. As an alternative medicine, traditional Chinese medicine (TCM) has provided some evidences based upon ancient texts and recent studies, not only to offer clinical benefit but also offer insights into their mechanisms of action. It has perceived advantages such as being natural, effective and safe to ameliorate symptoms of CFS such as fatigue, disordered sleep, cognitive handicaps and other complex complaints, although there are some limitations regarding the diagnostic standards and methodology in related clinical or experimental studies. Modern mechanisms of TCM on CFS mainly focus on adjusting immune dysfunction, regulating abnormal activity in the hypothalamic-pituitary-adrenal (HPA) axis and serving as an antioxidant. It is vitally important for the further development to establish standards for &lsquo;zheng&rsquo; of CFS, i.e. the different types of CFS pathogenesis in TCM, to perform randomized and controlled trials of TCM on CFS and to make full use of the latest biological, biochemical, molecular and immunological approaches in the experimental design.</p>
]]></description>
<dc:creator><![CDATA[Chen, R., Moriya, J., Yamakawa, J.-i., Takahashi, T., Kanda, T.]]></dc:creator>
<dc:date>2008-02-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen017</dc:identifier>
<dc:title><![CDATA[Traditional Chinese Medicine for Chronic Fatigue Syndrome]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen007v1?rss=1">
<title><![CDATA[Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen007v1?rss=1</link>
<description><![CDATA[
<p>Kampo (traditional Japanese herbal) medicines are taken orally due to which the gastric mucosal immune system may act as one of the major targets for the expression of pharmacological activity. The inner surface of the intestinal tract possesses a large area of mucosal membranes, and the intestinal epithelial cells sit at the interface between a lumen and a lymphocyte-rich lamina propria. The cross talk that occurs between these compartments serves to maintain intestinal homeostasis, and the cytokine network plays an important role in the cross talk. In this study, the effect of Hochuekkito (HET), one of Kampo medicines, on cytokine secretion of intestinal epithelial cells was investigated. When murine normal colonic epithelial cell-line MCE301 cells were stimulated with HET, the contents of granulocyte colony-stimulating factor (G-CSF) in the conditioned medium were significantly increased in dose- and time-dependent manners. The enhanced G-CSF gene transcription in MCE301 cells by the stimulation of HET was observed by RT-PCR. The enhanced G-CSF secretion by HET was also observed in C3H/HeJ mice-derived primary cultured colonic epithelial cells. When the HET was fractionated, only the polysaccharide fraction (F-5) enhanced the G-CSF secretion of MCE301 cells, and the activity of F-5 lost after the treatment of periodate that can degrade the carbohydrate moiety. These results suggest that HET enhances secretion of G-CSF from colonic epithelial cells and the polysaccharide is one of the active ingredients of HET. The enhanced G-CSF secretion by HET may partly contribute to the clinically observed various pharmacological activities of HET including immunomodulating activity.</p>
]]></description>
<dc:creator><![CDATA[Matsumoto, T., Moriya, M., Kiyohara, H., Tabuchi, Y., Yamada, H.]]></dc:creator>
<dc:date>2008-02-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen007</dc:identifier>
<dc:title><![CDATA[Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen010v1?rss=1">
<title><![CDATA[Mao-to Prolongs the Survival of and Reduces TNF-{alpha} Expression in Mice with Viral Myocarditis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen010v1?rss=1</link>
<description><![CDATA[
<p>Goal of this study was to evaluate effects of Mao-to on development of myocarditis induced by encephalomyocarditis (EMC) virus in mice. Mice were randomly divided into five groups. Group N included uninfected controls (<I>n</I> = 18), while group A, B and C underwent intraperitoneal injection of EMC virus. Group A was administered oral saline from day 0 to day 4. Group B was administered oral Mao-to (500 mg<sup>&ndash;1</sup> kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup>) from day 0 to day 4. Group C was administered Mao-to from day 2 to day 6. Group D was administered Mao-to from day 5 to day 10. Treated mice were followed for survival rates during 2 weeks after infection. Body weight (BW) and organ weights including heart (HW), lungs, thymus and spleen were examined on days 4, 6 and 14. Survival rate of group C (36.4%) was significantly improved compared with group A, B or D (0% of each, <I>P</I> &lt; 0.05). HW and HW/BW ratio in group C was significantly (<I>P</I> &lt; 0.05) lower than those in group A, B or D. Viral titers of hearts were significantly different among groups A, B and C. Cardiac expression in tumor necrosis factor- (TNF-) was significantly reduced in group C in comparison with group A, B or D on day 6 by immunohistochemical study. Administration of Mao-to starting on day 2 improves mortality resulting from viral myocarditis in mice with reduced expression of cardiac TNF-. These findings suggest that timing of Mao-to is crucial for preventing cardiac damage in mice with viral myocarditis.</p>
]]></description>
<dc:creator><![CDATA[Shijie, Z., Moriya, J., Yamakawa, J., Chen, R., Takahashi, T., Sumino, H., Nakahashi, T., Iwai, K., Morimoto, S., Yamaguchi, N., Kanda, T.]]></dc:creator>
<dc:date>2008-02-24</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen010</dc:identifier>
<dc:title><![CDATA[Mao-to Prolongs the Survival of and Reduces TNF-{alpha} Expression in Mice with Viral Myocarditis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen009v1?rss=1">
<title><![CDATA[Black Cohosh Hepatic Safety: Follow-up of 107 Patients Consuming a Special Cimicifuga racemosa rhizome Herbal Extract and Review of Literature]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen009v1?rss=1</link>
<description><![CDATA[
<p>European Medicines Agency (EMEA) and the Committee on Herbal Medicinal Products (HMPC) on July 2006 have released an alert to get European sanitary authorities aware of 42 cases of suspected hepatotoxic reactions in patients consuming <I>Cimicifuga racemosa rhizome</I>. In the public statement EMEA itself considered reliable as hepatotoxic reactions only four cases, on the base of RUCAM score: two were considered possible and two probable. Lacking in almost all of them a precise description of cases, especially a botanical&ndash;chemical analysis of the suspected substance, we think there is no real proof of supposed <I>C. racemosa rhizome</I> hepatotoxicity. In our department we administer from about 10 years <I>C. racemosa</I> as special herbal dry extract as single substance or mixed with other medicinal plants at the dose of 500&ndash;1000 mg daily, for treatment of menopause related disorders without any reported adverse effect. After EMEA's official signal we have contacted all our patients using a <I>C. racemosa rhizome</I> herbal extract continuously from more than 12 months to verify possible hepatotoxic effects. We followed-up 107 women, and asked them by telephone (33/107) and/or after anamnesis and clinical examination (74/107) to undergo a blood sample examination. In all the patients there was no sign of hepatic disease, or worsening of already altered but stable parameters. We think on the base of these data and current literature <I>C. racemosa rhizome</I> extract should not be considered a potential hepatotoxic substance.</p>
]]></description>
<dc:creator><![CDATA[Firenzuoli, F., Gori, L., di Sarsina, P. R.]]></dc:creator>
<dc:date>2008-02-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen009</dc:identifier>
<dc:title><![CDATA[Black Cohosh Hepatic Safety: Follow-up of 107 Patients Consuming a Special Cimicifuga racemosa rhizome Herbal Extract and Review of Literature]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen001v1?rss=1">
<title><![CDATA[Lipid Lowering Activity of Anthocephalus indicus Root in Hyperlipidemic Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen001v1?rss=1</link>
<description><![CDATA[
<p>The lipid lowering activity of <I>Anthocephalus indicus</I> (family Rubiaceae; Hindi name Kadamba) root extract has been studied in triton WR-1339 induced hyperlipidemia in rats. In this model, feeding with root extract (500 mg kg<sup>&ndash;1</sup> b.w.) lowered plasma lipids and reactivated post-heparin lipolytic activity in hyperlipidemic rats. Furthermore, the root extract (50&ndash;500 &micro;M) inhibited the generation of superoxide anions and hydroxyl radicals, in both enzymic and non-enzymic systems, <I>in vitro</I>. The results of the present study demonstrated both lipid lowering and antioxidant activities in root extract of <I>A. indicus</I>, which could help prevention of hyperlipidemia and related diseases.</p>
]]></description>
<dc:creator><![CDATA[Kumar, V., Khan, M. M., Khanna, A. K., Singh, R., Singh, S., Chander, R., Mahdi, F., Mahdi, A. A., Saxena, J. K., Singh, R. K.]]></dc:creator>
<dc:date>2008-02-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen001</dc:identifier>
<dc:title><![CDATA[Lipid Lowering Activity of Anthocephalus indicus Root in Hyperlipidemic Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem155v1?rss=1">
<title><![CDATA[History and Progress of Japanese Acupuncture]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem155v1?rss=1</link>
<description><![CDATA[
<p>After Chiso brought acupuncture to Japan from Wu (China) in the sixth century, it has progressed in unique ways within the various historical milieus of the past 1500 years. Ishitsu-rei, the first medical law of Japan established in 701, explains the medical system of acupuncture in detail showing that acupuncture was being administered under the authorization of the national government. For the next 1200 years, acupuncture continued to be an important facet of public health in Japan. From the Azuchimomoyama through the Edo period, the knowledge exchange with China became active and people who studied in China developed new styles and techniques of acupuncture treatment and organized their own private schools or <I>ryu-ha</I> in Japan. In 1635, when the Edo government decided to close the country, Japan cut-off exchange with foreign countries for over 200 years. The national isolation caused some development that was unique to Japan. During that time, acupuncture filtered into people's everyday lives. Moxibustion, in particular, became popular as a treatment that ordinary people could practice by themselves. Also in this period of isolation, Western medicine was imported from Holland, the only country allowed to maintain trade with Japan. This novel modern medicine had a strong impact on Japanese medicine, which has its foundation of Chinese traditional medicine. At the same time, Japanese acupuncture was introduced into Europe via Holland. When Japan opened its borders in 1865 period, the new government was eager to accept Western culture to the extent of prohibiting the progress of Japanese acupuncture for a period of time. Even so, Japanese acupuncture has survived and flourished up to the present day due to the strong demand and the great efforts of the practitioners. Scientific studies are now in the process of establishing a firm evidence base for over a millennium of clinical use, respecting the classic ideas of the traditional treatment.</p>
]]></description>
<dc:creator><![CDATA[Kobayashi, A., Uefuji, M., Yasumo, W.]]></dc:creator>
<dc:date>2008-02-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem155</dc:identifier>
<dc:title><![CDATA[History and Progress of Japanese Acupuncture]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen006v1?rss=1">
<title><![CDATA[The Effect of Therapeutic Touch on Pain and Fatigue of Cancer Patients Undergoing Chemotherapy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen006v1?rss=1</link>
<description><![CDATA[
<p>Despite major advances in pain management, cancer pain is managed poorly in 80% of the patients with cancer. Due to deleterious side effects of pharmacology therapy in these people, there is an urgent need for clinical trials of non-pharmacological interventions. To examine the effect of therapeutic touch (TT) on the pain and fatigue of the cancer patients undergoing chemotherapy, a randomized and three-groups experimental study&mdash;experimental (TT), placebo (placebo TT), and control (usual care)&mdash;was carried out. Ninety patients undergoing chemotherapy, exhibiting pain and fatigue of cancer, were randomized into one of the three groups in the Cancer Center of Imam Khomeini Hospital in Tehran, Iran. Pain and fatigue were measured and recorded by participants before and after the intervention for 5 days (once a day). The intervention consisted of 30 min TT given once a day for 5 days between 10:00 a.m. and 10:30 a.m. The Visual Analogue Scale (VAS) of pain and the Rhoten Fatigue Scale (RFS) were completed for 5 days before and after the intervention by the subjects. The TT (significant) was more effective in decreasing pain and fatigue of the cancer patients undergoing chemotherapy than the usual care group, while the placebo group indicated a decreasing trend in pain and fatigue scores compared with the usual care group.</p>
]]></description>
<dc:creator><![CDATA[Aghabati, N., Mohammadi, E., Pour Esmaiel, Z.]]></dc:creator>
<dc:date>2008-02-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen006</dc:identifier>
<dc:title><![CDATA[The Effect of Therapeutic Touch on Pain and Fatigue of Cancer Patients Undergoing Chemotherapy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen003v1?rss=1">
<title><![CDATA[Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen003v1?rss=1</link>
<description><![CDATA[
<p><I>Hochu-ekki-to</I> is a traditional herbal (Kampo) medicine that has been shown to be effective for patients with <I>Kikyo</I> (delicate, easily fatigable, or hypersensitive) constitution. Previous case reports have suggested that this herbal drug was effective for a certain subgroup of patients with atopic dermatitis (AD). We aimed to evaluate the efficacy and safety of <I>Hochu-ekki-to</I> in the long-term management of <I>Kikyo</I> patients with AD. In this multicenter, double blind, randomized, placebo-controlled study, 91 <I>Kikyo</I> patients with AD were enrolled. <I>Kikyo</I> condition was evaluated by a questionnaire scoring system. All patients continued their ordinary treatments (topical steroids, topical tacrolimus, emollients or oral antihistamines) before and after their protocol entry. <I>Hochu-ekki-to</I> or placebo was orally administered twice daily for 24 weeks. The skin severity scores, total equivalent amount (TEA) of topical agents used for AD treatment, prominent efficacy (cases with skin severity score = 0 at the end of the study) rate and aggravated rate (more than 50% increase of TEA of topical agents from the beginning of the study) were monitored and evaluated. Seventy-seven out of 91 enrolled patients completed the 24-week treatment course (<I>Hochu-ekki-to</I>: <I>n</I> = 37, placebo: <I>n</I> = 40). The TEA of topical agents (steroids and/or tacrolimus) was significantly (<I>P</I> &lt; 0.05) lower in the <I>Hochu-ekki-to</I> group than in the placebo group, although the overall skin severity scores were not statistically different. The prominent efficacy rate was 19% (7 of 37) in the <I>Hochu-ekki-to</I> group and 5% (2 of 40) in the placebo group (<I>P</I> = 0.06). The aggravated rate was significantly (<I>P</I> &lt; 0.05) lower in the <I>Hochu-ekki-to</I> group (3%; 1 of 37) than in the placebo group (18%; 7 of 39). Only mild adverse events such as nausea and diarrhea were noted in both groups without statistical difference. This placebo-controlled study demonstrates that <I>Hochu-ekki-to</I> is a useful adjunct to conventional treatments for AD patients with <I>Kikyo</I> constitution. Use of <I>Hochu-ekki-to</I> significantly reduces the dose of topical steroids and/or tacrolimus used for AD treatment without aggravating AD.</p>
]]></description>
<dc:creator><![CDATA[Kobayashi, H., Ishii, M., Takeuchi, S., Tanaka, Y., Shintani, T., Yamatodani, A., Kusunoki, T., Furue, M.]]></dc:creator>
<dc:date>2008-01-31</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen003</dc:identifier>
<dc:title><![CDATA[Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-31</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem177v1?rss=1">
<title><![CDATA[Seasonal Variation, Chemical Composition and Antioxidant activity of Brazilian Propolis Samples]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem177v1?rss=1</link>
<description><![CDATA[
<p>Total phenolic contents, antioxidant activity and chemical composition of propolis samples from three localities of Minas Gerais state (southeast Brazil) were determined. Total phenolic contents were determined by the Folin&ndash;Ciocalteau method, antioxidant activity was evaluated by DPPH, using BHT as reference, and chemical composition was analyzed by GC/MS. Propolis from Itapecerica and Paula C&acirc;ndido municipalities were found to have high phenolic contents and pronounced antioxidant activity. From these extracts, 40 substances were identified, among them were simple phenylpropanoids, prenylated phenylpropanoids, sesqui- and diterpenoids. Quantitatively, the main constituent of both samples was allyl-3-prenylcinnamic acid. A sample from Virgin&oacute;polis municipality had no detectable phenolic substances and contained mainly triterpenoids, the main constituents being - and &beta;-amyrins. Methanolic extracts from Itapecerica and Paula C&acirc;ndido exhibited pronounced scavenging activity towards DPPH, indistinguishable from BHT activity. However, extracts from Virgin&oacute;polis sample exhibited no antioxidant activity. Total phenolic substances, GC/MS analyses and antioxidant activity of samples from Itapecerica collected monthly over a period of 1 year revealed considerable variation. No correlation was observed between antioxidant activity and either total phenolic contents or contents of artepillin C and other phenolic substances, as assayed by CG/MS analysis.</p>
]]></description>
<dc:creator><![CDATA[Teixeira, E. W., Message, D., Negri, G., Salatino, A., Stringheta, P. C.]]></dc:creator>
<dc:date>2008-01-31</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem177</dc:identifier>
<dc:title><![CDATA[Seasonal Variation, Chemical Composition and Antioxidant activity of Brazilian Propolis Samples]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-31</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen004v1?rss=1">
<title><![CDATA[Antimicrobial, Antioxidant and Cytotoxic Activities and Phytochemical Screening of Some Yemeni Medicinal Plants]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen004v1?rss=1</link>
<description><![CDATA[
<p>The traditional medicine still plays an important role in the primary health care in Yemen. The current study represents the investigation of 16 selected plants, which were collected from different localities of Yemen. The plants were dried and extracted with two different solvents (methanol and hot water) to yield 34 crude extracts. The obtained extracts were tested for their antimicrobial activity against three Gram-positive bacteria, two Gram-negative bacteria, one yeast species and three multiresistant <I>Staphylococcus</I> strains using agar diffusion method, for their antioxidant activity using scavenging activity of DPPH radical method and for their cytotoxic activity using the neutral red uptake assay. In addition, a phytochemical screening of the methanolic extracts was done. Antibacterial activity was shown only against Gram-positive bacteria, among them multiresistant bacteria. The highest antimicrobial activity was exhibited by the methanolic extracts of <I>Acalypha fruticosa</I>, <I>Centaurea pseudosinaica</I>, <I>Dodonaea viscosa</I>, <I>Jatropha variegata</I>, <I>Lippia citriodora</I>, <I>Plectranthus hadiensis</I>, <I>Tragia pungens</I> and <I>Verbascum bottae.</I> Six methanolic extracts especially those of <I>A. fruticosa</I>, <I>Actiniopteris semiflabellata</I>, <I>D. viscosa</I>, <I>P. hadiensis</I>, <I>T. pungens</I> and <I>V. bottae</I> showed high free radical scavenging activity. Moreover, remarkable cytotoxic activity against FL-cells was found for the methanolic extracts of <I>A. fruticosa</I>, <I>Iris albicans</I>, <I>L. citriodora</I> and <I>T. pungens</I>. The phytochemical screening demonstrated the presence of different types of compounds like flavonoids, terpenoids and others, which could be responsible for the obtained activities.</p>
]]></description>
<dc:creator><![CDATA[Mothana, R. A. A., Abdo, S. A. A., Hasson, S., Althawab, F. M. N., Alaghbari, S. A. Z., Lindequist, U.]]></dc:creator>
<dc:date>2008-01-28</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen004</dc:identifier>
<dc:title><![CDATA[Antimicrobial, Antioxidant and Cytotoxic Activities and Phytochemical Screening of Some Yemeni Medicinal Plants]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-28</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem188v1?rss=1">
<title><![CDATA[A Comparison of Chinese and American Indian (Chumash) Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem188v1?rss=1</link>
<description><![CDATA[
<p>Chinese and Chumash traditional medical approaches are similar in terms of disease causation, use of acupuncture or healing touch, plants, spiritual and philosophical approaches. This article provides a brief comparison and discussion of Chinese and Chumash traditional medical practices. A table of 66 plants is presented along with Chinese and Chumash uses of each plant. These uses are compared and contrasted.</p>
]]></description>
<dc:creator><![CDATA[Adams, J. D., Garcia, C., Lien, E. J.]]></dc:creator>
<dc:date>2008-01-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem188</dc:identifier>
<dc:title><![CDATA[A Comparison of Chinese and American Indian (Chumash) Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem187v1?rss=1">
<title><![CDATA[Acupuncture Effects on Cardiac Functions Measured by Cardiac Magnetic Resonance Imaging in a Feline Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem187v1?rss=1</link>
<description><![CDATA[
<p>The usefulness of acupuncture (AP) as a complementary and/or alternative therapy in animals is well established but more research is needed on its clinical efficacy relative to conventional therapy, and on the underlying mechanisms of the effects of AP. Cardiac magnetic resonance imaging (CMRI), an important tool in monitoring cardiovascular diseases, provides a reliable method to monitor the effects of AP on the cardiovascular system. This controlled experiment monitored the effect electro-acupuncture (EA) at bilateral acupoint Neiguan (PC6) on recovery time after ketamine/xylazine cocktail anesthesia in healthy cats. The CMRI data established the basic feline cardiac function index (CFI), including cardiac output and major vessel velocity. To evaluate the effect of EA on the functions of the autonomic nervous and cardiovascular systems, heart rate, respiration rate, electrocardiogram and pulse rate were also measured. Ketamine/xylazine cocktail anesthesia caused a transient hypertension in the cats; EA inhibited this anesthetic-induced hypertension and shortened the post-anesthesia recovery time. Our data support existing knowledge on the cardiovascular benefits of EA at PC6, and also provide strong evidence for the combination of anesthesia and EA to shorten post-anesthesia recovery time and counter the negative effects of anesthetics on cardiac physiology.</p>
]]></description>
<dc:creator><![CDATA[Lin, J.-H., Shih, C.-H., Kaphle, K., Wu, L.-S., Tseng, W.-Y., Chiu, J.-H., Lee, T.-c., Wu, Y.-L.]]></dc:creator>
<dc:date>2008-01-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem187</dc:identifier>
<dc:title><![CDATA[Acupuncture Effects on Cardiac Functions Measured by Cardiac Magnetic Resonance Imaging in a Feline Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem186v1?rss=1">
<title><![CDATA[Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem186v1?rss=1</link>
<description><![CDATA[
<p>The purpose of this project was to conduct a systematic review to identify instruments designed to evaluate the quality of randomized controlled trials (RCTs) of natural health products (NHPs). Instruments were examined for inclusion of items assessing methods, identity and content of the NHP, generalizability of results and instructions for use. Online databases, websites, textbooks and reference lists were searched to identify instruments. Relevance assessment and data extraction of articles were completed by two investigators and disagreements were settled by the third investigator. Data were analyzed using descriptive statistics. Of the 4442 citations identified, 29 were potentially relevant with 16 meeting the criteria for inclusion. None of the instruments stated they were validated; content in the four areas of interest varied considerably. The most common items included randomization sequence generation (100%), blinding (100%), allocation concealment (75%) and participant flow (75%). Only nine of the NHP instruments included at least one item to appraise the specific content of the NHP. The CONSORT Statement for Herbal Interventions most closely addressed the four areas of interest; however, this instrument was specific for herbs. There is a need for the development of a validated instrument for assessment of the quality of RCTs that would be useful for herbs as well as other NHPs.</p>
]]></description>
<dc:creator><![CDATA[Whelan, A. M., Jurgens, T. M., Lord, L.]]></dc:creator>
<dc:date>2008-01-18</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem186</dc:identifier>
<dc:title><![CDATA[Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-18</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem185v1?rss=1">
<title><![CDATA[Complementary and Alternative Medicine Familiarization: What's happening in Medical Schools in Wales?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem185v1?rss=1</link>
<description><![CDATA[
<p>Despite recommendations that complementary and alternative medicine (CAM) familiarization should be offered to UK medical students, in Wales little such teaching was offered. We decided to assess medical students&rsquo; knowledge of CAMs, perceived training needs in CAMs, their view of its role in the National Health Service (NHS) and current teaching given. Analysis of data from a questionnaire given to medical students and direct questioning of senior academic medical school staff in Cardiff and Swansea Medical Schools was carried out. The participants comprised 78 first year medical students in the undergraduate entry program in Cardiff and 58 first year medical students from the graduate entry program in Swansea. Senior academic medical school staff at Cardiff and Swansea Medical Schools were asked about current CAM teaching. Results revealed that 32% of undergraduate entry students (UGES) had previous knowledge of CAMs compared with 51% of graduate entry students (GES). Of the UGES, 62% believed they should be taught about CAM's compared with 94% of GES. Of UGES 31% felt that CAMs have a role in the NHS compared with 50% of GES. None of the students had received teaching about CAMs and little formal CAM teaching is currently included in the curricula at each site. The majority of medical students in Wales would like to receive CAM teaching and significant numbers support a role for CAMs in the NHS. Little formal teaching is currently provided.</p>
]]></description>
<dc:creator><![CDATA[Taylor, N., Blackwell, A.]]></dc:creator>
<dc:date>2008-01-16</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem185</dc:identifier>
<dc:title><![CDATA[Complementary and Alternative Medicine Familiarization: What's happening in Medical Schools in Wales?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem183v1?rss=1">
<title><![CDATA[Anti-microbial Activity of Urine after Ingestion of Cranberry: A Pilot Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem183v1?rss=1</link>
<description><![CDATA[
<p>We explore the anti-microbial activity of urine specimens after the ingestion of a commercial cranberry preparation. Twenty subjects without urinary infection, off antibiotics and all supplements or vitamins were recruited. The study was conducted in two phases: in phase 1, subjects collected the first morning urine prior to ingesting 900 mg of cranberry and then at 2, 4 and 6 h. In phase 2, subjects collected urine on 2 consecutive days: on Day 1 no cranberry was ingested (control specimens), on Day 2, cranberry was ingested. The pH of all urine specimens were adjusted to the same pH as that of the first morning urine specimen. Aliquots of each specimen were independently inoculated with <I>Escherichia coli</I>, <I>Klebsiella pneumoniae</I> or <I>Candida albicans</I>. After incubation, colony forming units/ml (CFU ml<sup>&ndash;1</sup>) in the control specimen was compared with CFU ml<sup>&ndash;1</sup> in specimens collected 2, 4 and 6 h later. Specimens showing &ge;50% reduction in CFU ml<sup>&ndash;1</sup> were considered as having &lsquo;activity&rsquo; against the strains tested. In phase 1, 7/20 (35%) subjects had anti-microbial activity against <I>E</I>. <I>coli</I>, 13/20 (65%) against <I>K</I>. <I>pneumoniae</I> and 9/20 (45%) against <I>C</I>. <I>albicans</I> in specimens collected 2&ndash;6 h after ingestion of cranberry. In phase 2, 6/9 (67%) of the subjects had activity against <I>K</I>. <I>pneumoniae</I>. This pilot study demonstrates weak anti-microbial activity in urine specimens after ingestion of a single dose of commercial cranberry. Anti-microbial activity was noted only against <I>K</I>. <I>pneumoniae</I> 2&ndash;6 h after ingestion of the cranberry preparation.</p>
]]></description>
<dc:creator><![CDATA[Lee, Y. L., Najm, W. I., Owens, J., Thrupp, L., Baron, S., Shanbrom, E., Cesario, T.]]></dc:creator>
<dc:date>2008-01-16</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem183</dc:identifier>
<dc:title><![CDATA[Anti-microbial Activity of Urine after Ingestion of Cranberry: A Pilot Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem184v1?rss=1">
<title><![CDATA[Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid 'Ashwagandha' in Prostate Cancer Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem184v1?rss=1</link>
<description><![CDATA[
<p>Phytochemicals are dietary phytoestrogens that may play a role in prostate cancer prevention. Forty percent of Americans use complementary and alternative medicines (CAM) for disease prevention and therapy. Ashwagandha (<I>Withania somnifera</I>) contains flavonoids and active ingredients like alkaloids and steroidal lactones which are called &lsquo;Withanolides&rsquo;. We hypothesize that the immunomodulatory and anti-inflammatory properties of Ashwagandha might contribute to its overall effectiveness as an anti-carcinogenic agent. The goal of our study was gain insight into the general biological and molecular functions and immunomodulatory processes that are altered as a result of Ashwagandha treatment in prostate cancer cells, and to identify the key signaling mechanisms that are involved in the regulation of these physiological effects using genomic microarray analysis in conjunction with quantitative real-time PCR and western blot analysis. Ashwagandha treatment significantly downregulated the gene and protein expression of proinflammatory cytokines IL-6, IL-1&beta;, chemokine IL-8, Hsp70 and STAT-2, while a reciprocal upregulation was observed in gene and protein expression of p38 MAPK, PI3K, caspase 6, Cyclin D and c-myc. Furthermore, Ashwagandha treatment significantly modulated the JAK-STAT pathway which regulates both the apoptosis process as well as the MAP kinase signaling. These studies outline several functionally important classes of genes, which are associated with immune response, signal transduction, cell signaling, transcriptional regulation, apoptosis and cell cycle regulation and provide insight into the molecular signaling mechanisms that are modulated by Ashwagandha, thereby highlighting the use of this bioflavanoid as effective chemopreventive agent relevant to prostate cancer progression.</p>
]]></description>
<dc:creator><![CDATA[Aalinkeel, R., Hu, Z., Nair, B. B., Sykes, D. E., Reynolds, J. L., Mahajan, S. D., Schwartz, S. A.]]></dc:creator>
<dc:date>2008-01-10</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem184</dc:identifier>
<dc:title><![CDATA[Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid 'Ashwagandha' in Prostate Cancer Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem181v1?rss=1">
<title><![CDATA[Pediatric Acupuncture: A Review of Clinical Research]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem181v1?rss=1</link>
<description><![CDATA[
<p>Practiced in China for more than 2000 years, acupuncture has recently gained increased attention in the United States as an alternative treatment approach for a variety of medical conditions. Despite its growing prevalence and anecdotal reports of success among pediatric populations, few empirically based studies have assessed the efficacy of acupuncture for children and adolescents. This article presents a review of the current literature, including a systematic appraisal of the methodological value of each study and a discussion of potential benefits and adverse effects of acupuncture. While acupuncture holds great promise as a treatment modality for diverse pediatric conditions, a significant amount of additional research is necessary to establish an empirical basis for the incorporation of acupuncture into standard care.</p>
]]></description>
<dc:creator><![CDATA[Gold, J. I., Nicolaou, C. D., Belmont, K. A., Katz, A. R., Benaron, D. M., Yu, W.]]></dc:creator>
<dc:date>2008-01-10</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem181</dc:identifier>
<dc:title><![CDATA[Pediatric Acupuncture: A Review of Clinical Research]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-10</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem180v1?rss=1">
<title><![CDATA[The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem180v1?rss=1</link>
<description><![CDATA[
<p><I>Boehmeria nivea</I> extract (BNE) is widely used in southern Taiwan as a folk medicine for hepato-protection and hepatitis treatment. In previous studies, we demonstrated that BNE could reduce the supernatant hepatitis B virus (HBV) DNA in HBV-producing HepG2 2.2.15 cells. In the present study, we established an animal model of HBV viremia and used it to validate the efficacy of BNE <I>in vivo</I>. In this animal model, serum HBV DNA and HBsAg were elevated in accordance with tumor growth. To evaluate the anti-HBV activity of BNE, HBV-viremia mice were built up after one subcutaneous inoculation of HepG2 2.2.15 tumor cells in severe combined immunodeficiency mice over 13 days. The levels of serum HBV DNA were elevated around 10<sup>5</sup>&ndash;10<sup>6</sup> copies per milliliter. Both oral and intraperitoneal administration of BNE were effective at inhibiting the production of HBsAg and HBV DNA, whereas tumor growth was not affected by all test articles. Intraperitoneal administration of BNE appeared to have greater potential to inhibit serum HBV DNA levels compared with oral administration under the same dosage. Notably, reduced natural killer cell activity was also observed after high dosage of BNE administration, and this correlated with reduced serum HBV DNA. In conclusion, BNE exhibited potential anti-HBV activity in an animal model of HBV viremia.</p>
]]></description>
<dc:creator><![CDATA[Chang, J.-M., Huang, K.-L., Yuan, T. T.-T., Lai, Y.-K., Hung, L.-M.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem180</dc:identifier>
<dc:title><![CDATA[The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem176v1?rss=1">
<title><![CDATA[Pogostemon cablin as ROS Scavenger in Oxidant-induced Cell Death of Human Neuroglioma Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem176v1?rss=1</link>
<description><![CDATA[
<p>Reactive oxygen species (ROS) have been implicated in the pathogenesis of a wide range of acute and long-term neurodegenerative diseases. This study was undertaken to examine the efficacy of <I>Pogostemon cablin</I>, a well-known herb in Korean traditional medicine, on ROS-induced brain cell injury. <I>Pogostemon cablin</I> effectively protected human neuroglioma cell line A172 against both the necrotic and apoptotic cell death induced by hydrogen peroxide (H<SUB>2</SUB>O<SUB>2</SUB>). The effect of <I>Pogostemon cablin</I> was dose dependent at concentrations ranging from 0.2 to 5 mg ml<sup>&ndash;1</sup>. <I>Pogostemon cablin</I> significantly prevented depletion of cellular ATP and activation of poly ADP-ribose polymerase induced by H<SUB>2</SUB>O<SUB>2</SUB>. The preservation of functional integrity of mitochondria upon the treatment of <I>Pogostemon cablin</I> was also confirmed by 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2-H-tetrazolium bromide assay. Furthermore, <I>Pogostemon cablin</I> significantly prevented H<SUB>2</SUB>O<SUB>2</SUB>-induced release of cytochrome c into cytosol. Determination of intracellular ROS showed that <I>Pogostemon cablin</I> might exert its role as a powerful scavenger of intracellular ROS. The present study suggests the beneficial effect of <I>Pogostemon cablin</I> on ROS-induced neuroglial cell injury. The action of <I>Pogostemon cablin</I> as a ROS-scavenger might underlie the mechanism.</p>
]]></description>
<dc:creator><![CDATA[Kim, H. W., Cho, S. J., Kim, B.-Y., Cho, S. I., Kim, Y. K.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem176</dc:identifier>
<dc:title><![CDATA[Pogostemon cablin as ROS Scavenger in Oxidant-induced Cell Death of Human Neuroglioma Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem178v1?rss=1">
<title><![CDATA[Ginseng on Hyperglycemia: Effects and Mechanisms]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem178v1?rss=1</link>
<description><![CDATA[
<p>It has been reported that American ginseng attenuates hyperglycemia and may present itself as a supplement to diabetes therapy. However, the lack of standardization in the usage of ginseng root leads to inconclusive results when applied to diabetes treatment. The mechanisms of American ginseng root in the treatment of diabetes remains a mystery. This greatly limits the effective utilization of American ginseng in facilitating diabetic therapy. Initiating studies have shown that American ginseng increases insulin production and reduces cell death in pancreatic &beta;-cells. Also, studies have revealed American ginseng's ability to decrease blood glucose in type II diabetes patients as well as in streptozotocin-induced diabetic animals (STZ-diabetic mice). These data suggest that effects of ginseng in improving hyperglycemia may alter mitochondrial function as well as apoptosis cascades to ensure cell viability in pancreatic islet cells. This review briefly summarizes current knowledge of ginseng components and clinical studies related to diabetes. Further research will be needed to explore and identify the component(s) of ginseng, which may be responsible for the beneficial effects observed in animal studies which could then be extrapolated to human islets.</p>
]]></description>
<dc:creator><![CDATA[Luo, J. Z., Luo, L.]]></dc:creator>
<dc:date>2008-01-03</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem178</dc:identifier>
<dc:title><![CDATA[Ginseng on Hyperglycemia: Effects and Mechanisms]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-03</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem140v2?rss=1">
<title><![CDATA[Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem140v2?rss=1</link>
<description><![CDATA[
<p>We previously reported that catechins of green tea have different antiproliferative effects on cell lines derived from gender-dependent cancers; epicatechin 3-gallate (ECG) had the strongest inhibitory effect. In the present study, we examined the effects of epigallocatechin (EGC), epicatechin-gallate (ECG) and EGC 3-gallate (EGCG) on the viability, density, doubling time and cycle number of cell lines derived from melanoma metastasized to lymph nodes (MB-1133 and SE-0154) or distant organs (CH-0356, JK-0346, SA-1171, GE-0208, NS-1176 and LF-0023). These catechins have been documented to have no growth suppressive or apoptotic effects on normal melanocytes (Nihal et al., <I>Int J Cancer</I> 2005;114:513&ndash;21). EGCG (50 &micro;M) showed greater inhibitory potency than EGC (50 &micro;M) in SE-0154, NS-1176, GE-0208 and LF-0023 cell lines but the two catechins produced similar inhibitory effects in CH-0356, JK-0346 and SA-1171 cell lines. The IC<SUB>50</SUB> (50% inhibitory concentration) was lower for EGC than EGCG in MB-1133 and CH-0356 cells, higher for EGC than EGCG in GE-0208 cells and comparable (11&ndash;12 &micro;M) for both the catechins in LF-0023 cells. When compared with EGC, the cytotoxic effect (% dead cell counts) and the suppression of the growth (change in cell number) of all melanoma cell lines tested were pronounced with EGCG. This investigation validates the hypothesis that anticancer action of the various catechins may vary with the type of malignancy and provides a model for tumor cell heterogeneity based on susceptibility and resistance of tumor cells to different green tea catechins. Therefore, this information is critical for undertaking chemopreventive or chemotherapeutic trials against melanoma and gender-based cancers.</p>
]]></description>
<dc:creator><![CDATA[Ravindranath, M. H., Ramasamy, V., Moon, S., Ruiz, C., Muthugounder, S.]]></dc:creator>
<dc:date>2008-01-03</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem140</dc:identifier>
<dc:title><![CDATA[Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem172v1?rss=1">
<title><![CDATA[Comfrey (Symphytum Officinale. L.) and Experimental Hepatic Carcinogenesis: A Short-term Carcinogenesis Model Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem172v1?rss=1</link>
<description><![CDATA[
<p>Comfrey or <I>Symphytum officinale</I> (L.) (Boraginaceae) is a very popular plant used for therapeutic purposes. Since the 1980s, its effects have been studied in long-term carcinogenesis studies, in which Comfrey extract is administered at high doses during several months and the neoplastic hepatic lesions are evaluated. However, the literature on this topic is very poor considering the studies performed under short-term carcinogenesis protocols, such as the &lsquo;resistant hepatocyte model&rsquo; (RHM). In these studies, it is possible to observe easily the phenomena related to the early phases of tumor development, since pre-neoplastic lesions (PNLs) rise in about 1&ndash;2 months of chemical induction. Herein, the effects of chronic oral treatment of rats with 10% Comfrey ethanolic extract were evaluated in a RHM. Wistar rats were sequentially treated with <I>N</I>-nitrosodiethylamine (ip) and 2-acetilaminofluorene (po), and submitted to hepatectomy to induce carcinogenesis promotion. Macroscopic/microscopic quantitative analysis of PNL was performed. Non-parametric statistical tests (Mann&ndash;Whitney and <sup>2</sup>) were used, and the level of significance was set at <I>P</I> &le; 0.05. Comfrey treatment reduced the number of pre-neoplastic macroscopic lesions up to 1 mm (<I>P</I> &le; 0.05), the percentage of oval cells (<I>P</I> = 0.0001) and mitotic figures (<I>P</I> = 0.007), as well as the number of Proliferating Cell Nuclear Antigen (PCNA) positive cells (<I>P</I> = 0.0001) and acidophilic pre-neoplastic nodules (<I>P</I> = 0.05). On the other hand, the percentage of cells presenting megalocytosis (<I>P</I> = 0.0001) and vacuolar degeneration (<I>P</I> = 0.0001) was increased. Scores of fibrosis, glycogen stores and the number of nucleolus organizing regions were not altered. The study indicated that oral treatment of rats with 10% Comfrey alcoholic extract reduced cell proliferation in this model.</p>
]]></description>
<dc:creator><![CDATA[Gomes, M. F. P. L., de Oliveira Massoco, C., Xavier, J. G., Bonamin, L. V.]]></dc:creator>
<dc:date>2007-12-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem172</dc:identifier>
<dc:title><![CDATA[Comfrey (Symphytum Officinale. L.) and Experimental Hepatic Carcinogenesis: A Short-term Carcinogenesis Model Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-26</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem170v1?rss=1">
<title><![CDATA[The MIQ-RS: A Suitable Option for Examining Movement Imagery Ability]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem170v1?rss=1</link>
<description><![CDATA[
<p>Within rehabilitation settings, mental imagery helps to promote long-term recovery and facilitates compliance to rehabilitation exercises. Individuals who are able to effectively engage in imagery practice are likely to gain the most benefit from imagery training. Thus, a suitable imagery ability measurement tool for individuals with movement limitations is needed. The purpose of the present study was to evaluate the Movement Imagery Questionnaire&mdash;Revised second version (MIQ-RS), and compare the results of this new version with Hall and Martin's (1997) MIQ-R. Three-hundred and twenty participants from a variety of sports and performance levels agreed to take part. Results showed the internal consistency and test&ndash;retest reliability of the MIQ-RS were satisfactory, the two-factor structure of the MIQ-RS was supported by confirmatory factor analysis, and Pearson correlations indicated a strong relationship between the MIQ-R and MIQ-RS. It appears the MIQ-RS is a suitable option for examining movement imagery ability primarily aimed at the upper extremity.</p>
]]></description>
<dc:creator><![CDATA[Gregg, M., Hall, C., Butler, A.]]></dc:creator>
<dc:date>2007-12-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem170</dc:identifier>
<dc:title><![CDATA[The MIQ-RS: A Suitable Option for Examining Movement Imagery Ability]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-26</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem159v1?rss=1">
<title><![CDATA[Catalytic Therapy of Cancer with Ascorbate and Extracts of Medicinal Herbs]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem159v1?rss=1</link>
<description><![CDATA[
<p>Catalytic therapy (CT) is a cancer treatment modality based on the generation of reactive oxygen species (ROS) using a combination of substrate molecules and a catalyst. The most frequently used substrate/catalyst pair is ascorbate/Co phthalocyanine (PcCo). In the present work, herb extracts containing pigments have been studied as a catalyst in place of PcCo. Extracts from herbs are expected to have efficiency comparable with that of phthalocyanines but as natural products, to exhibit fewer side effects. The present studies demonstrate that a combined use of ascorbate and herbal extracts results in ROS production and a significant decrease in the number of cancer cells after a single <I>in vitro</I> treatment. Treatment with ascorbate in conjunction with extracts prepared from several medicinal herbs stimulated apoptosis and disrupted the cell cycle. The number of cells accumulating in the sub-G0/G1 stage of the cell cycle was increased 2- to 7-fold, and cells in G<SUB>2</SUB>/M increased 1.5- to 20-fold, indicating that the treatment protocol was highly effective in suppressing DNA synthesis and potentially reflecting DNA damage in the tumor cells. In addition, 20&ndash;40% of the cells underwent apoptosis within 24 h of completing treatment. Our results suggest that herbal extracts can function as CT catalysts in the treatment of cancer.</p>
]]></description>
<dc:creator><![CDATA[Rozanova, N., Zhang, J. Z., Heck, D. E.]]></dc:creator>
<dc:date>2007-12-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem159</dc:identifier>
<dc:title><![CDATA[Catalytic Therapy of Cancer with Ascorbate and Extracts of Medicinal Herbs]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-26</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem171v1?rss=1">
<title><![CDATA[Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem171v1?rss=1</link>
<description><![CDATA[
<p>The present investigation was undertaken to assess the role of <I>Mucuna pruriens</I> in infertile men who were under psychological stress. Study included 60 subjects who were undergoing infertility screening and were found to be suffering from psychological stress, assessed on the basis of a questionnaire and elevated serum cortisol levels. Age-matched 60 healthy men having normal semen parameters and who had previously initiated at least one pregnancy were included as controls. Infertile subjects were administered with <I>M. pruriens</I> seed powder (5 g day<sup>&ndash;1</sup>) orally. For carrying out morphological and biochemical analysis, semen samples were collected twice, first before starting treatment and second after 3 months of treatment. The results demonstrated decreased sperm count and motility in subjects who were under psychological stress. Moreover, serum cortisol and seminal plasma lipid peroxide levels were also found elevated along with decreased seminal plasma glutathione (GSH) and ascorbic acid contents and reduced superoxide dismutase (SOD) and catalase activity. Treatment with <I>M. pruriens</I> significantly ameliorated psychological stress and seminal plasma lipid peroxide levels along with improved sperm count and motility. Treatment also restored the levels of SOD, catalase, GSH and ascorbic acid in seminal plasma of infertile men. On the basis of results of the present study, it may be concluded that <I>M. pruriens</I> not only reactivates the anti-oxidant defense system of infertile men but it also helps in the management of stress and improves semen quality.</p>
]]></description>
<dc:creator><![CDATA[Shukla, K. K., Mahdi, A. A., Ahmad, M. K., Jaiswar, S. P., Shankwar, S. N., Tiwari, S. C.]]></dc:creator>
<dc:date>2007-12-18</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem171</dc:identifier>
<dc:title><![CDATA[Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-18</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem167v1?rss=1">
<title><![CDATA[Cost Effectiveness of Natural Health Products: A Systematic Review of Randomized Clinical Trials]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem167v1?rss=1</link>
<description><![CDATA[
<p>Health care spending in North America is consuming an ever-increasing share of Gross Domestic Product (GDP). A large proportion of alternative health care is consumed in the form of natural health products (NHPs). The question of whether or not NHPs may provide a cost-effective choice in the treatment of disease is important for patients, physicians and policy makers. The objective of this study was to conduct a systematic review of the literature in order to find, appraise and summarize high-quality studies that explore the cost effectiveness of NHPs as compared to conventional medicine. The following databases were searched independently in duplicate from inception to January 1, 2006: EMBASE, MEDLINE, CINAHL, BioethicsLine, Wilson General Science abstracts, EconLit, Cochrane Library, ABI/Inform and SciSearch. To be included in the review, trials had to be randomized, assessed for some measure of cost effectiveness and include the use of NHPs as defined by the Natural Health Products Directorate. Studies dealing with diseases due to malnutrition were excluded from appraisal. The pooled searches unveiled nine articles that fit the inclusion/exclusion criteria. The conditions assessed by the studies included three on postoperative complications, two on cardiovascular disease, two on gastrointestinal disorders, one on critically ill patients and one on urinary tract infections. Heterogeneity between the studies was too great to allow for meta-analysis of the results. The use of NHPs shows evidence of cost effectiveness in relation to postoperative surgery but not with respect to the other conditions assessed. In conclusion, NHPs may be of use in preventing complications associated with surgery. The cost effectiveness of some NHPs is encouraging in certain areas but needs confirmation from further research.</p>
]]></description>
<dc:creator><![CDATA[Kennedy, D. A., Hart, J., Seely, D.]]></dc:creator>
<dc:date>2007-12-05</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem167</dc:identifier>
<dc:title><![CDATA[Cost Effectiveness of Natural Health Products: A Systematic Review of Randomized Clinical Trials]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-05</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem162v1?rss=1">
<title><![CDATA[Guarana's Journey from Regional Tonic to Aphrodisiac and Global Energy Drink]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem162v1?rss=1</link>
<description><![CDATA[
<p>Guaran&aacute; (<I>Paullinia cupana</I> H.B.K., Sapindaceae) is a rainforest vine that was domesticated in the Amazon for its caffeine-rich fruits. Guaran&aacute; has long been used as a tonic and to treat various disorders in Brazil and abroad and became a national soda in Brazil about a century ago. In the last two decades or so, guaran&aacute; has emerged as a key ingredient in various &lsquo;sports&rsquo; and energy drinks as well as concoctions that allegedly boost one's libido. For some time, guaran&aacute;'s high caffeine content was thought to be a detriment because of health concerns about excessive intake of caffeine-rich drinks. But it is precisely this quality, and the fact that it has a mysterious name and comes from an exotic land, that has propelled guaran&aacute; into a global beverage.</p>
]]></description>
<dc:creator><![CDATA[Smith, N., Atroch, A. L.]]></dc:creator>
<dc:date>2007-12-05</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem162</dc:identifier>
<dc:title><![CDATA[Guarana's Journey from Regional Tonic to Aphrodisiac and Global Energy Drink]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-05</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem150v1?rss=1">
<title><![CDATA[Dietary Supplement Polypharmacy: An Unrecognized Public Health Problem?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem150v1?rss=1</link>
<description><![CDATA[
<p>Excessive and inappropriate use of medications, or &lsquo;polypharmacy&rsquo;, has been recognized as a public health problem. In addition, there is growing use of dietary supplements in the United States; however, little is known about the patterns of supplement use. Recent reports in the literature of cases of excessive or inappropriate use of herbal dietary supplements leading to the term &lsquo;polyherbacy&rsquo;. The clinical vignettes described in this article highlight the need for further research on the nature and extent of multiple and inappropriate dietary supplement use or &lsquo;dietary supplement polypharmacy&rsquo;. Clinical interviewing and population surveys both address this issue in complementary ways, and provide a further understanding of dietary supplement use patterns.</p>
]]></description>
<dc:creator><![CDATA[Nisly, N. L., Gryzlak, B. M., Zimmerman, M. B., Wallace, R. B.]]></dc:creator>
<dc:date>2007-12-05</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem150</dc:identifier>
<dc:title><![CDATA[Dietary Supplement Polypharmacy: An Unrecognized Public Health Problem?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-05</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem129v1?rss=1">
<title><![CDATA[Inhibitory Potencies of Several Iridoids on Cyclooxygenase-1, Cyclooxygnase-2 Enzymes Activities, Tumor Necrosis factor-{alpha} and Nitric Oxide Production In Vitro]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem129v1?rss=1</link>
<description><![CDATA[
<p>To verify the anti-inflammatory potency of iridoids, seven iridoid glucosides (aucubin, catalpol, gentiopicroside, swertiamarin, geniposide, geniposidic acid and loganin) and an iridoid aglycone (genipin) were investigated with <I>in vitro</I> testing model systems based on inhibition of cyclooxygenase (COX)-1/-2 enzymes, the tumor necrosis factor- (TNF-) formation and nitric oxide (NO) production. The hydrolyzed-iridoid products (H-iridoid) with &beta;-gludosidase treatment only showed inhibitory activities, and revealed different potencies, depending on their chemical structures. Without the &beta;-gludosidase treatment, no single iridoid glycoside exhibited any activities. The aglycone form (genipin) also did not show inhibitory activities. To compare anti-inflammatory potency, the inhibitory concentrations (IC<SUB>50</SUB>) in each testing system were measured. The hydrolyzed-aucubin product (H-aucubin) with &beta;-gludosidase treatment showed a moderate inhibition on COX-2 with IC<SUB>50</SUB> of 8.83 &micro;M, but much less inhibition (IC<SUB>50</SUB>, 68.9 &micro;M) on COX-1 was noted. Of the other H-iridoid products, the H-loganin and the H-geniposide exhibited higher inhibitory effects on COX-1, revealing IC<SUB>50</SUB> values of 3.55 and 5.37 &micro;M, respectively. In the case of TNF- assay, four H-iridoid products: H-aucubin, H-catalpol, H-geniposide and H-loganin suppressed the TNF- formation with IC<SUB>50</SUB> values of 11.2, 33.3, 58.2 and 154.6 &micro;M, respectively. But other H-iridoid products manifested no significant activity. Additional experiments on NO production were conducted. We observed that only the H-aucubin exhibited a significant suppression with IC<SUB>50</SUB> value of 14.1 &micro;M. Genipin, an agycone form, showed no inhibitory effects on all testing models, implying the hydrolysis of the glycosidic bond of iridoid glycoside is a pre-requisite step to produce various biological activities.</p>
]]></description>
<dc:creator><![CDATA[Park, K. S., Kim, B. H., Chang, I.-M.]]></dc:creator>
<dc:date>2007-12-03</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem129</dc:identifier>
<dc:title><![CDATA[Inhibitory Potencies of Several Iridoids on Cyclooxygenase-1, Cyclooxygnase-2 Enzymes Activities, Tumor Necrosis factor-{alpha} and Nitric Oxide Production In Vitro]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem124v1?rss=1">
<title><![CDATA[Effective Application of Knowledge Management in Evidence-based Chinese Medicine: A Case Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem124v1?rss=1</link>
<description><![CDATA[
<p>Chinese medicine (CM) practice, as a knowledge-based industry, has not embraced knowledge management (KM) techniques widely. However, KM may facilitate the adaptation and promotion of evidence-based CM. A KM framework was introduced to its activities in evidence-based CM through the development of a CM portal. A codification strategy was used to codify and store knowledge systematically in a database. Several approaches were developed and implemented to address specific needs for CM such as centralizing the information, encouraging collective efforts, promoting integration of explicit and tacit knowledge, and developing a flexible technology and support system. Following the established KM framework, the RMIT Chinese Medicine Portal (<inter-ref locator="www.chinese-medicine.com.au" locator-type="url">www.chinese-medicine.com.au</inter-ref>) was built up with four major components: organizational knowledge, knowledge workers, KM processes and information technology. Knowledge on Chinese herbs was classified into core, advanced and innovative categories, which involved the development of the monograph template. A working group was organized including CM, pharmacology and information technology professionals to implement this proposal with following sequential development stages: knowledge creation/acquisition, storage/organization, distribution and application. User interface and web language were also defined and accomplished. This case study demonstrates the applicability of KM in evidence-based CM through a multidisciplinary collaboration, such as, an effective collaboration between CM and information technology. The study also shows the potential of KM application in other disciplines of complementary and alternative medicine.</p>
]]></description>
<dc:creator><![CDATA[Yang, A. W., Allan, G., Li, C. G., Xue, C. C.]]></dc:creator>
<dc:date>2007-11-30</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem124</dc:identifier>
<dc:title><![CDATA[Effective Application of Knowledge Management in Evidence-based Chinese Medicine: A Case Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-11-30</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem168v1?rss=1">
<title><![CDATA[Potential Use of Plectranthus amboinicus in the Treatment of Rheumatoid Arthritis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem168v1?rss=1</link>
<description><![CDATA[
<p><I>Plectranthus amboinicus</I> (<I>P. amboinicus</I>) is a folk herb that is used to treat inflammatory diseases or swelling symptoms in Taiwan. We investigated therapeutic efficacy of <I>P. amboinicus</I> in treating Rheumatoid Arthritis (RA) using collagen-induced arthritis animal model. Arthritis was induced in Lewis rats by immunization with bovine type II collagen. Serum anti-collagen IgG, IgM and C-reactive protein (CRP) were analyzed. To understand the inflammation condition of treated animals, production of TNF-, IL-6 and IL-1&beta; from peritoneal exudates cells (PEC) were also analyzed. <I>P. amboinicus</I> significantly inhibited the footpad swelling and arthritic symptoms in collagen-induced arthritic rats, while the serum anti-collagen IgM and CRP levels were consistently decreased. The production of pro-inflammatory cytokines TNF-, IL-6 and IL-1&beta; were also decreased in the high dosage of <I>P. amboinicus</I> group. Here, we demonstrate the potential anti-arthritic effect of <I>P. amboinicus</I> for treating RA, which might confer its anti-rheumatic activity. This differs the pharmacological action mode of indomethacin.</p>
]]></description>
<dc:creator><![CDATA[Chang, J.-M., Cheng, C.-M., Hung, L.-M., Chung, Y.-S., Wu, R.-Y.]]></dc:creator>
<dc:date>2007-11-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem168</dc:identifier>
<dc:title><![CDATA[Potential Use of Plectranthus amboinicus in the Treatment of Rheumatoid Arthritis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-11-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem165v1?rss=1">
<title><![CDATA[N-butanol Extract from Melilotus Suaveolens Ledeb Affects Pro- and Anti-Inflammatory Cytokines and Mediators]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem165v1?rss=1</link>
<description><![CDATA[
<p><I>Melilotus suaveolens Ledeb</I> is a traditional medicinal plant for treating inflammation-related disease. This explores the inner anti-inflammatory mechanism of <I>n</I>-butanol extract from <I>M. suaveolens Ledeb</I>. Inflammatory cellular model was established by lipopolysaccharide intervention on RAW264.7 cell line. Levels of secreted cytokines TNF-, IL-1&beta;, IL-6, NO and IL-10 in supernatant, mRNA expression of TNF-, COX-2, iNOS and HO-1, protein expression of COX-2 and HO-1, activation of NF-B and ingredients in the extract were assayed by ELISA, real time quantitative PCR, western blot, immunocytochemical test and HPLC fingerprint test, respectively. As a result, the extract could not only markedly reduce the production of pro-inflammatory mediators to different extents by blocking NF-B activation but also promote the release of anti-inflammatory mediator HO-1 significantly. Each 1 g extract contained 0.023531 mg coumarin and another two high polar ingredients, probably saponins. It can be concluded that the extract has similar effects on antagonizing pro-inflammatory mediators and cytokines like Dexamethasone, and has effects on promoting the production of anti-inflammatory mediators.</p>
]]></description>
<dc:creator><![CDATA[Zhao, L., Tao, J.-Y., Zhang, S.-L., Jin, F., Pang, R., Dong, J.-H.]]></dc:creator>
<dc:date>2007-11-14</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem165</dc:identifier>
<dc:title><![CDATA[N-butanol Extract from Melilotus Suaveolens Ledeb Affects Pro- and Anti-Inflammatory Cytokines and Mediators]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-11-14</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem153v1?rss=1">
<title><![CDATA[A Kampo Medicine, Boi-ogi-to, Inhibits Obesity in Ovariectomized Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem153v1?rss=1</link>
<description><![CDATA[
<p>In women facing menopause, end of menstrual activity is accompanied by lower levels of estrogen and gradual weight gain. Postmenopausal weight gain sounds an alarm for women's health and may lead to hyperlipidemia, a lipid increase and glucose intolerance. These phenomena are connected to lifestyle-related diseases such as hypertension, type II diabetes mellitus, arteriosclerosis and metabolic syndrome, making it essential to prevent weight gain in women. A Kampo medicine, Boi-ogi-to, is traditionally used to treat obese conditions, but the mechanism has not yet been investigated. In this experiment, we tested the antiobesity properties of Boi-ogi-to in ovariectomized rats by measuring changes of serum cytokine levels and adipocytokines in fat cells. After treatment with this extract for 6 weeks (20-week-old rats), we found that there was a significant weight decrease in rats treated with Boi-ogi-to as compared with that in the control group. Serum tumor necrosis factor (TNF)- levels increased significantly in a dose-dependent manner. Gene expression of adipose tissue in uterus also dose dependently showed a significant increase of TNF- levels, suggesting that secretion of TNF- by fat cells might play a role in the ability of Boi-ogi-to to inhibit weight gain. While peroxisome proliferators-activated receptor- and adiponectin levels did not show a significant difference as compared with those in the control, levels of mRNA expression showed a tendency to increase dose dependently. Resistin did not show any significant change. These results suggest that Boi-ogi-to might be useful for the prevention of obesity that occurs in women with reduction of estrogen.</p>
]]></description>
<dc:creator><![CDATA[Yamakawa, J.-i., Moriya, J., Takahashi, T., Ishige, A., Motoo, Y., Yoshizaki, F., Kanda, T.]]></dc:creator>
<dc:date>2007-11-14</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem153</dc:identifier>
<dc:title><![CDATA[A Kampo Medicine, Boi-ogi-to, Inhibits Obesity in Ovariectomized Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-11-14</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem169v1?rss=1">
<title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture A Short Review of Centrally Measured Effects]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem169v1?rss=1</link>
<description><![CDATA[
<p>The assessment of acupuncture-induced effects on brain function is crucial. Ultrasound-assisted brain function monitoring and bioelectrical methods as well as near infrared spectroscopic procedures and functional magnetic resonance investigations form the basis for the latest scientific examination methods for acupuncture research. The laserneedle acupuncture, which was examined scientifically for the first time in Graz, represents a new painless and non-invasive acupuncture method. In this way, individual combinations of acupuncture points can be stimulated simultaneously according to traditional Chinese medicine. In the context of double-blind studies, effects in the brain could be demonstrated in a reproducible manner for the first time. This second part of the short review article summarizes some of the centrally measured effects of acupuncture obtained at the Medical University of Graz within the last 10 years.</p>
]]></description>
<dc:creator><![CDATA[Litscher, G.]]></dc:creator>
<dc:date>2007-11-12</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem169</dc:identifier>
<dc:title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture A Short Review of Centrally Measured Effects]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-11-12</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem118v1?rss=1">
<title><![CDATA[Anti-inflammatory and Immune-regulatory Effects of Subcutaneous Perillae Fructus Extract Injections on OVA-induced Asthma in Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem118v1?rss=1</link>
<description><![CDATA[
<p><I>Perillae fructus</I> (perilla seed) is a traditional medicinal herb used to treat bronchial asthma in Oriental medical clinics. ST36 is one of the most widely used acupuncture points, particularly for immune system regulation. Injection of an herbal extract into an acupuncture point (herbal acupuncture) is a therapeutic technique combining both acupuncture and herbal treatment. <I>Perillae fructus</I> extract was injected subcutaneously (<I>Perillae fructus</I> herbal acupuncture; PF-HA) at acupoint ST36 of OVA-induced asthmatic mice. The lung weight, bronchoalveolar fluid (BALF) cell count, the number of CCR3+, CD11b+, CD4+ and CD3e+/CD69+ cells in the lung, and the level of IgE, IL-4, IL-5 and IL-13 in BALF and serum were then measured. RT-PCR was used to measure the mRNA expression of IL-4, IL-5, IL-13 and TNF- in the lung. Lung sections were analyzed histologically. PF-HA significantly reduced lung weight, the number of inflammatory cells in the lung and BALF, the levels of IgE and Th2 cytokines in BALF and serum, mRNA expression of Th2 cytokines in the lung, and pathological changes in lung tissue. Our results suggest that PF-HA may have an anti-inflammatory and immune-regulatory effect on bronchial allergic asthma by restoring the Th1/Th2 imbalance in the immune system and suppressing eosinophilic inflammation in airways.</p>
]]></description>
<dc:creator><![CDATA[Yim, Y.-K., Lee, H., Hong, K.-E., Kim, Y.-I., Ko, S.-K., Kim, J.-E., Lee, S.-Y., Park, K.-S.]]></dc:creator>
<dc:date>2007-11-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem118</dc:identifier>
<dc:title><![CDATA[Anti-inflammatory and Immune-regulatory Effects of Subcutaneous Perillae Fructus Extract Injections on OVA-induced Asthma in Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-11-08</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem120v1?rss=1">
<title><![CDATA[Turo (Qi Dance) Training Attenuates Psychological Symptoms and Sympathetic Activation Induced by Mental Stress in Healthy Women]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem120v1?rss=1</link>
<description><![CDATA[
<p>Vagal withdrawal and sympathetic overactivity accompany various types of stress. Qi training is reported to reduce sympathetic hyper-reactivity in a stressful situation. Turo, which is a type of dance that uses the Meridian Qi System, may reduce the psychological symptoms induced by an imbalance of the autonomic nervous system (ANS). We observed whether Turo training alters psychopathological and psychological symptoms using the Symptom Checklist 90-Revision (SCL-90-R) and examined whether it attenuates the stress response to mental stress in healthy adolescent females using the power spectrum analysis of heart rate variability (HRV). Twenty-one subjects received Turo training and 27 subjects were trained with mimicking movements. The SCL-90-R was measured before and after the 2-month training period. Heart rate (HR), total power (TP) and the LF/HF ratio of HRV were compared between the Turo and control groups during and after mental stress. The somatization and hostility subscales of the SCL-90-R of the Turo group were significantly lower than those of the control group after 2 months. The increases in HR and the LF/HF ratio of HRV induced by the stress test were significantly lower in the Turo group than in the control group. The TP of the Turo group was significantly higher than that of the control group. The psychological symptoms and sympathetic activation induced by the artificial stress were significantly reduced by the Turo training. These findings suggest that Turo training can play a critical role in attenuating psychological symptoms and stress-induced sympathetic activation.</p>
]]></description>
<dc:creator><![CDATA[Lee, H.-J., Chae, Y., Park, H.-J., Hahm, D.-H., An, K., Lee, H.]]></dc:creator>
<dc:date>2007-11-01</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem120</dc:identifier>
<dc:title><![CDATA[Turo (Qi Dance) Training Attenuates Psychological Symptoms and Sympathetic Activation Induced by Mental Stress in Healthy Women]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-11-01</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem166v1?rss=1">
<title><![CDATA[Hochuekkito, a Kampo (traditional Japanese herbal) Medicine, Enhances Mucosal IgA Antibody Response in Mice Immunized with Antigen-entrapped Biodegradable Microparticles]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem166v1?rss=1</link>
<description><![CDATA[
<p>The effect of oral administration of Hochuekkito (HET; Bu-Zhong-Yi-Qi-Tang in Chinese), a traditional Japanese herbal medicine, on mucosal IgA immune response was investigated. To induce the antigen-specific antibodies in mucosal site, ovalbumin (OVA)-entrapped biodegradable microparticles (OVA-microparticles) were used as an antigen. Mice were orally immunized with OVA-microparticles for 3 successive days with intragastric gavage. From 7 days after the onset of immunization, the mice were boosted twice a week with the same antigen for 2 weeks. HET or water alone was orally administered to the mice via the intragastric route from 7 days before to 27 days after the onset of immunization. Although no significant change in total secretory IgA antibody level was observed in intestinal and nasal washes, OVA-specific IgA titers in intestinal washes were significantly enhanced by oral administration of HET. When lymphocytes from spleen, peripheral blood and Payer's patches were investigated for cytokines production, it was found that the IFN- secretion from the lymphocytes was increased by the administration of HET. Microarray analysis of Peyer's patch cells revealed enhanced expression of L-selectin gene. The increase of L-selectin positive cells in B lymphocytes fraction was observed in Peyer's patch cells and peripheral blood mononuclear cells by flow cytometry. These results suggest that the enhanced IFN- secretion and increased population of L-selectin positive B lymphocytes by orally administered HET may partly contribute to enhancement of IgA immune response against intestinal antigens, and orally administered HET may strengthen defensive systems against various pathogens and food antigens in intestine.</p>
]]></description>
<dc:creator><![CDATA[Matsumoto, T., Noguchi, M., Hayashi, O., Makino, K., Yamada, H.]]></dc:creator>
<dc:date>2007-10-29</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem166</dc:identifier>
<dc:title><![CDATA[Hochuekkito, a Kampo (traditional Japanese herbal) Medicine, Enhances Mucosal IgA Antibody Response in Mice Immunized with Antigen-entrapped Biodegradable Microparticles]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem161v1?rss=1">
<title><![CDATA[Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy? Encouraging Results of a Preliminary Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem161v1?rss=1</link>
<description><![CDATA[
<p>Several homeopathic remedies, namely, Pulsatilla Nigricans (30th potency), Ceanothus Americanus (both mother tincture and 6th potency) and Ferrum Metallicum (30th potency<b>)</b> selected as per similia principles were administered to 38 thalassemic patients receiving Hydroxyurea (HU) therapy for a varying period of time. Levels of serum ferritin (SF), fetal hemoglobin (HbF), hemoglobin (Hb), platelet count (PC), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), white blood cell (WBC) count, bilirubin content, alanine amino transferase (ALT), aspartate amino transferase (AST) and serum total protein content of patients were determined before and 3 months after administration of the homeopathic remedies in combination with HU to evaluate additional benefits, if any, derived by the homeopathic remedies, by comparing the data with those of 38 subjects receiving only HU therapy. Preliminary results indicated that there was a significant decrease in the SF and increase in HbF levels in the combined, treated subjects. Although the changes in other parameters were not so significant, there was a significant decrease in size of spleen in most patients with spleenomegaly and improvement in general health conditions along with an increased gap between transfusions in most patients receiving the combined homeopathic treatment. The homeopathic remedies being inexpensive and without any known side-effects seem to have great potentials in bringing additional benefits to thalassemic patients; particularly in the developing world where blood transfusions suffer from inadequate screening and fall short of the stringent safety standards followed in the developed countries. Further independent studies are encouraged.</p>
]]></description>
<dc:creator><![CDATA[Banerjee, A., Chakrabarty, S. B., Karmakar, S. R., Chakrabarty, A., Biswas, S. J., Haque, S., Das, D., Paul, S., Mandal, B., Naoual, B., Belon, P., Khuda-Bukhsh, A. R.]]></dc:creator>
<dc:date>2007-10-29</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem161</dc:identifier>
<dc:title><![CDATA[Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy? Encouraging Results of a Preliminary Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem146v1?rss=1">
<title><![CDATA[AMP N1-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem146v1?rss=1</link>
<description><![CDATA[
<p>Earlier we identified adenosine monophosphate (AMP) <I>N</I><SUB>1</SUB>-oxide as a unique compound of royal jelly (RJ) that induces neurite outgrowth (neuritegenesis) from cultured rat pheochromocytoma PC12 cells via the adenosine A<SUB>2A</SUB> receptor. Now, we found that AMP <I>N</I><SUB>1</SUB>-oxide stimulated the phosphorylation of not only mitogen-activated protein kinase (MAPK) but also that of cAMP/calcium-response element-binding protein (CREB) in a dose-dependent manner. Inhibition of MAPK activation by a MEK inhibitor, PD98059, did not influence the AMP <I>N</I><SUB>1</SUB>-oxide-induced neuritegenesis, whereas that of protein kinase A (PKA) by a selective inhibitor, KT5720, significantly reduced neurite outgrowth. AMP <I>N</I><SUB>1</SUB>-oxide also had the activity of suppressing the growth of PC12 cells, which correlated well with the neurite outgrowth-promoting activity. KT5720 restored the growth of AMP <I>N</I><SUB>1</SUB>-oxide-treated PC12 cells. It is well known that nerve growth factor suppresses proliferation of PC12 cells before causing stimulation of neuronal differentiation. Thus, AMP <I>N</I><SUB>1</SUB>-oxide elicited neuronal differentiation of PC12 cells, as evidenced by generation of neurites, and inhibited cell growth through adenosine A<SUB>2A</SUB> receptor-mediated PKA signaling, which may be responsible for characteristic actions of RJ.</p>
]]></description>
<dc:creator><![CDATA[Hattori, N., Nomoto, H., Fukumitsu, H., Mishima, S., Furukawa, S.]]></dc:creator>
<dc:date>2007-10-29</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem146</dc:identifier>
<dc:title><![CDATA[AMP N1-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem143v2?rss=1">
<title><![CDATA[Evaluating Complementary Therapies for Canine Osteoarthritis Part II: A Homeopathic Combination Preparation (Zeel(R))]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem143v2?rss=1</link>
<description><![CDATA[
<p>A homeopathic combination preparation (HCP) for canine osteoarthritic pain was evaluated in a randomized, double-controlled and double-blinded clinical trial. Forty-four dogs with osteoarthritis (OA) that were randomly allocated into one of three groups completed the study. All dogs were fed test products or placebo for 8 weeks. The dogs were evaluated at the clinic four times, with 4-week intervals. Six different variables were assessed: veterinary-assessed mobility, two force plate variables, an owner-evaluated chronic pain index and pain and locomotion visual analogue scales (VASs). Intake of extra non-steroidal anti-inflammatory drugs was also evaluated. A Chi-squared test and a Mann&ndash;Whitney test were used to determine significant improvement between groups. When changed into dichotomous responses of &lsquo;improved&rsquo; or &lsquo;not improved&rsquo; three out of the six variables showed a significant difference (<I>P</I> = 0.016, <I>P</I> = 0.008, <I>P</I> = 0.039) in improved dogs per group, between the HCP group and the placebo group. The odds ratios were over one for the same variables. As extent of improvement in the variables from start to end of treatment, the HCP product was significantly more improved in four (<I>P</I> = 0.015, <I>P</I> = 0.028, <I>P</I> = 0.049, <I>P</I> = 0.020) of the six variables, compared with the placebo. Our results indicated that the HCP Zeel&reg; was beneficial in alleviating chronic orthopedic pain in dogs although it was not as effective as carprofen.</p>
]]></description>
<dc:creator><![CDATA[Hielm-Bjorkman, A., Tulamo, R.-M., Salonen, H., Raekallio, M.]]></dc:creator>
<dc:date>2007-10-29</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem143</dc:identifier>
<dc:title><![CDATA[Evaluating Complementary Therapies for Canine Osteoarthritis Part II: A Homeopathic Combination Preparation (Zeel(R))]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem136v1?rss=1">
<title><![CDATA[Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem136v1?rss=1</link>
<description><![CDATA[
<p>A green-lipped mussel (GLM) preparation was evaluated in a randomized, double-controlled and double-blinded clinical trial. It was hypothesized that the treatment effect would be less than that of the positive control (carprofen) but more than that of the negative control (placebo). Forty-five dogs with chronic pain and a radiographic diagnosis of osteoarthritis that were randomly allocated into one of three groups completed the study. All dogs were fed the test products or placebo for 8 weeks. The dogs were evaluated four times, at 4-week intervals. Six different variables were assessed: veterinary-assessed mobility index, two force plate variables, owner-evaluated chronic pain index and pain as well as locomotion visual analogue scales (VASs). Intake of extra carprofen was also evaluated. A chi-squared and a Mann&ndash;Whitney test were used to determine significance between groups. When changed to dichotomous variables, there were more dogs in the GLM than in the placebo group that improved, according to veterinary-assessed mobility, owner-evaluated chronic pain index and pain VAS (<I>P</I> = 0.031, <I>P</I> = 0.025, <I>P</I> = 0.011, respectively). For the same three, the odds ratio and their confidence interval were over one. The extent of improvement was significantly different between the GLM and the control in veterinary-assessed mobility (<I>P</I> = 0.012) and pain VAS (<I>P</I> = 0.004). In conclusion, GLM alleviated chronic orthopedic pain in dogs although it was not as effective as carprofen. As no side-effects were detected, GLM may be beneficial in dogs e.g. when non-steroidal anti-inflammatory drugs cannot be used.</p>
]]></description>
<dc:creator><![CDATA[Hielm-Bjorkman, A., Tulamo, R.-M., Salonen, H., Raekallio, M.]]></dc:creator>
<dc:date>2007-10-29</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem136</dc:identifier>
<dc:title><![CDATA[Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem163v1?rss=1">
<title><![CDATA[Regional Brain Activation During Meditation Shows Time and Practice Effects: An Exploratory FMRI Study{dagger}]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem163v1?rss=1</link>
<description><![CDATA[
<p>Meditation involves attentional regulation and may lead to increased activity in brain regions associated with attention such as dorsal lateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC). Using functional magnetic resonance imaging, we examined whether DLPFC and ACC were activated during meditation. Subjects who meditate were recruited and scanned on a 3.0 Tesla scanner. Subjects meditated for four sessions of 12 min and performed four sessions of a 6 min control task. Individual and group t-maps were generated of overall meditation response versus control response and late meditation response versus early meditation response for each subject and time courses were plotted. For the overall group (<I>n</I> = 13), and using an overall brain analysis, there were no statistically significant regional activations of interest using conservative thresholds. A region of interest analysis of the entire group time courses of DLPFC and ACC were statistically more active throughout meditation in comparison to the control task. Moreover, dividing the cohort into short (<I>n</I> = 8) and long-term (<I>n</I> = 5) practitioners (&gt;10 years) revealed that the time courses of long-term practitioners had significantly more consistent and sustained activation in the DLPFC and the ACC during meditation versus control in comparison to short-term practitioners. The regional brain activations in the more practised subjects may correlate with better sustained attention and attentional error monitoring. In summary, brain regions associated with attention vary over the time of a meditation session and may differ between long- and short-term meditation practitioners.</p>
]]></description>
<dc:creator><![CDATA[Baron Short, E., Kose, S., Mu, Q., Borckardt, J., Newberg, A., George, M. S., Kozel, F. A.]]></dc:creator>
<dc:date>2007-10-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem163</dc:identifier>
<dc:title><![CDATA[Regional Brain Activation During Meditation Shows Time and Practice Effects: An Exploratory FMRI Study{dagger}]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem160v1?rss=1">
<title><![CDATA[In vitro Evaluation of the Antiviral Activity of an Extract of Date Palm (Phoenix dactylifera L.) Pits on a Pseudomonas Phage]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem160v1?rss=1</link>
<description><![CDATA[
<p>A crude acetone extract of the pit of date palm (<I>Phoenix dactylifera</I> L.) was prepared and its antiviral activity evaluated against lytic <I>Pseudomonas</I> phage ATCC 14209-B1, using <I>Pseudomonas aeruginosa</I> ATCC 25668 as the host cell. The antiviral activity of date pits was found to be mediated by binding to the phage, with minimum inhibitory concentration (MIC) of &lt;10 &micro;g ml<sup>&ndash;1</sup>. The decimal reduction time (<I>D</I>-values), the concentration exponent () and the phage inactivation kinetics were determined. The date pit extracts show a strong ability to inhibit the infectivity of <I>Pseudomonas</I> phage ATCC 14209-B1 and completely prevented bacterial lysis, which it is hoped will promote research into its potential as a novel antiviral agent against pathogenic human viruses.</p>
]]></description>
<dc:creator><![CDATA[Jassim, S. A. A., Naji, M. A.]]></dc:creator>
<dc:date>2007-10-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem160</dc:identifier>
<dc:title><![CDATA[In vitro Evaluation of the Antiviral Activity of an Extract of Date Palm (Phoenix dactylifera L.) Pits on a Pseudomonas Phage]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem151v1?rss=1">
<title><![CDATA[Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem151v1?rss=1</link>
<description><![CDATA[
<p><I>Vaccinium myrtillus</I> (Bilberry) extracts (VME) were tested for effects on angiogenesis <I>in vitro</I> and <I>in vivo</I>. VME (0.3&ndash;30 &micro;g ml<sup>&ndash;1</sup>) and GM6001 (0.1&ndash;100 &micro;M; a matrix metalloproteinase inhibitor) concentration-dependently inhibited both tube formation and migration of human umbilical vein endothelial cells (HUVECs) induced by vascular endothelial growth factor-A (VEGF-A). In addition, VME inhibited VEGF-A-induced proliferation of HUVECs. VME inhibited VEGF-A-induced phosphorylations of extracellular signal-regulated kinase 1/2 (ERK 1/2) and serine/threonine protein kinase family protein kinase B (Akt), but not that of phospholipase C (PLC). In an <I>in vivo</I> assay, intravitreal administration of VME inhibited the formation of neovascular tufts during oxygen-induced retinopathy in mice. Thus, VME inhibited angiogenesis both <I>in vitro</I> and <I>in vivo</I>, presumably by inhibiting the phosphorylations of ERK 1/2 and Akt. These findings indicate that VME may be effective against retinal diseases involving angiogenesis, providing it can reach the retina after its administration. Further investigations will be needed to clarify the major angiogenesis-modulating constituent(s) of VME.</p>
]]></description>
<dc:creator><![CDATA[Matsunaga, N., Chikaraishi, Y., Shimazawa, M., Yokota, S., Hara, H.]]></dc:creator>
<dc:date>2007-10-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem151</dc:identifier>
<dc:title><![CDATA[Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem126v1?rss=1">
<title><![CDATA[Improvement of Experimentally Induced Hepatic and Renal Disorders in Rats using Lactic Acid Bacteria-fermented Soybean Extract (BiofermenticsTM)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem126v1?rss=1</link>
<description><![CDATA[
<p>The effects of lactic acid bacteria-fermented soybean extract (Biofermentics<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP>; BF) on experimental models of hepatic and renal disorders were investigated <I>in vivo</I> and <I>in vitro</I>. In rat, hepatitis induced by feeding of deoxycholic acid (DCA, 0.5 wt/wt, <I>n</I> = 6) or intraperitoneal injection of <scp>d</scp>-galactosamine (GMN, 500 mg/body wt, <I>n</I> = 6), the increase in serum AST (aspartate aminotransferase) and ALT (alanine aminotransferase) levels were inhibited significantly (<I>P</I> &lt; 0.05) by feeding a diet containing 5% dried BF. Moreover, the BF-administered rat group showed lower concentrations of blood urea nitrogen and a larger amount of urine as compared with values in the control group. Pretreatment of primary cell cultures of rat hepatic and renal cells with BF prior to exposure to dichromate (K<SUB>2</SUB>Cr<SUB>2</SUB>O<SUB>7</SUB>) resulted in a marked decrease of dichromate-induced cytotoxicity as evaluated by the leakage of lactate dehydrogenase The levels of dichromate-induced lipid peroxidation, as monitored by malondialdehyde formation, were also reduced by pretreatment of hepatocytes with BF. These results suggest that BF may play a role in hepatic and renal disorders, and may be useful for maintaining health in humans as well.</p>
]]></description>
<dc:creator><![CDATA[Shin, R., Suzuki, M., Mizutani, T., Susa, N.]]></dc:creator>
<dc:date>2007-10-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem126</dc:identifier>
<dc:title><![CDATA[Improvement of Experimentally Induced Hepatic and Renal Disorders in Rats using Lactic Acid Bacteria-fermented Soybean Extract (BiofermenticsTM)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem156v1?rss=1">
<title><![CDATA[Antiviral Activity of Some Plants Used in Nepalese Traditional Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem156v1?rss=1</link>
<description><![CDATA[
<p>Methanolic extracts of 41 plant species belonging to 27 families used in the traditional medicine in Nepal have been investigated for <I>in vitro</I> antiviral activity against Herpes simplex virus type 1 (HSV-1) and influenza virus A by dye uptake assay in the systems HSV-1/Vero cells and influenza virus A/MDCK cells. The extracts of <I>Astilbe rivularis, Bergenia ciliata, Cassiope fastigiata</I> and <I>Thymus linearis</I> showed potent anti-herpes viral activity. The extracts of <I>Allium oreoprasum, Androsace strigilosa, Asparagus filicinus, Astilbe rivularis, Bergenia ciliata</I> and <I>Verbascum thapsus</I> exhibited strong anti-influenza viral activity. Only the extracts of <I>A. rivularis</I> and <I>B. ciliata</I> demonstrated remarkable activity against both viruses.</p>
]]></description>
<dc:creator><![CDATA[Rajbhandari, M., Mentel, R., Jha, P. K., Chaudhary, R. P., Bhattarai, S., Gewali, M. B., Karmacharya, N., Hipper, M., Lindequist, U.]]></dc:creator>
<dc:date>2007-10-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem156</dc:identifier>
<dc:title><![CDATA[Antiviral Activity of Some Plants Used in Nepalese Traditional Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem144v1?rss=1">
<title><![CDATA[The Homeopathic Preparation Nervoheel N can Offer an Alternative to Lorazepam Therapy for Mild Nervous Disorders]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem144v1?rss=1</link>
<description><![CDATA[
<p>In an open-label, prospective non-randomized cohort study, we compared the effectiveness and tolerability profiles of the homeopathic remedy Nervoheel N with those of the benzodiazepine, lorazepam, in 248 patients with insomnia, distress, anxieties, restlessness or burnout and similar nervous conditions (&lsquo;mild nervous disorders&rsquo;). Patients were treated with Nervoheel N or lorazepam at the recommended doses for a maximum of 4 weeks. Dose variations were allowed if in the patient's best interest. Treatment effects were evaluated by the practitioner in a dialogue with the patient at the start of treatment, after 2 weeks and after maximally 4 weeks of treatment. Tolerability data were recorded as adverse events. At baseline, lorazepam patients were on average slightly older and there was a somewhat greater percentage of men in this group than in the Nervoheel group. Both treatment groups reported significant symptomatic improvements of similar magnitude during the course of the study. The sum of symptom scores improved by 4.4 points with Nervoheel N and by 4.2 points with lorazepam. The differences between the treatment groups were not significant. All differences between treatments were within 10% of the maximum score ranges, demonstrating non-inferiority of Nervoheel N. Both treatments were well tolerated, with few adverse events and very good self-assessed tolerability ratings by the patients. Thus, in patients who opt for a homeopathic treatment regimen for the short-term relief of mild nervous disorders, the effects of Nervoheel N are non-inferior to those of lorazepam.</p>
]]></description>
<dc:creator><![CDATA[van den Meerschaut, L., Sunder, A.]]></dc:creator>
<dc:date>2007-10-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem144</dc:identifier>
<dc:title><![CDATA[The Homeopathic Preparation Nervoheel N can Offer an Alternative to Lorazepam Therapy for Mild Nervous Disorders]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem142v1?rss=1">
<title><![CDATA[Scleroderma, Stress and CAM Utilization]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem142v1?rss=1</link>
<description><![CDATA[
<p>Scleroderma is an autoimmune disease influenced by interplay among genetic and environmental factors, of which one is stress. Complementary and alternative medicine (CAM) is frequently used to treat stress and those diseases in which stress has been implicated. Results are presented from a survey of patients with scleroderma. Respondents were a convenient sample of those attending a national conference in Las Vegas in 2002. Findings implicate stress in the onset, continuation and exacerbation of scleroderma. The implication is that CAM providers may be filling an important patient need in their provision of services that identify and treat stress and its related disorders.</p>
]]></description>
<dc:creator><![CDATA[Hui, K.-K., Johnston, M. F., Brodsky, M., Tafur, J., Ho, M. K.]]></dc:creator>
<dc:date>2007-10-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem142</dc:identifier>
<dc:title><![CDATA[Scleroderma, Stress and CAM Utilization]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem141v1?rss=1">
<title><![CDATA[Orthosiphon Versus Placebo in Nephrolithiasis with Multiple Chronic Complaints: A Randomized Control Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem141v1?rss=1</link>
<description><![CDATA[
<p>Nephrolithiasis in the communities of Northeast Thailand frequently presents with multiple chronic health complaints, i.e. myofascial pain, back pain, dyspepsia, arthralgia, headache, fatigue, frank paresthesia, dysuria and any of these aggravated by purine-rich food (PRF). We assessed the efficacy of Orthosiphon in treating subjects with at least two active symptoms and negative for urine white blood cells. Subjects were randomly allocated to two groups. Crude extract of Orthosiphon given in a capsule (equivalent to 1.6&ndash;1.8 g of dried leaves of Orthosiphon) two times a day to Group 1 (<I>n</I> = 36) and a placebo to Group 2 (<I>n</I> = 40) for 14 days. The medication for each subject was packed and its code kept secret until the data analysis. Both groups were asked not to consume any of 25 purine-rich foods (PRFs) during treatment. The primary measure was the reduced sum of active severity symptoms as recorded using the visual analog scale before and after therapy (i.e. on day 7 and 14). The data on 76 subjects were processed. The mean of the total scores (95% CI) of the symptoms in each group were decreased significantly (<I>P</I> &lt; 0.001); 185.6 (153.3, 218.0) to 94.7 (58.2, 131.2) in the Orthosiphon group and 196.1 (164.4, 227.8) to 89.6 (62.8, 116.5) in the placebo group. When comparing between groups, no statistically significant difference was found. The mean consumption in PRFs was significantly decreased (<I>P</I> &lt; 0.001) in both groups; however, Orthosiphon did not have additional benefit over placebo at 7 and 14 days of treatment during which they reduced these foods.</p>
]]></description>
<dc:creator><![CDATA[Premgamone, A., Sriboonlue, P., Maskasem, S., Ditsataporncharoen, W., Jindawong, B.]]></dc:creator>
<dc:date>2007-10-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem141</dc:identifier>
<dc:title><![CDATA[Orthosiphon Versus Placebo in Nephrolithiasis with Multiple Chronic Complaints: A Randomized Control Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem127v1?rss=1">
<title><![CDATA[Evaluation of the Wound-healing Activity of Ethanolic Extract of Morinda citrifolia L. Leaf]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem127v1?rss=1</link>
<description><![CDATA[
<p><I>Morinda citrifolia</I> L. (noni) is one of the most important traditional Polynesian medicinal plants. The primary indigenous use of this plant appears to be of the leaves, as a topical treatment for wound healing. The ethanol extract of noni leaves (150 mg kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup>) was used to evaluate the wound-healing activity on rats, using excision and dead space wound models. Animals were randomly divided into two groups of six for each model. Test group animals in each model were treated with the ethanol extract of noni orally by mixing in drinking water and the control group animals were maintained with plain drinking water. Healing was assessed by the rate of wound contraction, time until complete epithelialization, granulation tissue weight and hydoxyproline content. On day 11, the extract-treated animals exhibited 71% reduction in the wound area when compared with controls which exhibited 57%. The granulation tissue weight and hydroxyproline content in the dead space wounds were also increased significantly in noni-treated animals compared with controls (<I>P</I> &lt; 0.002). Enhanced wound contraction, decreased epithelialization time, increased hydroxyproline content and histological characteristics suggest that noni leaf extract may have therapeutic benefits in wound healing.</p>
]]></description>
<dc:creator><![CDATA[Nayak, B. S., Sandiford, S., Maxwell, A.]]></dc:creator>
<dc:date>2007-10-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem127</dc:identifier>
<dc:title><![CDATA[Evaluation of the Wound-healing Activity of Ethanolic Extract of Morinda citrifolia L. Leaf]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem125v1?rss=1">
<title><![CDATA[Crocus Sativus L. (Saffron) Extract and its Active Constituents (Crocin and Safranal) on Ischemia-Reperfusion in Rat Skeletal Muscle]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem125v1?rss=1</link>
<description><![CDATA[
<p>Saffron and its constituents have been shown to decrease ischemia-reperfusion (I/R) injury in kidney or brain tissues. In this study, the effects of saffron ethanolic extract and its constituents, crocin and safranal, were evaluated in skeletal muscle during I/R injury. Hind limb ischemia was induced using clamping the common femoral artery and vein. After 2 h ischemia, the clamp of the femoral vessels of animals was taken off and the animal underwent 1h reperfusion. Muscle injuries were evaluated by recording of the electromyographic (EMG) potentials and performing some biochemical analysis including thiobarbituric acid reactive substances (TBARS), total sulfhydryl (SH) groups and antioxidant capacity of muscle (using FRAP assay). The ethanolic extract of saffron (5, 20 and 80 mg kg<sup>&ndash;1</sup>), crocin (50, 200 and 400 mg kg<sup>&ndash;1</sup>), safranal (0.1, 0.25 and 0.5 ml kg<sup>&ndash;1</sup>) and normal saline (10 ml kg<sup>&ndash;1</sup>) were administered intraperitoneally 1 h prior reperfusion. The average peak-to-peak amplitude during I/R was significantly increased in extract, crocin and safranal groups in comparison with control-ischemic group. Following saffron, crocin and safranal administration, the total SH contents and antioxidant capacity were elevated in muscle flap. The MDA level was declined significantly in test groups. It is concluded that saffron extract and its constituents show a protective effect against lower limb I/R in rat.</p>
]]></description>
<dc:creator><![CDATA[Hosseinzadeh, H., Modaghegh, M. H., Saffari, Z.]]></dc:creator>
<dc:date>2007-10-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem125</dc:identifier>
<dc:title><![CDATA[Crocus Sativus L. (Saffron) Extract and its Active Constituents (Crocin and Safranal) on Ischemia-Reperfusion in Rat Skeletal Muscle]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem102v1?rss=1">
<title><![CDATA[How Far Can Ki-energy Reach? A Hypothetical Mechanism for the Generation and Transmission of Ki-energy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem102v1?rss=1</link>
<description><![CDATA[
<p>&lsquo;Ki-energy&rsquo;, which can be enhanced through the practice of Nishino Breathing Method, was reported to have beneficial health effects. Although Ki-energy can play an important role in complementary and alternative medicine (CAM), as yet it is unknown how Ki-energy is generated, transmitted through air and received by another individual. We previously proposed that Ki-energy may include near-infrared radiation, and that the wavelength was between 800 and 2700 nm. Since Ki-energy is reflected by a mirror, we believe that the &lsquo;Ki-beam&rsquo; has a small divergence angle. It can also be guided in a desired direction. The acrylic mirror reflection experiment suggests that the wavelength may be between 800 and 1600 nm. Using a linear variable interference filter, we found that Ki-energy may have a peak around 1000 nm. We have also observed that &lsquo;sensitive&rsquo; practitioners responded to Ki sent from a distance of 100 m. All of these results suggest that (i) Ki-energy can be guided as a directional &lsquo;beam&rsquo; with a small divergence angle; (ii) the beam can be reflected by a mirror and (iii) Ki-energy may have a specific wavelength. Since these properties are characteristics of the laser radiation, we propose a quantum physics-based mechanism of &lsquo;Light Amplification by the Stimulated Emission of Radiation&rsquo; (i.e. LASER) for the generation of Ki-energy. Volunteers responded to Ki even with a blindfold. This suggests that the skin must be detecting Ki-energy. We propose that the detector at the skin level may also have the stimulated emission mechanism, which amplifies the weak incident infrared radiation.</p>
]]></description>
<dc:creator><![CDATA[Ohnishi, S. T., Ohnishi, T.]]></dc:creator>
<dc:date>2007-10-25</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem102</dc:identifier>
<dc:title><![CDATA[How Far Can Ki-energy Reach? A Hypothetical Mechanism for the Generation and Transmission of Ki-energy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-25</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem158v1?rss=1">
<title><![CDATA[Acori graminei rhizoma Ameliorated Ibotenic Acid-Induced Amnesia in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem158v1?rss=1</link>
<description><![CDATA[
<p>In the present study, we investigated the effects of <I>Acori graminei rhizoma</I> (AGR) on learning and memory for the Morris water maze task and on the central cholinergic system of the rats with excitotoxic medial septum (MS) lesion. On the water maze test, the rats were trained to find a platform that was in a fixed position during 6 days and then they received a 60 s probe trial in which the platform was removed from the pool on the 7th day. Ibotenic lesioning of the MS impaired the performance on the maze test and it caused degeneration of choline acetyltransferase and acetylcholine esterase in the hippocampus, which are markers of the central cholinergic system. Daily administrations of AGR (100 mg kg<sup>&ndash;1</sup>, i.p.) for 21 consecutive days produced reversals of the ibotenic acid-induced deficit in learning and memory. These treatments also reduced the loss of cholinergic immunoreactivity in the hippocampus that was induced by ibotenic acid. These results demonstrated that AGR ameliorated learning and memory deficits through their effects on the central nervous system, and neuroprotection was partly evaluated through the effect of AGR on the cholinergic system. Our studies suggest that AGR can possibly be used as treatment for Alzheimer's disease.</p>
]]></description>
<dc:creator><![CDATA[Kim, J. H., Hahm, D.-H., Lee, H.-J., Pyun, K. H., Shim, I.]]></dc:creator>
<dc:date>2007-10-22</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem158</dc:identifier>
<dc:title><![CDATA[Acori graminei rhizoma Ameliorated Ibotenic Acid-Induced Amnesia in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem152v1?rss=1">
<title><![CDATA[10-Hydroxy-2-decenoic Acid, a Major Fatty Acid from Royal Jelly, Inhibits VEGF-induced Angiogenesis in Human Umbilical Vein Endothelial Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem152v1?rss=1</link>
<description><![CDATA[
<p>Vascular endothelial growth factor (VEGF) is reported to be a potent pro-angiogenic factor that plays a pivotal role in both physiological and pathological angiogenesis. Royal jelly (RJ) is a honeybee product containing various proteins, sugars, lipids, vitamins and free amino acids. 10-Hydroxy-2-decenoic acid (10HDA), a major fatty acid component of RJ, is known to have various pharmacological effects; its antitumor activity being especially noteworthy. However, the mechanism underlying this effect is unclear. We examined the effect of 10HDA on VEGF-induced proliferation, migration and tube formation in human umbilical vein endothelial cells (HUVECs). Our findings showed that, 10HDA at 20 &micro;M or more significantly inhibited such proliferation, migration and tube formation. Similarly, 10 &micro;M GM6001, a matrix metalloprotease inhibitor, prevented VEGF-induced migration and tube formation. These findings indicate that 10HDA exerts an inhibitory effect on VEGF-induced angiogenesis, partly by inhibiting both cell proliferation and migration. Further experiments will be needed to clarify the detailed mechanism.</p>
]]></description>
<dc:creator><![CDATA[Izuta, H., Chikaraishi, Y., Shimazawa, M., Mishima, S., Hara, H.]]></dc:creator>
<dc:date>2007-10-22</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem152</dc:identifier>
<dc:title><![CDATA[10-Hydroxy-2-decenoic Acid, a Major Fatty Acid from Royal Jelly, Inhibits VEGF-induced Angiogenesis in Human Umbilical Vein Endothelial Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem148v1?rss=1">
<title><![CDATA[Assessment of antimalarial activity against Plasmodium falciparum and phytochemical screening of some Yemeni medicinal plants]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem148v1?rss=1</link>
<description><![CDATA[
<p>Developing countries, where malaria is one of the most prevalent diseases, still rely on traditional medicine as a source for the treatment of this disease. In the present study, six selected plants (<I>Acalypha fruticosa</I>, <I>Azadirachta indica</I>, <I>Cissus rotundifolia</I>, <I>Echium rauwalfii</I>, <I>Dendrosicyos socotrana</I> and <I>Boswellia elongata</I>) commonly used in Yemen by traditional healers for the treatment of malaria as well as other diseases, were collected from different localities of Yemen, dried and extracted with methanol and water successfully. The antiplasmodial activity of the extracts was evaluated against fresh clinical isolates of <I>Plasmodium falciparum</I>. The selectivity parameters to evaluate the efficacy of these medicinal plants were measured by <I>in vitro</I> micro test (Mark III) according to World Health Organization (WHO) 1996 &amp; WHO 2001 protocols of antimalarial drug tests. Among the investigated 12 extracts, three were found to have significant antiplasmodial activity with IC<SUB>50</SUB> values less than 4 &micro;g/ml, namely the water extracts of <I>A. fruticosa</I>, <I>A. indica</I> and <I>D. socotrana</I>. Six extracts showed moderate activity with IC<SUB>50</SUB> values ranging from 10 to 30 &micro;g/ml and three appeared to be inactive with IC<SUB>50</SUB> values more than 30 &micro;g/ml. In addition, preliminary phytochemical screening of the methanolic and aqueous extracts indicated the presence of saponins, tannins, flavonoids, terpenoids, polysaccharides and peptides.</p>
]]></description>
<dc:creator><![CDATA[Alshawsh, M. A., Mothana, R. A., Al-shamahy, H. A., Alsllami, S. F., Lindequist, U.]]></dc:creator>
<dc:date>2007-10-22</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem148</dc:identifier>
<dc:title><![CDATA[Assessment of antimalarial activity against Plasmodium falciparum and phytochemical screening of some Yemeni medicinal plants]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem147v1?rss=1">
<title><![CDATA[In vitro Cytotoxic Effect of Brazilian Green Propolis on Human Laryngeal Epidermoid Carcinoma (HEp-2) Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem147v1?rss=1</link>
<description><![CDATA[
<p>Propolis is a sticky dark-colored material showing a very complex chemical composition that honeybees collect from plants. It has been used in folk medicine since ancient times, due to several biological properties, such as antimicrobial, anti-inflammatory, antioxidant and immunomodulatory activities, among others. Its antitumor action <I>in vivo</I> and <I>in vitro</I> has also been reported, using propolis extracts or its isolated compounds. The goal of this work was to evaluate propolis's cytotoxic action <I>in vitro</I> on human laryngeal epidermoid carcinoma (Hep-2) cells. These cells were incubated with different concentrations of this bee product for different time periods, and morphology and the number of viable HEp-2 cells analyzed. Data showed that propolis exhibited a cytotoxic effect <I>in vitro</I> against HEp-2 cells, in a dose- and time-dependent way. Propolis solvent had no effects on morphology and number of viable cells, proving that the cytotoxic effects were exclusively due to propolis components. Since humans have been using propolis for a long time, further assays will provide a better comprehension of propolis's antitumor action.</p>
]]></description>
<dc:creator><![CDATA[Bufalo, M. C., Candeias, J. M. G., Sforcin, J. M.]]></dc:creator>
<dc:date>2007-10-22</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem147</dc:identifier>
<dc:title><![CDATA[In vitro Cytotoxic Effect of Brazilian Green Propolis on Human Laryngeal Epidermoid Carcinoma (HEp-2) Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-22</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem137v1?rss=1">
<title><![CDATA[Phytic Acid Exposure Alters AflatoxinB1-induced Reproductive and Oxidative Toxicity in Albino Rats (Rattus norvegicus)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem137v1?rss=1</link>
<description><![CDATA[
<p>The increased use of feed in Egypt's aquaculture and animal industries raises concerns about the possible presence of mycotoxins in feedstuffs. The use of alternative medicine, such as botanicals and nutritional supplements, has become popular with inflammatory cases. The present study aimed to testify the role played by phytic acid (IP6) in enhancing the reproductive and oxidative toxicity induced in aflatoxinB1 (AFB1) treated white male albino rats (<I>Rattus norvegicus</I>) throughout treatment and withdrawal periods. One hundred and twenty white male albino rats were grouped into four groups. Group 1, was injected with 300 &micro;g kg<sup>&ndash;1</sup> body wt of AFB1 once every 3 days for 15 days and left uninjected for another 15 days to study the withdrawal effect. Group 2, was injected with 300 &micro;g kg<sup>&ndash;1</sup> body wt of AFB1 once every 3 days for 15 days and treated simultaneously with IP6 daily for another 15 days. Group 3, was treated daily with IP6 (40 mg kg<sup>&ndash;1</sup> body wt) for 15 days and with no treatment for other 15 days. Group 4, injected with equivalent volume of sterile phosphate buffer saline solution as a control group. Sera were taken at the experimental intervals and assayed for testosterone hormone, follicular-stimulating hormone (FSH) and luteinizing hormone (LH) to determine the toxicological impact of AFB1 and the possibility of amelioration by phytic acid on the reproductive performance of the studied animal. The effects of AFB1 treatment on the absolute and relative weight of testis as well as its histopathologic effect on the testis and the possibility of amelioration by IP6 treatment were evaluated. The activities of enzymatic and non-enzymatic anti-oxidants, in addition to lipid peroxidation were measured in the testis&rsquo; homogenate of AFB1-treated rats. A decrease in sex hormone levels, an increase in testicular lipid peroxidation product levels and a significant decrease in testicular glutathione content, catalase and total peroxidase and superoxide dismutase activities were recorded. The histopathologic alterations revealed a degeneration and highly mitotic division within the spermatogenic nuclei, in addition to some karyomegaly and nuclear pyknosis. It is concluded that the reduction in the toxicity of free radicals by phytic acid might be responsible for the protective influence observed.</p>
]]></description>
<dc:creator><![CDATA[Abu El-Saad, A. S., Mahmoud, H. M.]]></dc:creator>
<dc:date>2007-10-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem137</dc:identifier>
<dc:title><![CDATA[Phytic Acid Exposure Alters AflatoxinB1-induced Reproductive and Oxidative Toxicity in Albino Rats (Rattus norvegicus)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-17</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem138v1?rss=1">
<title><![CDATA[Novel Diagnosis of Lyme Disease: Potential for CAM Intervention]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem138v1?rss=1</link>
<description><![CDATA[
<p>Lyme disease (LD) is the most common tick-borne disease in the northern hemisphere, producing a wide range of disabling effects on multiple human targets, including the skin, the nervous system, the joints and the heart. Insufficient clinical diagnostic methods, the necessity for prompt antibiotic treatment along with the pervasive nature of infection impel the development and establishment of new clinical diagnostic tools with increased accuracy, sensitivity and specificity. The goal of this article is 4-fold: (i) to detail LD infection and pathology, (ii) to review prevalent diagnostic methods, emphasizing inherent problems, (iii) to introduce the usage of <I>in vivo</I> induced antigen technology (IVIAT) in clinical diagnostics and (iv) to underscore the relevance of a novel comprehensive LD diagnostic approach to practitioners of Complementary and Alternative Medicine (CAM). Utilization of this analytical method will increase the accuracy of the diagnostic process and abridge the time to treatment, with antibiotics, herbal medicines and nutritional supplements, resulting in improved quality of care and disease prognosis.</p>
]]></description>
<dc:creator><![CDATA[Vojdani, A., Hebroni, F., Raphael, Y., Erde, J., Raxlen, B.]]></dc:creator>
<dc:date>2007-10-15</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem138</dc:identifier>
<dc:title><![CDATA[Novel Diagnosis of Lyme Disease: Potential for CAM Intervention]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-15</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem103v1?rss=1">
<title><![CDATA[Modified Wendan Decoction can Attenuate Neurotoxic Action Associated with Alzheimer's Disease]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem103v1?rss=1</link>
<description><![CDATA[
<p>We observed the effect of modified Wendan decoction (modified Wen-Dan-Tang) on a cellular model of Alzheimer's disease. Amyloid beta (A&beta;) 25&ndash;35 segment neurotoxin was employed to induce a PC12 cellular model of Alzheimer's disease. After modified Wendan decoction was fed to rats, the serum containing medicine was prepared and changes in cell morphology observed. Cell mortality and survival rate was examined by trypan blue stain assay and MTT method and caspase-3 expression was detected by western blot, while cell apoptosis was examined by flow cytometry. Cell morphology of prepared serum group was better than that of controls, and cell survival rate in prepared serum group was higher than that in control (<I>P</I> &lt; 0.01 or <I>P</I> &lt; 0.05). Cell mortality, caspase-3 expression and apoptosis rate in prepared serum group were lower than that in control (<I>P</I> &lt; 0.01 or <I>P</I> &lt; 0.05). We conclude that Modified Wendan Decoction can attenuate the neurotoxicity of A&beta; 25&ndash;35 and rescue neurons via suppressing apoptotic process.</p>
]]></description>
<dc:creator><![CDATA[Liu, P., Zhao, L., Zhang, S.-L., Xiang, J.-Z.]]></dc:creator>
<dc:date>2007-10-10</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem103</dc:identifier>
<dc:title><![CDATA[Modified Wendan Decoction can Attenuate Neurotoxic Action Associated with Alzheimer's Disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem128v1?rss=1">
<title><![CDATA[Brief Homeopathic Pathogenetic Experimentation: A Unique Educational Tool in Brazil]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem128v1?rss=1</link>
<description><![CDATA[
<p>In homeopathy, many difficulties are encountered in understanding theoretical presuppositions because they represent different paradigms from those of hegemonic science. In our medical school, we developed a brief homeopathic pathogenetic experimentation course to be added as curricular content and a didactic method in homeopathic disciplines to add practical experience to the theoretical approach of homeopathic presuppositions. In accordance with the premises laid out by Hahnemann, the father of homeopathy, brief pathogenetic experimentation was offered on a voluntary basis for students who were free of chronic diseases and who had not regularly used medication in the last 3 months. The clinical test, either crossed or sequential (randomized and blind), was used as a study model. Single weekly doses of a homeopathic medicine of 30 cH or placebo were taken by participants during 4 weeks after which crossover of the experimented substances took place for another 4 weeks. Polycrest medicines were used so that symptoms developed by the participants could be compared to those described in Homeopathic Materia Medica. Thirty-three of the 50 students who studied homeopathy as an elective discipline over the last 4 years at the School of Medicine of the University of S&atilde;o Paulo (FMUSP) participated. Participants described symptoms according to specific methodology including many comments with peculiar characteristics and notable idiosyncrasies. All these students endorsed the course because it contributed to their understanding of how dynamized substances produced symptoms in healthy participants as well as the cure of symptoms according to the casual similitude principle. Brief homeopathic pathogenetic experimentation proved to be an effective method to observe the idiosyncratic manifestations of human individuality based on qualitative methodology, thus building a basis of understanding of homeopathy.</p>
]]></description>
<dc:creator><![CDATA[Teixeira, M. Z.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem128</dc:identifier>
<dc:title><![CDATA[Brief Homeopathic Pathogenetic Experimentation: A Unique Educational Tool in Brazil]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-04</prism:publicationDate>
<prism:section>Review For Education Section</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem119v1?rss=1">
<title><![CDATA[Ficus racemosa Stem Bark Extract: A Potent Antioxidant and a Probable Natural Radioprotector]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem119v1?rss=1</link>
<description><![CDATA[
<p>Ethanol extract (FRE) and water extract (FRW) of <I>Ficus racemosa</I> (family: Moraceae) were subjected to free radical scavenging both by steady state and time resolved methods such as nanosecond pulse radiolysis and stopped-flow spectrophotometric analyses. FRE exhibited significantly higher steady state antioxidant activity than FRW. FRE exhibited concentration dependent DPPH, ABTS<sup>&bull;&ndash;</sup>, hydroxyl radical and superoxide radical scavenging and inhibition of lipid peroxidation with IC<SUB>50</SUB> comparable with tested standard compounds. <I>In vitro</I> radioprotective potential of FRE was studied using micronucleus assay in irradiated Chinese hamster lung fibroblast cells (V79). Pretreatment with different doses of FRE 1h prior to 2 Gy -radiation resulted in a significant (<I>P</I> &lt; 0.001) decrease in the percentage of micronucleated binuclear V79 cells. Maximum radioprotection was observed at 20 &micro;g/ml of FRE. The radioprotection was found to be significant (<I>P</I> &lt; 0.01) when cells were treated with optimum dose of FRE (20 &micro;g/ml) 1 h prior to 0.5, 1, 2, 3 and 4 Gy -irradiation compared to the respective radiation controls. The cytokinesis-block proliferative index indicated that FRE does not alter radiation induced cell cycle delay. Based on all these results we conclude that the ethanol extract of <I>F. racemosa</I> acts as a potent antioxidant and a probable radioprotector.</p>
]]></description>
<dc:creator><![CDATA[Veerapur, V. P., Prabhakar, K. R., Parihar, V. k., Kandadi, M. R., Ramakrishana, S., Mishra, B., Rao, B. S. S., Srinivasan, K. K., Priyadarsini, K. I., Unnikrishnan, M. K.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem119</dc:identifier>
<dc:title><![CDATA[Ficus racemosa Stem Bark Extract: A Potent Antioxidant and a Probable Natural Radioprotector]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem101v1?rss=1">
<title><![CDATA[Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem101v1?rss=1</link>
<description><![CDATA[
<p>Although abdominal bloating is one of the most bothersome symptoms experienced by patients with functional dyspepsia (FD), therapeutic drugs to relieve abdominal bloating have not been established. We investigated the Kampo (Chinese herbal) medicine, Hangekobokuto (Banxia-houpo-tang, HKT) for patients with FD from the standpoint of bowel gas retention. The bowel gas volume calculated from a plain abdominal radiogram (gas volume score, GVS) in FD patients was significantly higher than that in healthy subjects. Two week administration of HKT in the FD patients showed a significant decrease of GVS. Furthermore, gastrointestinal symptoms, especially symptoms of abdominal pain, indigestion and constipation, all of which are closely related to abdominal bloating, improved significantly in FD patients after the administration of HKT. These results suggest that HKT improves abdominal bloating accompanied by the reduction of bowel gas in FD patients.</p>
]]></description>
<dc:creator><![CDATA[Oikawa, T., Ito, G., Hoshino, T., Koyama, H., Hanawa, T.]]></dc:creator>
<dc:date>2007-10-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem101</dc:identifier>
<dc:title><![CDATA[Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-10-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem076v1?rss=1">
<title><![CDATA[Touch and Massage for Medically Fragile Infants]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem076v1?rss=1</link>
<description><![CDATA[
<p>Research investigating the efficacy of infant massage has largely focused on premature and low birth weight infants. The majority of investigations have neglected highly acute patients in academic neonatal intensive care units (NICUs). The current study was developed with two aims: (Phase 1) to develop, implement and demonstrate the feasibility and safety of a parent-trained compassionate touch/massage program for infants with complex medical conditions and (Phase 2) to conduct a longitudinal randomized control trial (RCT) of hand containment/massage versus standard of care in a level III academic Center for Newborn and Infant Critical Care (CNICC). Certified infant massage instructors (CIMIs) taught parents to massage their hospitalized infants. Massage therapy and instruction were performed for seven consecutive days and health outcomes were collected for up to 1 month following treatment. Caregivers, nurses and certified infant massage therapists indicated moderate to high levels of satisfaction and feasibility with the implementation of hand containment/massage in a level III academic center CNICC. In addition, infant behavioral and physiological measures were within safe limits during the massage sessions. All caregivers participating in the massage group reported high levels of satisfaction 7 days into the intervention and at the 1-month follow-up with regards to their relationship with their infant, the massage program's impact on that relationship and the massage program. Due to unequal and small sample sizes, between group analyses (control versus massage) were not conducted. Descriptive infant characteristics of health outcomes are described. Preliminary data from this study indicates feasibility and safety of infant massage and satisfaction among the caregivers, CIMIs and the nurses in the CNICC. An important contribution from this study was the demonstration of the infants&rsquo; safety based on physiological stability and no change in agitation/pain scores of the infants receiving massage. Massage in a tertiary urban academic NICU continues to be an area of needed study. Future studies examining infant health outcomes, such as weight gain, decreased length of hospitalization and caregiver&ndash;infant bonding, would provide greater insight into the impact of massage for medically fragile infants.</p>
]]></description>
<dc:creator><![CDATA[Livingston, K., Beider, S., Kant, A. J., Gallardo, C. C., Joseph, M. H., Gold, J. I.]]></dc:creator>
<dc:date>2007-08-06</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem076</dc:identifier>
<dc:title><![CDATA[Touch and Massage for Medically Fragile Infants]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-08-06</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

</rdf:RDF>